STOCK TITAN

Virtuix Q2 net loss widens to $6.37M as sales rise

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

Virtuix Holdings Inc. (VTIX) reported second-quarter net sales of $1,190,097, versus $984,812 a year earlier, while net loss widened to $6,367,511 from $1,866,696. For the six months ended September 30, sales were $1,957,397 versus $2,016,948, and net loss was $13,538,077 versus $4,173,851. Quarterly operating expenses were $5,132,655, compared with $1,942,317.

Six-month operating cash use was $6,857,206; cash and equivalents were $4,963,127 at September 30, down from $9,471,288 at March 31. The balance sheet reported $16,289,115 of liabilities, $10,112,263 of assets and a $6,176,852 stockholders’ deficit. Management said limited working capital and liquid assets relative to anticipated needs raise substantial doubt about the company’s ability to continue as a going concern within one year; its plans do not alleviate that doubt. No additional funding was available under the $50,000,000 equity purchase agreement because required conditions were unmet, absent Streeterville’s waiver.

Virtuix revised comparative statements to correct financing-accounting errors that management concluded were not material to previously issued statements; the revisions had no cash-flow effect.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

3 major · 3 points

How the balance works

Positive

  • Moderate pointQuarterly sales were $1,190,097, versus $984,812 a year earlier.

Negative

  • Major pointSix-month net loss reached $13,538,077, versus $4,173,851 a year earlier.
  • Major pointSix-month operating cash use was $6,857,206, versus $3,636,689.
  • Major pointManagement cited substantial doubt about going-concern ability within one year.

Filing Explained

The completed exchange issued 465,840 Class A shares, reducing existing holders’ percentage ownership as the debt obligation fell.

Virtuix’s second-quarter report records a completed Exchange Note redemption settled in shares, converting part of a Streeterville debt obligation into Class A equity rather than cash repayment. The filing says the six-month settlement issued 465,840 Class A shares for a $852,976 redemption amount and reduced principal by $786,862. Issuing additional shares increases the total share count and reduces existing holders’ percentage ownership, absent offsetting changes.

Separately, both Streeterville prepaid purchase arrangements allow the holder to elect cash settlement of an applicable purchase amount if the purchase price remains below the $2-per-share floor for six consecutive months. As of September 30, 2026, the valuation model included 46 consecutive trading days below the floor and said the six-month condition had not been met.

Quarterly net sales $1,190,097 Three months ended September 30, 2026; $984,812 in the comparable 2025 period
Quarterly net loss $6,367,511 Three months ended September 30, 2026; $1,866,696 in the comparable 2025 period
Six-month net loss $13,538,077 Six months ended September 30, 2026; $4,173,851 in the comparable 2025 period
Cash used in operating activities $6,857,206 Six months ended September 30, 2026; $3,636,689 in the comparable 2025 period
Cash and cash equivalents $4,963,127 As of September 30, 2026; $9,471,288 as of March 31, 2026
Total liabilities $16,289,115 As of September 30, 2026
Accumulated deficit $92,884,512 As of September 30, 2026
Purchase price under prepaid purchase arrangements Approximately $0.87 per share Calculated as of September 30, 2026
going concern financial
"ability to continue as a going concern within one year"
Going concern is the accounting assumption that a company will keep operating and meeting its obligations for the foreseeable future. The phrase matters most when a company or its auditors disclose substantial doubt about it, a formal warning that the business may not have enough resources to continue without raising money, restructuring, or selling assets. That language in a filing or press release signals elevated financial risk.
embedded derivative liabilities financial
"recognition of embedded derivative liabilities"
An embedded derivative liability is a feature hidden inside a larger contract (like a loan, bond, or lease) that makes the contract behave partly like a separate side bet whose value moves up and down with an external factor (such as an interest rate, currency, commodity price, or stock). For investors this matters because that built‑in “option” can add sudden gains or losses to a company’s reported liabilities and earnings, creating extra volatility and valuation uncertainty that may not be obvious from the headline debt totals.
fair value option financial
"elected the fair value option for its second pre-paid purchase arrangement"
An accounting election that lets a company measure eligible financial assets and liabilities at their current market price, recording gains and losses in the income statement as those prices move. For investors it matters because choosing the fair value option makes reported profits and asset values respond immediately to market swings—like revaluing a house to today’s sale price—so it can increase earnings volatility while giving a more up‑to‑date view of value.
Floor Price financial
"below the Floor Price for six consecutive months"
The floor price is the minimum price at which a security, asset, or offering will be sold or accepted, acting like a seller’s “bottom line” or a reserve in an auction. For investors it matters because it sets a visible downside limit and can influence trading, valuation, and expectations of risk—like knowing there’s a safety net that a sale won’t go below a set level.
beneficial ownership limitation financial
"a beneficial ownership limitation that generally prohibits the investor"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
Monte Carlo simulation technical
"valued using a Monte Carlo simulation"
A Monte Carlo simulation is a computerized way to model many possible future outcomes by running thousands of randomized “what-if” scenarios, like rolling dice repeatedly to see the range of results. For investors it shows the probability of different returns, losses, or timing outcomes under varied assumptions, helping quantify uncertainty and compare risk — similar to using many practice runs to judge how often a plan succeeds or fails.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were VTIX’s quarterly sales and net loss?

For the three months ended September 30, 2026, net sales were $1,190,097 and net loss was $6,367,511. In the comparable 2025 quarter, net sales were $984,812 and net loss was $1,866,696.

What are the terms of VTIX’s second prepaid purchase agreement?

PPP #2 had an original principal amount of $3,471,923 and bears interest at 6% per annum. The investor may apply outstanding amounts toward purchases of Class A common stock; the agreement generally prohibits the investor from beneficially owning more than 9.99% of that stock. Virtuix may prepay subject to premiums based on repayment timing.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
1 http://fasb.org/srt/2026#ChiefExecutiveOfficerMember Q2 0001606242 --03-31 2027 false 0001606242 2026-07-01 2026-09-30 0001606242 2026-04-01 2026-09-30 0001606242 us-gaap:SubsequentEventMember vtix:ProposedAcquisitionMember 2026-11-12 2026-11-12 0001606242 us-gaap:SubsequentEventMember vtix:ProposedAcquisitionMember 2026-11-12 0001606242 us-gaap:CommonClassAMember srt:ScenarioForecastMember 2026-11-30 0001606242 us-gaap:CommonClassAMember us-gaap:SubsequentEventMember 2026-10-30 0001606242 vtix:OmniOneSubscriptionAndWarrantMember 2025-04-01 2025-09-30 0001606242 vtix:OmniOneSubscriptionAndWarrantMember 2026-04-01 2026-09-30 0001606242 2025-04-01 2025-09-30 0001606242 vtix:OmniCareProgramMember 2025-04-01 2025-09-30 0001606242 vtix:OmniCareProgramMember 2026-04-01 2026-09-30 0001606242 vtix:OmniverseCreditsMember 2025-04-01 2025-09-30 0001606242 vtix:OmniverseCreditsMember 2026-04-01 2026-09-30 0001606242 vtix:OmniProUnitsAndAccessoriesMember 2025-04-01 2025-09-30 0001606242 vtix:OmniProUnitsAndAccessoriesMember 2026-04-01 2026-09-30 0001606242 vtix:OmniArenaMember 2025-04-01 2025-09-30 0001606242 vtix:OmniArenaMember 2026-04-01 2026-09-30 0001606242 vtix:OmniOneMember 2025-04-01 2025-09-30 0001606242 vtix:OmniOneMember 2026-04-01 2026-09-30 0001606242 vtix:OmniOneSubscriptionAndWarrantMember 2025-07-01 2025-09-30 0001606242 vtix:OmniOneSubscriptionAndWarrantMember 2026-07-01 2026-09-30 0001606242 2025-07-01 2025-09-30 0001606242 vtix:OmniCareProgramMember 2025-07-01 2025-09-30 0001606242 vtix:OmniCareProgramMember 2026-07-01 2026-09-30 0001606242 vtix:OmniverseCreditsMember 2025-07-01 2025-09-30 0001606242 vtix:OmniverseCreditsMember 2026-07-01 2026-09-30 0001606242 vtix:OmniProUnitsAndAccessoriesMember 2025-07-01 2025-09-30 0001606242 vtix:OmniProUnitsAndAccessoriesMember 2026-07-01 2026-09-30 0001606242 vtix:OmniArenaMember 2025-07-01 2025-09-30 0001606242 vtix:OmniArenaMember 2026-07-01 2026-09-30 0001606242 vtix:OmniOneMember 2025-07-01 2025-09-30 0001606242 vtix:OmniOneMember 2026-07-01 2026-09-30 0001606242 2025-04-01 2025-06-30 0001606242 us-gaap:CorporateJointVentureMember 2025-04-01 2025-06-30 0001606242 us-gaap:CorporateJointVentureMember 2026-04-01 2026-09-30 0001606242 vtix:VirtuixManufacturingLimitedMember 2026-09-30 0001606242 us-gaap:RestrictedStockUnitsRSUMember srt:ChiefFinancialOfficerMember 2026-09-01 2026-09-30 0001606242 us-gaap:RestrictedStockUnitsRSUMember srt:DirectorMember 2026-09-01 2026-09-30 0001606242 2026-09-24 2026-09-24 0001606242 us-gaap:RestrictedStockUnitsRSUMember 2026-07-01 2026-09-30 0001606242 us-gaap:RestrictedStockUnitsRSUMember 2026-04-01 2026-09-30 0001606242 2026-09-30 0001606242 us-gaap:EmployeeStockOptionMember 2026-04-01 2026-09-30 0001606242 us-gaap:EmployeeStockOptionMember 2026-09-30 0001606242 us-gaap:EmployeeStockOptionMember 2025-04-01 2025-09-30 0001606242 us-gaap:EmployeeStockOptionMember 2025-07-01 2025-09-30 0001606242 us-gaap:EmployeeStockOptionMember 2026-07-01 2026-09-30 0001606242 us-gaap:WarrantMember 2026-09-30 0001606242 us-gaap:WarrantMember 2026-04-01 2026-09-30 0001606242 us-gaap:WarrantMember 2026-03-31 0001606242 us-gaap:CommonClassAMember us-gaap:WarrantMember 2026-09-30 0001606242 us-gaap:WarrantMember vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember 2026-04-01 2026-09-30 0001606242 vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember 2026-04-01 2026-09-30 0001606242 vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember 2026-07-21 0001606242 vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember 2026-11-01 2026-11-30 0001606242 vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember 2026-10-01 2026-10-31 0001606242 vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember 2026-09-01 2026-09-30 0001606242 vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember 2026-08-01 2026-08-31 0001606242 vtix:AfterTheModificationMember vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember us-gaap:MeasurementInputExercisePriceMember 2026-07-21 0001606242 vtix:BeforeTheModificationMember vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember us-gaap:MeasurementInputExercisePriceMember 2026-07-21 0001606242 vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember vtix:DividendYieldMember 2026-07-21 0001606242 srt:MaximumMember vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-07-21 0001606242 srt:MinimumMember vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-07-21 0001606242 vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember us-gaap:MeasurementInputPriceVolatilityMember 2026-07-21 0001606242 vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember us-gaap:MeasurementInputSharePriceMember 2026-07-21 0001606242 srt:MinimumMember vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember 2026-07-21 0001606242 srt:MaximumMember vtix:JulyTwentyOneTwoThousandTwentySixWarrantAmendmentMember 2026-07-21 0001606242 vtix:JuneTwentySixTwentyTwentySixWarrantAmendmentMember 2026-06-29 2026-06-29 0001606242 vtix:AfterTheModificationMember vtix:JuneTwentySixTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputExercisePriceMember 2026-06-29 0001606242 vtix:BeforeTheModificationMember vtix:JuneTwentySixTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputExercisePriceMember 2026-06-29 0001606242 vtix:JuneTwentySixTwentyTwentySixWarrantAmendmentMember vtix:DividendYieldMember 2026-06-29 0001606242 vtix:JuneTwentySixTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-06-29 0001606242 vtix:JuneTwentySixTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputPriceVolatilityMember 2026-06-29 0001606242 vtix:JuneTwentySixTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputExpectedTermMember 2026-06-29 0001606242 vtix:JuneTwentySixTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputSharePriceMember 2026-06-29 0001606242 srt:MinimumMember vtix:JuneTwentySixTwentyTwentySixWarrantAmendmentMember 2026-06-29 0001606242 srt:MaximumMember vtix:JuneTwentySixTwentyTwentySixWarrantAmendmentMember 2026-06-29 0001606242 vtix:JuneOneTwentyTwentySixWarrantAmendmentMember 2026-06-01 2026-06-01 0001606242 vtix:AfterTheModificationMember vtix:JuneOneTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputExercisePriceMember 2026-06-01 0001606242 vtix:BeforeTheModificationMember vtix:JuneOneTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputExercisePriceMember 2026-06-01 0001606242 vtix:JuneOneTwentyTwentySixWarrantAmendmentMember vtix:DividendYieldMember 2026-06-01 0001606242 vtix:JuneOneTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2026-06-01 0001606242 vtix:JuneOneTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputPriceVolatilityMember 2026-06-01 0001606242 vtix:JuneOneTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputExpectedTermMember 2026-06-01 0001606242 vtix:JuneOneTwentyTwentySixWarrantAmendmentMember us-gaap:MeasurementInputSharePriceMember 2026-06-01 0001606242 srt:MinimumMember vtix:JuneOneTwentyTwentySixWarrantAmendmentMember 2026-06-01 0001606242 srt:MaximumMember vtix:JuneOneTwentyTwentySixWarrantAmendmentMember 2026-06-01 0001606242 us-gaap:MeasurementInputPriceVolatilityMember 2026-04-01 2026-09-30 0001606242 us-gaap:WarrantMember us-gaap:MeasurementInputPriceVolatilityMember 2026-04-01 2026-09-30 0001606242 us-gaap:CommonClassAMember us-gaap:WarrantMember 2026-07-01 2026-09-30 0001606242 vtix:ExchangeAgreementMember 2026-04-01 2026-09-30 0001606242 us-gaap:CommonClassAMember vtix:StreetervilleCapitalLLCMember 2026-09-30 0001606242 us-gaap:CommonClassAMember vtix:StreetervilleCapitalLLCMember 2026-04-01 2026-09-30 0001606242 vtix:EuroswissCapitalPartnersInc.Member 2026-08-24 0001606242 2026-08-19 2026-08-19 0001606242 vtix:FMWMediaWorksLLCMember 2026-07-27 0001606242 2026-07-27 2026-07-27 0001606242 us-gaap:CommonClassAMember vtix:FMWMediaWorksLLCMember 2026-01-29 0001606242 vtix:FMWMediaWorksLLCMember 2026-04-01 2026-09-30 0001606242 us-gaap:CommonClassAMember vtix:FMWMediaWorksLLCMember 2026-04-01 2026-09-30 0001606242 us-gaap:CommonClassBMember 2026-04-01 2026-09-30 0001606242 us-gaap:CommonClassAMember 2026-04-01 2026-09-30 0001606242 us-gaap:PreferredStockMember 2026-09-30 0001606242 us-gaap:CommonClassBMember 2026-09-30 0001606242 us-gaap:CommonClassAMember 2026-09-30 0001606242 2026-03-31 0001606242 vtix:LeaseAgreementMember 2026-03-31 0001606242 vtix:LeaseAgreementMember 2026-09-30 0001606242 vtix:ApartmentSpaceLeasesMember 2025-07-01 2025-07-31 0001606242 us-gaap:OfficeEquipmentMember 2025-07-01 2025-07-31 0001606242 vtix:LeaseAgreementMember 2026-04-01 2026-09-30 0001606242 us-gaap:OfficeEquipmentMember vtix:LeaseAgreementMember 2026-04-01 2026-09-30 0001606242 vtix:EIDLMember 2026-09-30 0001606242 us-gaap:NotesPayableOtherPayablesMember 2026-09-30 0001606242 vtix:EconomicInjuryDisasterLoanMember 2026-03-31 0001606242 vtix:EconomicInjuryDisasterLoanMember 2026-09-30 0001606242 vtix:EconomicInjuryDisasterLoanMember 2020-08-29 0001606242 vtix:EconomicInjuryDisasterLoanMember 2020-08-29 2020-08-29 0001606242 vtix:WesternTechnologyInvestmentNoteMember 2025-04-01 2025-09-30 0001606242 vtix:WesternTechnologyInvestmentNoteMember 2025-07-01 2025-09-30 0001606242 us-gaap:SeriesBPreferredStockMember 2025-06-30 0001606242 2025-06-30 0001606242 vtix:Notes2024Member 2025-04-01 2025-06-30 0001606242 us-gaap:SeriesBPreferredStockMember 2025-06-30 2025-06-30 0001606242 srt:MinimumMember 2026-07-21 0001606242 srt:MaximumMember 2026-07-21 0001606242 srt:MaximumMember 2026-06-29 0001606242 srt:MinimumMember 2026-06-29 0001606242 srt:MinimumMember 2026-06-01 0001606242 srt:MaximumMember 2026-06-01 0001606242 vtix:ExchangeNoteMember 2026-09-30 0001606242 vtix:ExchangeNoteMember 2026-04-01 2026-09-30 0001606242 vtix:Notes2024Member 2026-04-01 2026-09-30 0001606242 vtix:Notes2024Member 2026-07-01 2026-09-30 0001606242 vtix:Notes2024Member vtix:ExchangeNoteMember 2026-04-01 2026-09-30 0001606242 vtix:Notes2024Member vtix:ExchangeNoteMember 2026-07-01 2026-09-30 0001606242 vtix:ExchangeNoteMember 2026-03-31 0001606242 vtix:StreetervilleCapitalLLCMember vtix:Notes2024Member vtix:ExchangeNoteMember 2026-03-31 0001606242 vtix:StreetervilleCapitalLLCMember vtix:Notes2024Member vtix:ExchangeNoteMember 2026-09-30 0001606242 us-gaap:CommonClassAMember vtix:StreetervilleCapitalLLCMember vtix:ExchangeNoteMember 2026-09-30 0001606242 vtix:StreetervilleCapitalLLCMember vtix:ExchangeNoteMember 2026-09-30 0001606242 vtix:StreetervilleCapitalLLCMember 2026-03-30 2026-03-30 0001606242 vtix:StreetervilleCapitalLLCMember 2026-03-31 2026-03-31 0001606242 us-gaap:ConvertibleNotesPayableMember srt:ScenarioForecastMember 2027-07-01 0001606242 vtix:StreetervilleCapitalLLCMember vtix:ExchangeOf2024NotesMember 2024-12-10 0001606242 vtix:SecondPrepaidPurchaseAgreementMember 2026-04-01 2026-09-30 0001606242 vtix:SecondPrepaidPurchaseAgreementMember 2026-07-01 2026-09-30 0001606242 vtix:SecondPrepaidPurchaseAgreementMember 2026-04-01 2026-06-30 0001606242 vtix:SecondPrepaidPurchaseAgreementMember 2026-06-30 0001606242 vtix:SecondPrepaidPurchaseAgreementMember 2026-09-30 0001606242 2026-05-22 2026-05-22 0001606242 2026-05-22 0001606242 vtix:PPPAgreementMember 2025-04-01 2025-06-30 0001606242 vtix:PPPAgreementMember 2026-04-01 2026-09-30 0001606242 vtix:PPPAgreementMember 2026-07-01 2026-09-30 0001606242 vtix:PPPAgreementMember 2026-03-31 0001606242 vtix:PPPAgreementMember 2026-09-30 0001606242 us-gaap:ConvertibleNotesPayableMember vtix:PPPAgreementMember 2026-09-30 0001606242 vtix:PPPAgreementMember vtix:EmbeddedDerivativeLiabilitiesMember 2026-09-30 0001606242 vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2026-04-01 2026-09-30 0001606242 vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2026-07-01 2026-09-30 0001606242 vtix:StreetervilleCapitalLLCMember 2026-07-21 2026-07-21 0001606242 us-gaap:ConvertibleNotesPayableMember 2026-07-21 0001606242 vtix:StreetervilleCapitalLLCMember 2026-04-01 2026-09-30 0001606242 us-gaap:ConvertibleNotesPayableMember 2026-06-29 0001606242 us-gaap:ConvertibleNotesPayableMember 2026-06-01 0001606242 us-gaap:CommonClassAMember us-gaap:WarrantMember vtix:PPPAgreementMember 2026-04-01 2026-09-30 0001606242 us-gaap:CommonClassAMember us-gaap:WarrantMember 2026-04-01 2026-09-30 0001606242 vtix:PPPAgreementMember 2025-08-25 0001606242 vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2026-01-27 0001606242 vtix:StreetervilleCapitalLLCMember 2025-08-25 0001606242 vtix:ExtinguishmentOfConvertiblePromissoryNotesMember 2026-09-30 0001606242 vtix:ExtinguishmentOfConvertiblePromissoryNotesMember 2026-04-01 2026-09-30 0001606242 2025-12-19 0001606242 2026-10-30 0001606242 2025-08-25 0001606242 2025-10-30 0001606242 vtix:EmbeddedDerivativeLiabilitiesMember 2026-05-22 0001606242 vtix:EmbeddedDerivativeLiabilitiesMember 2026-05-22 2026-05-22 0001606242 vtix:EmbeddedDerivativeLiabilitiesMember 2026-03-31 0001606242 vtix:EmbeddedDerivativeLiabilitiesMember 2026-04-01 2026-09-30 0001606242 vtix:SecuredConvertiblePromissoryNoteMember 2026-05-22 2026-05-22 0001606242 us-gaap:ConvertibleNotesPayableMember 2026-05-22 0001606242 us-gaap:ConvertibleNotesPayableMember 2026-03-31 0001606242 vtix:ThirdNoteMember 2026-05-22 0001606242 us-gaap:ConvertibleNotesPayableMember 2026-04-01 2026-09-30 0001606242 us-gaap:CommonClassAMember us-gaap:WarrantMember vtix:ThirdNoteMember 2026-04-01 2026-09-30 0001606242 us-gaap:WarrantMember vtix:ThirdNoteMember 2026-04-01 2026-09-30 0001606242 vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2025-12-19 2025-12-19 0001606242 vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2025-12-19 0001606242 vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2026-03-31 0001606242 us-gaap:WarrantMember 2026-04-01 2026-09-30 0001606242 us-gaap:WarrantMember vtix:SecondNoteMember 2026-07-21 2026-07-21 0001606242 us-gaap:WarrantMember 2026-07-21 0001606242 us-gaap:CommonClassAMember us-gaap:WarrantMember vtix:SecondNoteMember 2026-04-01 2026-09-30 0001606242 us-gaap:WarrantMember vtix:SecondNoteMember 2026-04-01 2026-09-30 0001606242 us-gaap:CommonClassAMember us-gaap:ConvertibleNotesPayableMember us-gaap:WarrantMember 2026-04-01 2026-09-30 0001606242 vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2026-09-30 0001606242 vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2025-10-30 0001606242 us-gaap:CommonClassAMember vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2025-10-30 0001606242 us-gaap:CommonClassAMember vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2025-10-30 2025-10-30 0001606242 vtix:StreetervilleCapitalLLCMember 2026-03-31 0001606242 vtix:StreetervilleCapitalLLCMember vtix:SecuredConvertiblePromissoryNoteMember 2026-03-31 0001606242 us-gaap:ConvertibleNotesPayableMember us-gaap:WarrantMember 2026-02-09 2026-02-09 0001606242 us-gaap:ConvertibleNotesPayableMember us-gaap:WarrantMember 2026-04-01 2026-09-30 0001606242 vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2025-08-25 0001606242 us-gaap:CommonClassAMember vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2025-08-25 0001606242 us-gaap:CommonClassAMember vtix:StreetervilleCapitalLLCMember us-gaap:ConvertibleNotesPayableMember 2025-08-25 2025-08-25 0001606242 vtix:WebsiteMember 2026-03-31 0001606242 vtix:WebsiteMember 2026-09-30 0001606242 us-gaap:TrademarksMember 2026-03-31 0001606242 us-gaap:TrademarksMember 2026-09-30 0001606242 vtix:SoftwareAndGameDesignMember 2026-03-31 0001606242 vtix:SoftwareAndGameDesignMember 2026-09-30 0001606242 us-gaap:LeaseholdImprovementsMember 2026-03-31 0001606242 us-gaap:LeaseholdImprovementsMember 2026-09-30 0001606242 us-gaap:MachineryAndEquipmentMember 2026-03-31 0001606242 us-gaap:MachineryAndEquipmentMember 2026-09-30 0001606242 us-gaap:FurnitureAndFixturesMember 2026-03-31 0001606242 us-gaap:FurnitureAndFixturesMember 2026-09-30 0001606242 us-gaap:ComputerEquipmentMember 2026-03-31 0001606242 us-gaap:ComputerEquipmentMember 2026-09-30 0001606242 2025-09-30 0001606242 2025-03-31 0001606242 2026-06-30 0001606242 us-gaap:CustomerConcentrationRiskMember vtix:TwoCustomerMember us-gaap:AccountsReceivableMember 2026-04-01 2026-09-30 0001606242 us-gaap:CustomerConcentrationRiskMember vtix:OneCustomerMember us-gaap:AccountsReceivableMember 2026-04-01 2026-09-30 0001606242 vtix:TwoCustomerMember 2026-09-30 0001606242 vtix:OneCustomerMember 2026-09-30 0001606242 us-gaap:WarrantMember 2025-04-01 2025-09-30 0001606242 us-gaap:WarrantMember 2026-04-01 2026-09-30 0001606242 us-gaap:RestrictedStockUnitsRSUMember 2026-04-01 2026-09-30 0001606242 us-gaap:EmployeeStockOptionMember 2025-04-01 2025-09-30 0001606242 us-gaap:EmployeeStockOptionMember 2026-04-01 2026-09-30 0001606242 2025-04-01 2026-03-31 0001606242 vtix:CustomerMember 2025-07-01 2025-09-30 0001606242 vtix:CustomerMember 2026-07-01 2026-09-30 0001606242 vtix:CustomerMember 2025-04-01 2025-09-30 0001606242 vtix:CustomerMember 2026-04-01 2026-09-30 0001606242 vtix:OmniCareSubscriptionsMember 2026-03-31 0001606242 vtix:OmniCareSubscriptionsMember 2026-09-30 0001606242 vtix:OmniverseCreditsMember 2026-03-31 0001606242 vtix:OmniverseCreditsMember 2026-09-30 0001606242 vtix:OmniOnlineMember 2026-03-31 0001606242 vtix:OmniOnlineMember 2026-09-30 0001606242 vtix:OmniArenaMember 2026-03-31 0001606242 vtix:OmniArenaMember 2026-09-30 0001606242 vtix:OmniProMember 2026-03-31 0001606242 vtix:OmniProMember 2026-09-30 0001606242 vtix:OmniOneExtendedWarrantyMember 2026-03-31 0001606242 vtix:OmniOneExtendedWarrantyMember 2026-09-30 0001606242 vtix:OmniOneMember 2026-03-31 0001606242 vtix:OmniOneMember 2026-09-30 0001606242 us-gaap:CustomerListsMember 2026-09-30 0001606242 us-gaap:TrademarksMember 2026-04-01 2026-09-30 0001606242 us-gaap:SoftwareDevelopmentMember srt:MaximumMember 2026-09-30 0001606242 us-gaap:SoftwareDevelopmentMember srt:MinimumMember 2026-09-30 0001606242 vtix:December192025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:Change-of-controlProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:October302025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:Change-of-controlProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:August252025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:Change-of-controlProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:December192025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:DefaultProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:October302025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:DefaultProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:August252025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:DefaultProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:December192025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:TotalPrepaymentProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:October302025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:TotalPrepaymentProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:August252025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:TotalPrepaymentProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:December192025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:AutomaticExchangeProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:October302025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:AutomaticExchangeProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:August252025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:AutomaticExchangeProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:December192025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:InvestorConversionProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:October302025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:InvestorConversionProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:August252025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember vtix:InvestorConversionProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:December192025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember us-gaap:MeasurementInputDiscountRateMember 2026-04-01 2026-09-30 0001606242 vtix:October302025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember us-gaap:MeasurementInputDiscountRateMember 2026-04-01 2026-09-30 0001606242 vtix:August252025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember us-gaap:MeasurementInputDiscountRateMember 2026-04-01 2026-09-30 0001606242 vtix:December192025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember us-gaap:MeasurementInputPriceVolatilityMember 2026-04-01 2026-09-30 0001606242 vtix:October302025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember us-gaap:MeasurementInputPriceVolatilityMember 2026-04-01 2026-09-30 0001606242 vtix:August252025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember us-gaap:MeasurementInputPriceVolatilityMember 2026-04-01 2026-09-30 0001606242 vtix:December192025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember 2026-04-01 2026-09-30 0001606242 vtix:October302025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember 2026-04-01 2026-09-30 0001606242 vtix:August252025SecuredConvertiblePromissoryNoteEmbeddedDerivativeLiabilityMember 2026-04-01 2026-09-30 0001606242 vtix:BothArrangementsContainAContingentCash-electionMember us-gaap:CommonStockMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPre-paidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityTwoMember us-gaap:CommonStockMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityOneMember us-gaap:CommonStockMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityMember us-gaap:CommonStockMember 2026-04-01 2026-09-30 0001606242 vtix:SecondPrepaidPurchaseArrangementPPP2FairValueOptionMember vtix:Change-of-controlProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityOneMember vtix:Change-of-controlProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityMember vtix:Change-of-controlProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:SecondPrepaidPurchaseArrangementPPP2FairValueOptionMember vtix:DefaultProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityOneMember vtix:DefaultProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityMember vtix:DefaultProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:SecondPrepaidPurchaseArrangementPPP2FairValueOptionMember vtix:TotalPrepaymentProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityOneMember vtix:TotalPrepaymentProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityMember vtix:TotalPrepaymentProbabilityMember 2026-04-01 2026-09-30 0001606242 vtix:SecondPrepaidPurchaseArrangementPPP2FairValueOptionMember vtix:ModeledSettlementTimingMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityOneMember vtix:ModeledSettlementTimingMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityMember vtix:ModeledSettlementTimingMember 2026-04-01 2026-09-30 0001606242 vtix:SecondPrepaidPurchaseArrangementPPP2FairValueOptionMember us-gaap:MeasurementInputDiscountRateMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityOneMember us-gaap:MeasurementInputDiscountRateMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityMember us-gaap:MeasurementInputDiscountRateMember 2026-04-01 2026-09-30 0001606242 vtix:SecondPrepaidPurchaseArrangementPPP2FairValueOptionMember us-gaap:MeasurementInputPriceVolatilityMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityOneMember us-gaap:MeasurementInputPriceVolatilityMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityMember us-gaap:MeasurementInputPriceVolatilityMember 2026-04-01 2026-09-30 0001606242 vtix:SecondPrepaidPurchaseArrangementPPP2FairValueOptionMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityOneMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityMember 2026-04-01 2026-09-30 0001606242 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2025-09-30 0001606242 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2025-07-01 2025-09-30 0001606242 srt:RestatementAdjustmentMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPre-paidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityTwoMember 2026-04-01 2026-09-30 0001606242 vtix:FirstPre-paidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityTwoMember 2026-09-30 0001606242 us-gaap:FairValueInputsLevel3Member 2026-09-30 0001606242 vtix:SecondPre-paidPurchaseAtFairValueMember us-gaap:FairValueInputsLevel3Member 2026-09-30 0001606242 vtix:FirstPre-paidPurchaseEmbeddedDerivativeMember us-gaap:FairValueInputsLevel3Member 2026-09-30 0001606242 us-gaap:FairValueInputsLevel3Member 2026-07-01 2026-09-30 0001606242 vtix:SecondPre-paidPurchaseAtFairValueMember us-gaap:FairValueInputsLevel3Member 2026-07-01 2026-09-30 0001606242 vtix:FirstPre-paidPurchaseEmbeddedDerivativeMember us-gaap:FairValueInputsLevel3Member 2026-07-01 2026-09-30 0001606242 us-gaap:FairValueInputsLevel3Member 2026-06-30 0001606242 vtix:SecondPre-paidPurchaseAtFairValueMember us-gaap:FairValueInputsLevel3Member 2026-06-30 0001606242 vtix:FirstPre-paidPurchaseEmbeddedDerivativeMember us-gaap:FairValueInputsLevel3Member 2026-06-30 0001606242 us-gaap:FairValueInputsLevel3Member 2026-04-01 2026-06-30 0001606242 vtix:SecondPre-paidPurchaseAtFairValueMember us-gaap:FairValueInputsLevel3Member 2026-04-01 2026-06-30 0001606242 vtix:ConvertibleNoteEmbeddedDerivativesMember us-gaap:FairValueInputsLevel3Member 2026-04-01 2026-06-30 0001606242 vtix:FirstPre-paidPurchaseEmbeddedDerivativeMember us-gaap:FairValueInputsLevel3Member 2026-04-01 2026-06-30 0001606242 us-gaap:FairValueInputsLevel3Member 2026-03-31 0001606242 vtix:ConvertibleNoteEmbeddedDerivativesMember us-gaap:FairValueInputsLevel3Member 2026-03-31 0001606242 vtix:FirstPre-paidPurchaseEmbeddedDerivativeMember us-gaap:FairValueInputsLevel3Member 2026-03-31 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityMember 2026-03-31 0001606242 vtix:FirstPrepaidPurchaseArrangementPPP1EmbeddedDerivativeLiabilityMember 2026-09-30 0001606242 us-gaap:FairValueInputsLevel3Member 2026-04-01 2026-09-30 0001606242 us-gaap:FairValueInputsLevel3Member 2025-04-01 2026-03-31 0001606242 us-gaap:LeaseholdImprovementsMember srt:MaximumMember 2026-09-30 0001606242 us-gaap:LeaseholdImprovementsMember srt:MinimumMember 2026-09-30 0001606242 us-gaap:OfficeEquipmentMember srt:MaximumMember 2026-09-30 0001606242 us-gaap:OfficeEquipmentMember srt:MinimumMember 2026-09-30 0001606242 us-gaap:MachineryAndEquipmentMember srt:MaximumMember 2026-09-30 0001606242 us-gaap:MachineryAndEquipmentMember srt:MinimumMember 2026-09-30 0001606242 vtix:OmniCareServicesMember 2026-09-30 0001606242 vtix:OmniCareServicesMember 2026-04-01 2026-09-30 0001606242 vtix:GoingConcernMember 2025-04-01 2025-09-30 0001606242 vtix:GoingConcernMember 2026-04-01 2026-09-30 0001606242 srt:MinimumMember 2025-04-01 2026-03-31 0001606242 srt:RestatementAdjustmentMember 2025-12-31 0001606242 srt:RestatementAdjustmentMember 2025-09-30 0001606242 srt:RestatementAdjustmentMember 2025-04-01 2026-03-31 0001606242 srt:ScenarioPreviouslyReportedMember 2025-04-01 2026-03-31 0001606242 2025-04-01 2025-12-31 0001606242 srt:RestatementAdjustmentMember 2025-04-01 2025-12-31 0001606242 srt:ScenarioPreviouslyReportedMember 2025-04-01 2025-12-31 0001606242 2025-10-01 2025-12-31 0001606242 srt:RestatementAdjustmentMember 2025-10-01 2025-12-31 0001606242 srt:ScenarioPreviouslyReportedMember 2025-10-01 2025-12-31 0001606242 srt:RestatementAdjustmentMember 2025-04-01 2025-09-30 0001606242 srt:ScenarioPreviouslyReportedMember 2025-04-01 2025-09-30 0001606242 srt:RestatementAdjustmentMember 2025-07-01 2025-09-30 0001606242 srt:ScenarioPreviouslyReportedMember 2025-07-01 2025-09-30 0001606242 srt:ScenarioPreviouslyReportedMember 2026-03-31 0001606242 srt:RestatementAdjustmentMember 2026-03-31 0001606242 vtix:VirtuixHoldingsIncMember 2026-04-01 2026-09-30 0001606242 vtix:VirtuixArabiaLLCMember 2026-09-30 0001606242 us-gaap:RetainedEarningsMember 2026-09-30 0001606242 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001606242 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-09-30 0001606242 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-09-30 0001606242 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001606242 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001606242 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-07-01 2026-09-30 0001606242 us-gaap:RetainedEarningsMember 2026-06-30 0001606242 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001606242 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-06-30 0001606242 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-06-30 0001606242 2026-04-01 2026-06-30 0001606242 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001606242 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001606242 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-04-01 2026-06-30 0001606242 us-gaap:RetainedEarningsMember 2026-03-31 0001606242 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001606242 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-03-31 0001606242 us-gaap:CommonStockMember us-gaap:CommonClassAMember 2026-03-31 0001606242 us-gaap:RetainedEarningsMember 2025-09-30 0001606242 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001606242 us-gaap:CommonStockMember 2025-09-30 0001606242 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001606242 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001606242 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001606242 us-gaap:PreferredStockMember 2025-07-01 2025-09-30 0001606242 us-gaap:RetainedEarningsMember 2025-06-30 0001606242 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001606242 us-gaap:CommonStockMember 2025-06-30 0001606242 us-gaap:PreferredStockMember 2025-06-30 0001606242 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001606242 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001606242 us-gaap:PreferredStockMember 2025-04-01 2025-06-30 0001606242 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001606242 us-gaap:RetainedEarningsMember 2025-03-31 0001606242 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001606242 us-gaap:CommonStockMember 2025-03-31 0001606242 us-gaap:PreferredStockMember 2025-03-31 0001606242 us-gaap:CommonClassBMember 2026-03-31 0001606242 us-gaap:CommonClassAMember 2026-03-31 0001606242 us-gaap:CommonClassBMember 2026-11-13 0001606242 us-gaap:CommonClassAMember 2026-11-13 0001606242 us-gaap:RestrictedStockUnitsRSUMember 2025-04-01 2025-09-30 0001606242 vtix:SecondPre-paidPurchaseAtFairValueMember us-gaap:FairValueInputsLevel3Member 2026-03-31 0001606242 vtix:ConvertibleNoteEmbeddedDerivativesMember us-gaap:FairValueInputsLevel3Member 2026-07-01 2026-09-30 0001606242 vtix:ConvertibleNoteEmbeddedDerivativesMember us-gaap:FairValueInputsLevel3Member 2026-09-30 0001606242 vtix:ConvertibleNoteEmbeddedDerivativesMember us-gaap:FairValueInputsLevel3Member 2026-06-30 0001606242 us-gaap:EmbeddedDerivativeFinancialInstrumentsMember 2025-06-30 0001606242 us-gaap:PreferredStockMember 2025-09-30 0001606242 us-gaap:PreferredStockMember 2026-03-31 0001606242 us-gaap:PreferredStockMember 2026-06-30 0001606242 us-gaap:PreferredStockMember 2026-04-01 2026-06-30 0001606242 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-04-01 2026-06-30 0001606242 us-gaap:PreferredStockMember 2026-07-01 2026-09-30 0001606242 us-gaap:CommonStockMember us-gaap:CommonClassBMember 2026-07-01 2026-09-30 iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares vtix:Segment

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________ to __________

 

Commission File Number: 001-43067

 

Virtuix Holdings Inc. 

(Exact name of registrant as specified in its charter)

 

Delaware   46-4371395
(State or other jurisdiction of
incorporation or organization)
  (I.R.S. Employer
Identification No.)

 

11500 Metric Blvd, Suite 430
Austin, TX 
  78758
(Address of principal executive offices)   (Zip Code)

 

(512) 947-9029

(Registrant’s telephone number, including area code)

 

N/A 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A common stock, par value $0.001 per share   VTIX   The Nasdaq Global Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ Yes   ☐ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ Yes   ☐ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
  Emerging growth company ☒

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). ☐ Yes   ☒ No

 

As of November 13, 2026, the registrant had a total of 30,609,775 shares of Class A common stock, $0.001 par value, issued and outstanding and 4,000,000 shares of Class B common stock, $0.001 par value, issued and outstanding.

 

 

 

 

 

 

VIRTUIX HOLDINGS INC.

 

INDEX TO FORM 10-Q

 

    Page #
PART I - FINANCIAL INFORMATION   1
Item 1. Interim Financial Statements   1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations   39
Item 3. Quantitative and Qualitative Disclosures About Market Risk   54
Item 4. Controls and Procedures   54
     
PART II - OTHER INFORMATION   55
Item 1. Legal Proceedings   55
Item 1A. Risk Factors   55
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds   57
Item 3. Defaults Upon Senior Securities   57
Item 4. Mine Safety Disclosure   57
Item 5. Other Information   57
Item 6. Exhibits   57
     
SIGNATURES   58

 

i

 

 

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING STATEMENTS

 

Certain statements in this Quarterly Report on Form 10-Q are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbor created thereby. All statements contained in this Quarterly Report on Form 10-Q other than statements of historical facts, including statements regarding our future results of operations and financial position, our business strategy and plans and our objectives for future operations, are forward-looking statements. The words “believe,” “may,” “will,” “estimate,” “continue,” “anticipate,” “intend,” “expect” and similar expressions are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in “Risk Factors” of our Prospectus dated January 26, 2026 and in any subsequent filing we make with the SEC, as well as in any documents incorporated by reference that describe risks and factors that could cause results to differ materially from those projected in these forward-looking statements.

 

Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this Quarterly Report on Form 10-Q may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

 

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, achievements or events and circumstances reflected in the forward-looking statements will occur. We are under no duty to update any of these forward-looking statements after the filing of this Quarterly Report on Form 10-Q to conform these statements to actual results or revised expectations.

 

ii

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Interim Financial Statements.

 

VIRTUIX HOLDINGS INC.

 

INDEX TO FINANCIAL STATEMENTS

 

    Page
Financial Statements:    
Condensed Consolidated Balance Sheets as of September 30, 2026 and March 31, 2026 (Unaudited)   2
Condensed Consolidated Statements of Operations for the three and six months ended September 30, 2026 and 2025 (Unaudited)   4
Condensed Consolidated Statements of Changes in Stockholders’ (Deficit) Equity for the three and six months ended September 30, 2026 and 2025 (Unaudited)   5
Condensed Consolidated Statements of Cash Flows for the six months ended September 30, 2026 and 2025 (Unaudited)   6
Notes to the Condensed Consolidated Financial Statements (Unaudited)   8

 

1

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

SEPTEMBER 30, 2026 AND MARCH 31, 2026 (UNAUDITED)

 

ASSETS

 

          March 31,  
    September 30,
2026
    2026
(As Revised)
 
CURRENT ASSETS            
Cash and cash equivalents   $ 4,963,127     $ 9,471,288  
Receivables, net of allowance for credit losses     419,899       379,289  
Inventory     1,672,155       1,188,623  
Prepaids and other current assets     740,469       897,109  
TOTAL CURRENT ASSETS     7,795,650       11,936,309  
                 
NONCURRENT ASSETS                
Property and equipment     1,418,811       1,413,294  
Less: accumulated depreciation     (1,113,622 )     (1,034,984 )
Net property and equipment     305,189       378,310  
                 
Intangibles     2,809,629       2,797,741  
Less: accumulated amortization     (1,481,744 )     (1,258,387 )
Net intangibles     1,327,885       1,539,354  
                 
Investment in joint venture     -       40,619  
                 
Other assets     61,169       87,264  
                 
Right-of-use asset - operating     622,370       779,514  
TOTAL NONCURRENT ASSETS     2,316,613       2,825,061  
                 
TOTAL ASSETS   $ 10,112,263     $ 14,761,370  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

2

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

SEPTEMBER 30, 2026 AND MARCH 31, 2026 (UNAUDITED)

 

LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY

 

          March 31,  
    September 30,
2026
    2026
(As Revised)
 
CURRENT LIABILITIES            
Accounts payable   $ 663,625     $ 721,792  
Accrued expenses     836,572       559,517  
Deferred revenue     652,612       666,327  
Gift card liability     439,144       446,252  
Current portion of notes payable, net of discount and unamortized deferred loan costs     8,207,781       5,328,477  
Notes payable measured under the fair value option – PPP #2     3,610,158       -  
Derivative liabilities at fair value     1,233,095       2,709,817  
Current portion of EIDL loan     581       570  
Lease liability - operating     219,202       286,702  
TOTAL CURRENT LIABILITIES     15,862,770       10,719,454  
                 
LONG-TERM LIABILITIES                
Notes payable, net of discount and unamortized deferred loan costs     -       2,428,835  
EIDL loan     23,177       23,517  
Lease liability, net of current portion - operating     403,168       492,812  
TOTAL LONG-TERM LIABILITIES     426,345       2,945,164  
                 
TOTAL LIABILITIES     16,289,115       13,664,618  
                 
STOCKHOLDERS’ (DEFICIT) EQUITY                
                 
Class A common stock, $.001 par value, 300,000,000 shares authorized at September 30, 2026 and March 31, 2026 and 30,601,775 and 28,562,693 shares issued and outstanding at September 30, 2026 and March 31, 2026, respectively     30,602       28,562  
Class B common stock, $.001 par value, 50,000,000 shares authorized at September 30, 2026 and March 31, 2026 and 4,000,000 shares issued and outstanding at September 30, 2026 and March 31, 2026, respectively     4,000       4,000  
Additional paid-in capital     86,673,058       80,410,625  
Accumulated deficit     (92,884,512 )     (79,346,435 )
TOTAL STOCKHOLDERS’ (DEFICIT) EQUITY     (6,176,852 )     1,096,752  
                 
TOTAL LIABILITIES AND STOCKHOLDERS’ (DEFICIT) EQUITY   $ 10,112,263     $ 14,761,370  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

    Three Months Ended
September 30,
    Six Months Ended
September 30,
 
    2026     2025
(As Revised)
    2026     2025
(As Revised)
 
                         
NET SALES   $ 1,190,097     $ 984,812     $ 1,957,397     $ 2,016,948  
                                 
COST OF GOODS SOLD     894,898       577,263       1,435,040       1,433,322  
                                 
GROSS PROFIT     295,199       407,549       522,357       583,626  
                                 
OPERATING EXPENSES                                
Selling expenses     924,457       345,791       1,663,435       1,395,449  
General and administrative expenses     4,005,950       1,407,057       7,086,728       2,366,449  
Research and development expenses     202,248       189,469       511,623       398,185  
                                 
TOTAL OPERATING EXPENSES     5,132,655       1,942,317       9,261,786       4,160,083  
                                 
LOSS FROM OPERATIONS     (4,837,456 )     (1,534,768 )     (8,739,429 )     (3,576,457 )
                                 
OTHER INCOME (EXPENSE)                                
Loss on disposal of assets     -       -       (5,132 )     -  
Interest income     87       114       250       299  
Other income     73       170       9,075       170  
Gain (loss) on extinguishment of debt     37,492       -       (393,732 )     (122,864 )
Loss on derecognition of equity method investment     -       -       (40,619 )     -  
Change in fair value of derivative liabilities     667,554       -       1,016,682       -  
Change in fair value of debt     263,620       -       286,842       -  
Interest expense     (2,047,820 )     (331,459 )     (4,587,412 )     (450,758 )
Financing expense     (426,249 )     -       (1,010,399 )     -  
                                 
TOTAL OTHER EXPENSE, NET     (1,505,243 )     (331,175 )     (4,724,445 )     (573,153 )
                                 
PROVISION FOR INCOME TAX     24,812       753       74,203       24,171  
                                 
SHARE OF LOSS IN JOINT VENTURE     -       -       -       (70 )
                                 
NET LOSS   $ (6,367,511 )   $ (1,866,696 )   $ (13,538,077 )   $ (4,173,851 )
                                 
Weighted average common shares outstanding:                                
Basic and Diluted     33,913,262       21,588,700       33,353,686       14,964,525  
Net loss per share:                                
Basic and Diluted   $ (0.19 )   $ (0.09 )   $ (0.41 )   $ (0.28 )

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ (DEFICIT) EQUITY

FOR THE THREE AND SIX MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

    Preferred Stock     Common Stock     Additional
Paid-In
    Accumulated        
    Shares     Amount     Shares     Amount     Capital     Deficit     Total  
Balance at March 31, 2025     21,688,242     $ 21,688       8,259,644     $ 8,259     $ 61,668,608     $ (62,492,590 )   $ (794,035 )
Stock-based compensation     -       -       -       -       10,897       -       10,897  
Exercise of common stock warrants     -       -       8,038       7       72       -       79  
Issuance of preferred stock     303,435       304       -       -       1,493,569       -       1,493,873  
Issuance of preferred stock for debt extinguishment     74,430       74       -       -       462,901       -       462,975  
Issuance of warrants for debt extinguishment     -       -       -       -       122,864       -       122,864  
Net loss     -       -       -       -       -       (2,307,155 )     (2,307,155 )
Balance at June 30, 2025     22,066,107     $ 22,066       8,267,682     $ 8,266     $ 63,758,911     $ (64,799,745 )   $ (1,010,502 )
Stock-based compensation     -       -       -       -       10,953       -       10,953  
Exercise of common stock warrants     -       -       237,892       239       2,141       -       2,380  
Issuance of preferred stock     87,059       87       -       -       451,392       -       451,479  
Preferred stock reclass     (22,153,166 )     (22,153 )     22,153,166       22,153       -       -       -  
Investor incentive     -       -       -       -       (214,906 )     -       (214,906 )
Fair value of common stock warrants     -       -       -       -       1,229,045       -       1,229,045  
Issuance of common stock for services     -       -       115,169       115       194,520       -       194,635  
Fractional share rounding     -       -       (1,888 )     (1 )     -       -       (1 )
Net loss     -       -       -       -       -       (1,866,696 )     (1,866,696 )
Balance at September 30, 2025, as revised     -     $ -       30,772,021     $ 30,772     $ 65,432,056     $ (66,666,441 )   $ (1,203,613 )

 

    Preferred Stock     Class A
Common Stock
    Class B
Common Stock
    Additional
Paid-In
    Accumulated        
    Shares     Amount     Shares     Amount     Shares     Amount     Capital     Deficit     Total  
                                                       
Balance at March 31, 2026, as revised               -     $            -       28,562,693     $ 28,562       4,000,000     $ 4,000     $ 80,410,625     $ (79,346,435 )   $ 1,096,752  
Stock-based compensation     -       -       -       -       -       -       619,857       -       619,857  
Exercise of common stock warrants, net of issuance costs     -       -       230,000       230       -       -       1,283,170       -       1,283,400  
Issuance of common stock for debt extinguishment     -       -       93,333       93       -       -       402,739       -       402,832  
Issuance of common stock for services     -       -       12,000       12       -       -       103,068       -       103,080  
Warrant modification (financing expense)     -       -       -       -       -       -       584,150       -       584,150  
Net loss     -       -       -       -       -       -       -       (7,170,566 )     (7,170,566 )
Balance at June 30, 2026     -     $ -       28,898,026     $ 28,897       4,000,000     $ 4,000     $ 83,403,609     $ (86,517,001 )   $ (3,080,495 )
Stock-based compensation     -       -       -       -       -       -       826,328       -       826,328  
Exercise of common stock warrants, net of issuance costs     -       -       455,500       456       -       -       1,098,107       -       1,098,563  
Exercise of employee stock options     -       -       125,000       125       -       -       207,375       -       207,500  
Issuance of common stock for debt extinguishment     -       -       372,507       373       -       -       497,861       -       498,234  
Issuance of common stock upon RSU settlement     -       -       678,742       679       -       -       (679 )     -       -  
Issuance of common stock for services     -       -       72,000       72       -       -       214,208       -       214,280  
Warrant modification (financing expense)     -       -       -       -       -       -       426,249       -       426,249  
Net loss     -       -       -       -       -       -       -       (6,367,511 )     (6,367,511 )
Balance at September 30, 2026     -     $ -       30,601,775     $ 30,602       4,000,000     $ 4,000     $ 86,673,058     $ (92,884,512 )   $ (6,176,852 )

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

    Six Months Ended
September 30,
 
    2026     2025
(As Revised)
 
CASH FLOWS FROM OPERATING ACTIVITIES            
Net loss   $ (13,538,077 )   $ (4,173,851 )
Adjustments to reconcile net loss to net cash used in operating activities:                
Depreciation and amortization expense     302,529       315,782  
Amortization of debt discounts and debt issuance costs     4,140,678       235,213  
Credit loss expense     14,259       49,755  
Amortization on operating lease right of use asset     157,144       142,120  
Stock-based compensation     1,446,185       21,850  
Change in fair value of derivative liabilities     (1,016,682 )     -  
Change in fair value of debt     (286,842 )     -  
Loss on disposal of assets     5,132       -  
Inventory write-offs     8,109       -  
Loss on derecognition of the equity method investment     40,619       -  
Share of loss in joint venture     -       70  
Warrant modification expense     1,010,399       -  
Loss on extinguishment of debt     393,732       122,864  
Stock issuance in exchange for services     317,360       194,635  
(Increase) decrease in assets:                
Prepaid expenses and other current assets     222,014       (305,033 )
Accounts receivable     (54,869 )     (157,990 )
Other assets     26,095       (98,890 )
Inventory     (491,449 )     323,466  
Increase (decrease) in liabilities:                
Accounts payable     (58,167 )     330,065  
Accrued expenses     682,592       80,181  
Gift card liability     (7,108 )     456,552  
Operating lease liabilities     (157,144 )     (142,120 )
Deferred revenue     (13,715 )     (1,031,358 )
CASH USED IN OPERATING ACTIVITIES     (6,857,206 )     (3,636,689 )
                 
CASH FLOWS FROM INVESTING ACTIVITIES                
Cash paid for purchases of property and equipment     (11,375 )     (20,388 )
Cash paid for purchases of intangibles     (11,888 )     (2,192 )
CASH USED IN INVESTING ACTIVITIES     (23,263 )     (22,580 )
                 
CASH FLOWS FROM FINANCING ACTIVITIES                
Issuance of preferred stock     -       1,945,352  
Payments on short-term notes payable     (9,326 )     (443,186 )
Payments on long-term notes payable     (329 )     (271 )
Proceeds from short-term notes payable     -       217,678  
Proceeds from convertible notes     -       2,000,000  
Due (to) from related parties     -       23,896  
Warrants exercised     2,561,250       2,459  
Equity issuance costs     (179,287 )     -  
CASH PROVIDED BY FINANCING ACTIVITIES     2,372,308       3,745,928  
                 
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS     (4,508,161 )     86,659  
                 
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD     9,471,288       477,908  
                 
CASH AND CASH EQUIVALENTS AT END OF PERIOD   $ 4,963,127     $ 564,567  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

6

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE SIX MONTHS ENDED SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

    Six Months Ended
September 30,
 
    2026     2025
(As Revised)
 
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:            
Interest paid   $ 403     $ 8,755  
Enterprise income taxes paid to People’s Republic of China   $ 1,757     $ 1,429  
Delaware franchise tax paid   $ 72,446     $ 44,845  
                 
SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:                
Debt extinguished for issuance of preferred stock   $ -     $ 462,975  
Exchange of Streeterville Notes for PPP #2   $ 3,471,923     $ -  
Derecognition of derivative liabilities upon exchange of Streeterville Notes for PPP #2   $ 460,040     $ -  
Conversion of preferred stock to common stock   $ -     $ 22,153  
Investor incentive   $ -     $ 214,906  
Fair value of warrants issued with convertible note   $ -     $ 1,229,045  
Reduction of debt and accrued interest through issuance of common stock   $ 852,976     $ -  
Exercise of stock options through noncash settlement of accrued compensation   $ 207,500     $ -  
Issuance of common stock for debt extinguishment   $ 901,066     $ -  

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

7

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 1. Nature of Operations

 

Virtuix Holdings Inc. (“Virtuix Holdings” or “VHI” or the “Company”) was formed on December 20, 2013 as a Delaware Corporation. The Company has a wholly-owned subsidiary, Virtuix Inc., a Delaware corporation formed on April 15, 2013. Virtuix Inc. develops AI-driven, full-body simulation systems, originally the Omni Pro, the first omni-directional treadmill that lets players walk and run freely in 360 degrees inside video games and other virtual worlds. In February 2019, the Company began to offer Omni Arena, a four-player esports attraction that includes four Omni Pro motion platforms. In January 2023, the Company started shipping beta units of Omni One, the first Omni entertainment system designed for the home. Virtuix Manufacturing, Limited (“VML”), a wholly-owned subsidiary, is a Hong Kong corporation that was formed to conduct manufacturing operations and transact USD-denominated business with suppliers. Virtuix Manufacturing (Zhuhai) Co., Ltd. (“VML_ZH”) was formed on July 28, 2016, and is a wholly-owned subsidiary of VML. VML_ZH is a Wholly Foreign-Owned Enterprise (“WFOE”) registered in Zhuhai, Guangdong, China that was formed to sell products to Chinese customers and transact CNY-denominated business with Chinese suppliers. Virtuix Manufacturing Taiwan Ltd. (“VMT”) was formed on January 17, 2023, and is a wholly-owned foreign subsidiary of VHI. VMT is a Taiwan corporation that was formed to employ staff in Taiwan and conduct manufacturing operations. Virtuix Arabia LLC (“VA”) was formed in June 2024, and is a 57.5% owned foreign subsidiary of VHI. VA has not yet begun operations.

 

In July 2016, the Company formed a joint venture with Hero Entertainment, a Chinese game publisher and esports operator, to develop active virtual reality content and product bundles for the Chinese and U.S. markets. The joint venture, named Heroix VR (Shanghai) Co., Ltd. (the “Joint Venture” or “Heroix”), was a Sino-foreign equity joint venture company established under the laws of the People’s Republic of China and registered in Shanghai. The Company held a 49% ownership interest and accounted for its investment using the equity method because it did not control the Joint Venture. Heroix commenced operations in October 2016.

 

To service the Chinese market more efficiently, Hero Entertainment and the Company transferred the China sales channel to the Company’s China subsidiary and initiated the process to dissolve Heroix during fiscal year 2026. During the quarter ended June 30, 2026, the Company received a Certification of Dissolution and Tax Clearance from the People’s Republic of China confirming that Heroix had been legally dissolved, liquidated, and deregistered, with its legal personality terminated effective September 29, 2025. Based on this information, the Company concluded that it no longer possessed an ownership interest in Heroix and, accordingly, derecognized its remaining equity method investment. The Company recognized a non-cash loss on derecognition of $40,619 during the six months ended September 30, 2026.

 

Note 2. Summary of Significant Accounting Policies

 

Revision of Previously Issued Financial Statements

 

In connection with the preparation and review of the Company’s financial statements for the quarter ended June 30, 2026, management, with the assistance of its accounting advisers, performed additional analysis of the accounting treatment of certain complex financing arrangements with Streeterville Capital, LLC. As a result of that analysis, management identified errors related principally to the accounting for embedded features in certain debt and other financing instruments under ASC 815, including the initial recognition and subsequent measurement of embedded derivative liabilities and the related accounting for the host instruments, the resulting allocation among the related debt host instruments, embedded derivatives and detachable warrants, and the related debt-discount amortization.

 

Management evaluated the errors, individually and in the aggregate, in accordance with ASC 250, Accounting Changes and Error Corrections, and SEC Staff Accounting Bulletins No. 99, Materiality, and No. 108, Considering the Effects of Prior Year Misstatements when Quantifying Misstatements in Current Year Financial Statements. Management concluded that the errors were not material to the Company’s previously issued consolidated financial statements as of and for the year ended March 31, 2026, or to the previously reported interim financial information for the three and six months ended September 30, 2025. Accordingly, amendment of the previously issued financial statements was not required.

 

8

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

However, the Company has revised the previously reported March 31, 2026 financial information and the comparative financial information for the three and six months ended September 30, 2025 presented in this Quarterly Report to correct the errors. The revisions resulted principally in the recognition of embedded derivative liabilities, corresponding adjustments to the carrying amounts of the related debt instruments and debt discounts, adjustments to amounts recorded in additional paid-in capital related to detachable warrants, and the recognition of related interest expense and changes in fair value in the periods in which such amounts should have been recognized. 

 

The revisions to the comparative financial information for the three and six months ended September 30, 2025 primarily relate to the accounting for the secured convertible promissory note issued to Streeterville Capital, LLC on August 25, 2025.

 

The following table presents the effect of the revisions on the Company’s previously reported consolidated balance sheet as of March 31, 2026:

 

    As
Previously
Reported
    Adjustment     As Revised  
Balance Sheet Caption:                  
Current portion of notes payable, net of discount and unamortized deferred loan costs   $ 6,086,943     $ (758,466 )   $ 5,328,477  
Derivative liabilities     -     $ 2,709,817     $ 2,709,817  
Total current liabilities   $ 8,768,103     $ 1,951,351     $ 10,719,454  
Total liabilities   $ 11,713,267     $ 1,951,351     $ 13,664,618  
Additional paid-in capital   $ 82,307,384     $ (1,896,759 )   $ 80,410,625  
Accumulated deficit   $ (79,291,843 )   $ (54,592 )   $ (79,346,435 )
Total stockholders’ equity   $ 3,048,103     $ (1,951,351 )   $ 1,096,752  
Total liabilities and stockholders’ equity   $ 14,761,370     $ -     $ 14,761,370  

 

The following table summarizes the effect of the revisions on the Company’s previously reported net loss for the periods indicated:

 

Period   As Previously
Reported
    Adjustment     As Revised  
Three months ended September 30, 2025   $ (1,854,203 )   $ (12,493 )   $ (1,866,696 )
Six months ended September 30, 2025     (4,161,358 )     (12,493 )     (4,173,851 )
Three months ended December 31, 2025     (2,730,944 )     (81,699 )     (2,812,643 )
Nine months ended December 31, 2025     (6,892,302 )     (94,192 )     (6,986,494 )
Year ended March 31, 2026   $ (16,799,253 )   $ (54,592 )   $ (16,853,845 )

 

The revisions resulted in net increases in total liabilities of $211,101 as of September 30, 2025 and $398,061 as of December 31, 2025, while the corresponding increases in accumulated deficit were $12,493 and $94,192, respectively, with the remaining effects reflected principally in additional paid-in capital. For the year ended March 31, 2026, basic and diluted net loss per share remained approximately $0.73. The revisions did not affect the Company’s loss from operations and were noncash, with no effect on net cash flows from operating, investing or financing activities or on the Company’s ending cash balance.

 

Basis of Presentation and Principles of Consolidation

 

The accompanying financial statements have been prepared in conformity with generally accepted accounting principles in the United States of America (“GAAP”). Any reference in these notes to applicable guidance is meant to refer to GAAP as found in the Accounting Standards Codification (“ASC”) and the Accounting Standards Updates (“ASU”) of the Financial Accounting Standards Board (“FASB”). Significant intercompany accounts and transactions have been eliminated upon consolidation.

 

9

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

The Company’s fiscal year ends March 31.

 

The accompanying interim condensed consolidated financial statements are unaudited and have been prepared on substantially the same basis as the Company’s annual consolidated financial statements for the fiscal year ended March 31, 2026. In the opinion of the Company’s management, these interim condensed consolidated financial statements reflect all adjustments considered necessary for a fair statement of the Company’s financial position, results of operations and cash flows for the periods presented. The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from these estimates.

 

The March 31, 2026 year-end condensed consolidated balance sheet data in the accompanying interim condensed consolidated financial statements was derived from audited consolidated financial statements and has been revised to correct immaterial errors as described under “Revision of Previously Issued Financial Statements” above. These condensed consolidated financial statements and notes do not include all disclosures required by GAAP and should be read in conjunction with the Company’s audited consolidated financial statements as of and for the year ended March 31, 2026 and the notes thereto included in the Company’s Annual Report on Form 10-K, dated June 25, 2026, on file with the Securities and Exchange Commission.

 

The results of operations and cash flows for the interim periods included in these condensed consolidated financial statements are not necessarily indicative of the results to be expected for any future period or the entire fiscal year.

 

Management’s Estimates

 

Preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions affecting reported amounts of assets, liabilities, revenues, and expenses, as well as disclosures of contingent items. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Actual results could differ from these estimates.

 

Significant estimates and judgments include the valuation of embedded derivative liabilities and financial instruments measured at fair value, including assumptions regarding expected volatility, discount rates, expected term, probabilities and timing of contractual settlement features, and other market and instrument-specific inputs.

 

Going Concern

 

The consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business.

 

The Company has not generated profits since inception and has incurred net losses of $13,538,077 and $4,173,851 for the six months ended September 30, 2026 and 2025, respectively, and has an accumulated deficit of $92,884,512 as of September 30, 2026. These factors, together with limited working capital and liquid assets relative to anticipated operating cash flow needs, raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these financial statements are issued.

 

10

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

Management has taken several actions to support the Company’s ability to continue as a going concern, including:

 

  1. Continuing to ramp up marketing and sales of Omni One, with anticipated increased revenues from this product line;

 

  2.  Expanding sales to higher-margin enterprise and defense markets, pursuing larger contracts and awards for defense training and simulation; and

 

  3. Raising capital from existing and new shareholders as necessary to fund operations.

 

Although management is undertaking these actions to improve the Company’s financial condition and liquidity, these plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued. No assurance can be given that the Company will be successful in executing these plans. The condensed consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts with Customers, which provides a five-step model to determine when and how revenue is recognized. Under this model, revenue is recognized in an amount that reflects the consideration the Company expects to be entitled to in exchange for transferring control of goods or services to a customer.

 

The Company applies the following five steps to all revenue-generating arrangements:

 

  1. Identify the contract with a customer;

 

  2. Identify the performance obligations in the contract;

 

  3. Determine the transaction price;

 

  4. Allocate the transaction price to the performance obligations; and

 

  5. Recognize revenue when or as each performance obligation is satisfied.

 

The Company’s contracts typically include product sales, installation services, support programs, or the sale of digital playtime credits. Each arrangement is evaluated to determine whether it contains one or more performance obligations. The majority of contracts involve a single performance obligation to transfer or install physical goods. Revenue is recognized when control transfers to the customer, which occurs as follows:

 

  ● Omni Pro units and related accessories – revenue recognized upon shipment, when control and title pass.

 

  ● Omni One units – revenue recognized upon shipment, consistent with the Company’s shipping terms.

 

  ● Omni Arena systems – revenue recognized upon installation at the customer’s location, when control transfers.

 

  ● Omniverse credits – revenue recognized over the estimated consumption period, typically two months from purchase based on usage patterns.

 

11

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

  ● Omni Online – revenue recognized ratably over the subscription period.

 

  ● Omni Care service program – Treated as a separate performance obligation included with each Omni Arena contract. The transaction price is allocated to this performance obligation on a relative standalone selling price basis, using observable standalone pricing of $2,000 per quarter. Accordingly, $8,000 associated with Omni Care is included in the initial contract transaction price and is recognized ratably over the first 12 months of the contract term, as the services are provided evenly over time. Following the initial 12-month period, customers are billed $2,000 per quarter, or less frequently based on usage, for continued Omni Care services. Fees billed after the first year are recognized ratably over the applicable quarterly service period.

 

  ● Omni One extended warranty – Sold separately from the Omni One unit and represents a service–type warranty. The transaction price is allocated on a relative standalone selling price basis, with observable standalone pricing of $295 per warranty. Revenue is recognized ratably over the 3-year warranty term.

 

  ● Omni One games – Revenue from sales of digital games is recognized when the game is made available for download to the customer.

 

Contracts with multiple performance obligations are allocated based on relative standalone selling prices. Payment terms are generally fixed and do not include significant financing components.

 

Amounts received in advance of satisfying performance obligations are recorded as contract liabilities and recognized when the related obligation is fulfilled.

 

Other than the Omni One extended warranty described above, the Company’s contracts generally do not include variable consideration, material rights, or warranties that give rise to separate performance obligations. The Company has also concluded it acts as the principal in the sale of digital content, as it controls the content before transfer to the customer.

 

Cash and Cash Equivalents

 

The Company considers deposits that can be redeemed on demand and investments with original maturities of three months or less, when purchased, to be cash equivalents. As of September 30, 2026 and March 31, 2026, the Company’s cash and cash equivalents were deposited primarily in five financial institutions. Deposits with these institutions may exceed federally insured limits. Management believes that the financial institutions holding the Company’s cash are financially sound and, accordingly, the Company does not believe it is exposed to any significant credit risk related to its cash and cash equivalents.

 

Accounts Receivable

 

Trade receivables are generally due within thirty days. Receivables are presented net of an allowance for credit losses, which is estimated using the current expected credit loss model and is based on historical loss experience, current economic conditions, and customers’ ability to pay. The Company evaluates the collectability of trade receivables and records estimated credit losses based on expected losses over the contractual life of the receivables.

 

Inventory

 

Inventory is stated at lower of cost or net realizable value. Cost is computed using weighted average cost at one subsidiary and specific identification cost at the remaining subsidiaries.

 

Net realizable value is estimated based on projected demand; slow-moving products are impaired accordingly.

 

12

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

Property and Equipment

 

Property and equipment are recorded at cost, less accumulated depreciation. Depreciation is straight-line over the following estimated useful lives:

 

Computer Equipment 5 years
Furniture and Fixtures 7 years
Machinery and Equipment 3 – 7 years
Office Equipment 5 – 7 years
Leasehold Improvements Shorter of the remaining lease term or estimated useful life of 3 – 5 years

 

Fair Value Measurements

 

The Company determines the fair value of its financial instruments in accordance with ASC 820, Fair Value Measurement. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level fair value hierarchy that prioritizes the inputs used in measuring fair value:

 

Level 1 — Quoted prices in active markets for identical assets or liabilities.

 

Level 2 — Observable inputs other than Level 1 quoted prices, including quoted prices for similar assets or liabilities in active markets or other inputs that are observable or can be corroborated by observable market data.

 

Level 3 — Unobservable inputs that reflect management’s assumptions regarding the assumptions market participants would use in pricing the asset or liability.

 

The classification of a fair value measurement within the hierarchy is based on the lowest-level input that is significant to the measurement. The Company’s derivative liabilities and certain debt instruments measured at fair value are classified within Level 3 because their valuations incorporate significant unobservable inputs. Changes in fair value are recognized in earnings, except as otherwise required by GAAP.

 

The carrying amounts of the Company’s other financial instruments, including cash, accounts receivable, accounts payable and accrued expenses, approximate fair value primarily due to their short-term nature.

 

Financial liabilities measured at fair value on a recurring basis were as follows: 

 

Financial liability   Hierarchy   September 30,
2026
    March 31, 2026
(As Revised)
 
First pre-paid purchase arrangement embedded derivative liability   Level 3   $ 1,233,095     $ 2,249,777  
Secured convertible promissory notes - embedded derivative liabilities   Level 3     -       460,040  
Second pre-paid purchase arrangement – at fair value, including accrued interest   Level 3     3,687,380       -  
Total Level 3 liabilities       $ 4,920,475     $ 2,709,817  

 

13

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

As of September 30, 2026, the fair value of the first pre-paid purchase arrangement embedded derivative liability of $1,233,095 was included in derivative liabilities at fair value on the condensed consolidated balance sheet. The fair value of the second pre-paid purchase arrangement of $3,687,380 consisted of $3,610,158 separately presented in current notes payable under the fair value option and $77,222 of accrued contractual interest included in accrued expenses. As of March 31, 2026, the aggregate fair value of $2,709,817, consisting of the embedded derivative liabilities associated with the first pre-paid purchase arrangement and the secured convertible promissory notes, was included in derivative liabilities at fair value on the condensed consolidated balance sheet.

 

The following table presents a reconciliation of the Company’s Level 3 financial liabilities measured at fair value on a recurring basis for the six months ended September 30, 2026, with activity presented separately for each quarter:

 

    First pre-paid
purchase
embedded
derivative
    Convertible note
embedded
derivatives
    Second
pre-paid
purchase at
fair value
    Total  
Balance at March 31, 2026, as revised   $ 2,249,777     $ 460,040       -     $ 2,709,817  
Three months ended June 30, 2026:                                
Change in fair value     (349,128 )     -       (23,222 )     (372,350 )
Derecognition upon extinguishment     -       (460,040 )     -       (460,040 )
Initial recognition of PPP #2     -       -       3,897,000       3,897,000  
Accrued contractual interest     -       -       23,222       23,222  
Balance at June 30, 2026   $ 1,900,649       -     $ 3,897,000     $ 5,797,649  
Three months ended September 30, 2026:                                
Change in fair value     (667,554 )     -       (263,620 )     (931,174 )
Accrued contractual interest     -       -       54,000       54,000  
Balance at September 30, 2026   $ 1,233,095       -     $ 3,687,380     $ 4,920,475  

 

PPP #2 was initially recognized at its fair value of $3,897,000. In connection with the exchange, the Company extinguished the three predecessor notes, which had an aggregate principal and accrued interest of $3,471,923, and the related derivative liabilities of $460,040. The Company recognized a loss on extinguishment of debt of $292,304 as a result of the exchange. Changes in the fair value of the PPP #1 embedded derivative liability and PPP #2 are included in change in fair value of derivative liabilities and change in fair value of debt, respectively, in the condensed consolidated statements of operations. Contractual interest accrued on PPP #2 is recognized in interest expense.

 

    Three months ended
September 30, 2025
    Six months ended
September 30, 2025
 
Beginning balance     -       -  
Initial recognition of convertible note embedded derivative   $ 294,980     $ 294,980  
Change in fair value     -       -  
Ending balance, as revised   $ 294,980     $ 294,980  

 

14

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

During the three and six months ended September 30, 2025, the Company recognized an embedded derivative liability of $294,980 in connection with the secured convertible promissory note issued on August 25, 2025, with a corresponding debt discount. There were no material changes in the fair value of the derivative liability from initial recognition through September 30, 2025. Amortization of the related debt discount was included in interest expense.

 

Valuation Techniques and Significant Unobservable Inputs

 

The Company used valuation techniques that were considered appropriate based on the contractual terms and economic characteristics of the respective instruments. The embedded derivative liabilities associated with the pre-paid purchase arrangement and secured convertible promissory notes were valued using valuation techniques that incorporated simulated equity-price paths, probability-weighted outcomes and the contractual settlement provisions of the instruments. The second pre-paid purchase arrangement was valued as a single financial liability using a Monte Carlo simulation that incorporated the instrument’s share-settlement rights, market-price provisions, floor-price cash-election feature, prepayment rights and other contingent settlement events.

 

Financial Instrument   First pre-paid purchase
arrangement (PPP #1) –
embedded derivative
liability
  First pre-paid purchase
arrangement (PPP #1) –
embedded derivative
liability
 

Second pre-paid

purchase arrangement
(PPP #2) – fair value
option

Valuation Date   March 31, 2026   September 30, 2026   September 30, 2026
Valuation Technique   Monte Carlo simulation / probability-weighted scenario analysis   Monte Carlo simulation / with-and-without methodology   Monte Carlo simulation
Significant Unobservable Inputs
Annualized equity volatility   70.0%   76.0%   76.0%
Derivative / hybrid discount rate   20.0%   22.0%   22.0%
Modeled settlement timing   nine monthly tranches at 11.1% each   nine monthly tranches at 11.1% each   nine monthly tranches at 11.1% each
Total prepayment probability   0.0%   0.0%   0.0%
Default probability   5.0%   5.0%   5.0%
Change-of-control probability   5.0%   5.0%   5.0%

 

The period-to-period fair value measurements incorporated changes in observable market inputs and significant unobservable assumptions.

 

For PPP #1, the common-stock price used in the valuations decreased from $6.77 at March 31, 2026 to $3.05 at June 30, 2026 and $1.23 at September 30, 2026. The corresponding historical lowest ten-trading-day VWAP inputs were $4.50, $3.32 and $0.97, respectively. The PPP #1 valuations continued to assume nine monthly purchases of approximately 11.1% each; however, the expected purchase dates were revised. The March 31, 2026 valuation assumed purchases from May 20, 2026 through January 27, 2027; the June 30, 2026 valuation assumed purchases from July 31, 2026 through March 31, 2027; and the September 30, 2026 valuation assumed purchases from October 30, 2026 through June 30, 2027. These schedules reflect assumptions regarding the holder’s exercise of its purchase rights rather than contractually required repayment dates.

 

15

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

For PPP #2, the common-stock price and historical lowest ten-trading-day VWAP inputs decreased from $3.32 and $3.72, respectively, at May 22, 2026 to $1.23 and $0.97, respectively, at September 30, 2026. The modeled nine-month purchase schedule changed from June 30, 2026 through February 28, 2027 to October 30, 2026 through June 30, 2027.

 

Both PPP arrangements contain a contingent cash-election feature under which the holder may elect cash settlement of an applicable purchase amount if the contractual Purchase Share Purchase Price remains below the $2.00 Floor Price for six consecutive months. Following a Trigger Event, the Purchase Share Purchase Price is the lower of the $10.50 fixed price and 90% of the lowest daily VWAP during the preceding ten trading days. At September 30, 2026, this calculation resulted in a purchase price of approximately $0.87 per share. The September 30 valuation models incorporated 46 consecutive trading days below the Floor Price beginning July 28, 2026 and used 126 trading days as a proxy for the contractual six-month period. Accordingly, the modeled six-month condition had not been satisfied as of September 30, 2026.

 

Changes in the Company’s common-stock price and the historical ten-trading-day VWAP affect the valuations through both the market value of the shares deliverable upon settlement and the contractual purchase price used to determine the number of shares issued. Because a lower purchase price increases the number of shares required to settle a given purchase amount, a decline in the common-stock price does not necessarily result in a proportional decline in the value of the settlement obligation. The relationship between the simulated common-stock price and the applicable purchase price is therefore relevant to the value of the share-settlement feature.

 

The lower purchase price and the elapsed period below the $2.00 Floor Price also affect the modeled availability and timing of the holder’s contingent cash-election right. The models evaluate whether the purchase price remains below the Floor Price for the required consecutive period and incorporate the applicable settlement assumptions when the election becomes available. Accordingly, the effect of the lower-price environment depends on both the simulated share-settlement economics and the potential cash-settlement outcomes. The likelihood of satisfying the floor-price condition is generated within the simulations rather than assigned as a separate fixed probability, and the holder’s cash-election right is distinct from the Company’s voluntary prepayment right.

 

Higher discount rates reduce the present value of otherwise unchanged future settlement amounts. Changes in expected volatility affect simulated share-price movements, the relationship between market prices and the ten-trading-day lookback purchase price, and whether the floor-price condition is satisfied. The assumed purchase dates also affect contractual interest accrual and the periods over which settlement amounts are discounted. These effects are evaluated together in determining fair value. For PPP #1, the lower embedded derivative measurement represents a reduction in the value attributable to the embedded features relative to the separately valued straight-debt host; for PPP #2, the lower measurement represents a reduction in the modeled present value of the entire instrument’s settlement obligations.

 

Financial Instrument   August 25, 2025 secured
convertible promissory
note – embedded
derivative liability
  October 30, 2025
secured convertible
promissory note –
embedded derivative
liability
  December 19, 2025
secured convertible
promissory note –
embedded derivative
liability
Valuation Date   March 31, 2026   March 31, 2026   March 31, 2026
Valuation Technique   Monte Carlo simulation / probability-weighted scenario analysis   Monte Carlo simulation / probability-weighted scenario analysis   Monte Carlo simulation / probability-weighted scenario analysis
Significant Unobservable Inputs
Annualized equity volatility   70.0%   70.0%   70.0%
Derivative / hybrid discount rate   18.0%   18.0%   20.0%
Investor conversion probability   35.0%   35.0%   35.0%
Automatic exchange probability   85.0%   85.0%   85.0%
Total prepayment probability   0.0%   0.0%   0.0%
Default probability   2.5%   2.5%   2.5%
Change-of-control probability   2.5%   2.5%   2.5%

 

16

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

Significant unobservable inputs used in the Level 3 measurements included expected equity volatility, discount rates, the expected timing of share settlements, and management’s estimates of the probability and timing of prepayment, default, change-of-control and other contractual settlement events. Observable inputs included the Company’s common stock price and market interest rates at the applicable measurement dates.

 

There were no transfers into or out of Level 3 during the periods presented.

 

The Company’s Level 3 fair value measurements are sensitive to changes in significant unobservable inputs. In general, changes in expected volatility, discount rates, expected settlement timing or the probability of contingent settlement events could result in a higher or lower fair value measurement. Because certain contractual features interact with one another, changes in one assumption may affect the impact of other assumptions, and the effect of changes in individual inputs may therefore not be independent.

 

Derivative Liabilities

 

Certain of the Company’s financing arrangements contain embedded features that require bifurcation and separate accounting as derivative liabilities under ASC 815, Derivatives and Hedging. The derivative liabilities are initially and subsequently measured at fair value, with changes in fair value recognized in earnings. Amounts initially recognized as derivative liabilities may result in a discount to the related debt host, which is subsequently amortized to interest expense.

 

Fair Value Option

 

ASC 825, Financial Instruments, permits an entity to elect the fair value option for certain eligible financial instruments on an instrument-by-instrument basis at specified election dates, including upon initial recognition of an eligible instrument. Once elected, the fair value option is generally irrevocable. Financial instruments for which the fair value option is elected are measured at fair value, with changes in fair value recognized in earnings, except for changes in the fair value of financial liabilities attributable to instrument-specific credit risk, which are recognized in other comprehensive income.

 

On May 22, 2026, the Company elected the fair value option for its second pre-paid purchase arrangement with Streeterville Capital, LLC (the “Second Pre-Paid Purchase Arrangement” or “PPP #2”) upon its initial recognition. PPP #2 is therefore measured in its entirety at fair value rather than separately accounting for embedded features. Contractual interest expense is recognized separately in interest expense, and changes in the fair value of PPP #2, other than changes attributable to instrument-specific credit risk, are recognized in other income (expense).

 

During the six months ended September 30, 2026, the Company determined that no portion of the change in the fair value of PPP #2 was attributable to changes in instrument-specific credit risk. Accordingly, no amount related to PPP #2 was recognized in other comprehensive income during the period.

 

17

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

Intangibles

 

Intangible assets include software, trademarks, customer lists, and a website. Amortization is straight-line over the following estimated useful lives:

 

Software 3 - 5 years
Trademarks Indefinite
Customer Lists 3 years
Website 3 years

 

Software and Website Development Costs

 

The Company accounts for software development costs in accordance with several accounting pronouncements, including Topic 730, Research and Development, Topic 985-20, Costs of Computer Software to be Sold, Leased, or Marketed, and Topic 330-10, Inventory. Costs incurred during the period of planning and design, before technological feasibility is established, for all software developed for internal and external use, are charged to operations in the period incurred as research and development costs. Additionally, costs incurred after determination of readiness for market are expensed as research and development.

 

The Company capitalizes certain costs in the development of its proprietary software (computer software to be sold, leased, or licensed) for the period after technological feasibility has been determined and prior to marketing and initial sales. Once technological feasibility is reached, and the software has been released for sale, such costs are capitalized and amortized to cost of revenue over the estimated lives of the products. These capitalized costs are amortized over their estimated useful lives and reviewed for impairment in accordance with Topic 330 when indicators of impairment exist.

 

Website development costs are accounted for separately under Topic 350-50, Website Development Costs.

 

Deferred Revenue

 

Deferred revenue represents cash received from customers for which the related revenue has not yet been earned. Deferred revenue primarily consists of (i) orders of Omni One units and extended warranties, (ii) unfilled orders of Omni Pro systems, (iii) amounts billed but not yet recognized for Omni Arena installations, (iv) unearned subscription revenue related to Omni Online, (v) unredeemed Omniverse game credits, and (vi) unearned subscription revenue related to Omni Care.

 

18

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

The following table summarizes deferred revenue balances:

 

    September 30,     March 31,  
    2026     2026  
Omni One   $ 8,772     $ 24,121  
Omni One extended warranty     46,577       21,855  
Omni Pro     450,732       450,732  
Omni Arena     91,677       94,744  
Omni Online     31,619       29,874  
Omniverse credits     19,901       27,001  
Omni Care subscriptions     3,334       18,000  
Total deferred revenue   $ 652,612     $ 666,327  

 

Total deferred revenue as of March 31, 2025 was $1,769,556.

 

Revenue recognized during the six months ended September 30, 2026 and 2025, that was included in deferred revenue at the beginning of the respective periods, was $1,608,353 and $1,695,562, respectively. Revenue recognized during the three months ended September 30, 2026 and 2025, that was included in deferred revenue at the beginning of the respective periods, was $1,115,663 and $812,092, respectively.

 

Refunds issued to customers during the six months ended September 30, 2026 and 2025, which reduced deferred revenue, were $3,117 and $2,800, respectively. Refunds issued to customers during the three months ended September 30, 2026 and 2025, which reduced deferred revenue, were $2,917 and $600, respectively.

 

Payments received from customers during the six months ended September 30, 2026 and 2025, that increased deferred revenue were $1,597,755 and $910,651, respectively. Payments received from customers during the three months ended September 30, 2026 and 2025, that increased deferred revenue were $1,131,641 and $364,887, respectively.

 

Gift Card Liability

 

During the fiscal year ended March 31, 2026, the Company converted outstanding customer Omni One preorder deposits to gift cards and reclassed them from deferred revenue. The total amount reclassed from deferred revenue was $226,445. Additionally, the Company issued store credits (subsequently converted to gift cards) to certain investors as an incentive for purchasing shares. The total amount issued in connection with equity transactions was $214,906. For the six months ended September 30, 2026, there were no additional gift cards issued. These gift cards are redeemable for Company products and represent an obligation to deliver goods in the future. They have been recorded as a gift card liability, included in current liabilities on the consolidated balance sheet as of September 30, 2026. Total gift card liabilities were $439,144 as of September 30, 2026, and $446,252 as of March 31, 2026.

 

The Company’s gift cards generally expire five years after issuance, with expiration dates determined individually based on the date each card was issued. Consistent with ASC 606, the gift card liability will be recognized as revenue when the cards are redeemed.

 

Advertising Costs

 

Advertising costs are expensed as incurred, and are included in selling expenses in the accompanying consolidated statements of operations. Total advertising expense for the three months ended September 30, 2026 and 2025, was $393,794 and $65,454, respectively. Total advertising expense for the six months ended September 30, 2026 and 2025, was $679,976 and $892,984, respectively.

 

Federal Income Taxes

 

No uncertain tax positions were identified. Tax-related interest and penalties, if any, are included in income tax expense. The U.S. federal tax returns are subject to examination by the Internal Revenue Service, generally for three years after they are filed. State tax returns are subject to examination generally for five years after they are filed.

 

19

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 2. Summary of Significant Accounting Policies (continued)

 

Net Loss Per Share

 

Basic and diluted net loss per share is computed by dividing net loss by weighted-average shares outstanding. Potentially dilutive securities that were excluded from the computation of diluted net loss per share because their effect would have been anti-dilutive include stock options, restricted stock units, and warrants. The total number of potentially dilutive shares excluded from the computation of diluted net loss per share was as follows:

 

    September 30,     September 30,  
    2026     2025  
Shares underlying outstanding stock options (vested and unvested)     2,058,750       2,199,470  
Shares underlying outstanding restricted stock units (unvested)     2,572,193       -  
Shares underlying outstanding warrants     736,642       649,940  
Total potentially dilutive shares     5,367,585       2,849,410  

 

Major Customer Concentrations

 

For the three and six months ended September 30, 2026, no individual customer accounted for 10% or more of the Company’s revenue. As of September 30, 2026, accounts receivable from two customers totaled $205,288 and $44,988, representing 49% and 11%, respectively, of the Company’s total accounts receivable balance. For the three and six months ended September 30, 2025, no individual customer accounted for 10% or more of the Company’s revenue. As of September 30, 2025, no individual customer accounted for 10% or more of the Company’s accounts receivable balance.

 

Recent Accounting Pronouncements

 

On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) — Improvements to Income Tax Disclosures, which enhances transparency regarding income tax disclosures, primarily through additional information regarding the income tax rate reconciliation and income taxes paid by jurisdiction. The Company adopted ASU 2023-09 effective April 1, 2026. The amendments are applied prospectively, with retrospective application permitted. Because the amendments relate solely to disclosures, adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows. The Company is currently evaluating the impact of the ASU on its annual income tax disclosures, which will first be reflected in the Company’s financial statements for the fiscal year ending March 31, 2027.

 

In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income (Subtopic 220-40): Expense Disaggregation Disclosures. The ASU requires public business entities to disclose in a tabular format significant expense categories that are included in each relevant income statement line item. As clarified by ASU 2025-01, the standard is effective for annual reporting periods beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact that this standard may have on its consolidated financial statements and related disclosures.

 

Foreign Currency Remeasurements

 

The Company’s non-U.S. subsidiaries, VML and its wholly-owned subsidiary VML_ZH, along with VMT, operate using the U.S. dollar as the functional currency. The effect of foreign currency exchange rate fluctuations on consolidated balance sheet accounts was not material for the three and six months ended September 30, 2026 and 2025.

 

20

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 3. Receivables

 

Receivables, net of allowance for credit losses consisted of the following at:

 

    September 30,     March 31,  
    2026     2026  
Accounts receivable, trade   $ 420,430     $ 372,436  
Other receivables     1,469       18,249  
Allowance for credit losses     (2,000 )     (11,396 )
Receivables, net   $ 419,899     $ 379,289  

 

Changes in the allowance for credit losses for the three and six months ended September 30, 2026 and 2025 are as follows:

 

    Three months ended
September 30,
    Six months ended
September 30,
 
    2026     2025     2026     2025  
Beginning balance   $ 4,833     $ 35,296     $ 11,396     $ 827  
Credit loss expense     8,165       12,837       14,259       49,755  
Write-offs charged against the allowance     (12,665 )     (38,133 )     (12,656 )     (38,133 )
Recoveries of amounts written off     1,667       0       (10,999 )     (2,449 )
Ending balance   $ 2,000     $ 10,000     $ 2,000     $ 10,000  

 

Note 4. Prepaids and Other Current Assets

 

Prepaids and other current assets consisted of the following at:

 

    September 30,     March 31,  
    2026     2026  
Security deposits   $ 192,220     $ 188,375  
Recoverable VAT     201,662       132,234  
Prepaid insurance     326,361       554,240  
Other prepaid expenses     20,226       22,260  
    $ 740,469     $ 897,109  

 

21

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 5. Inventory

 

Inventory consisted of the following at:

 

    September 30,     March 31,  
    2026     2026  
Raw materials   $ 1,104,822     $ 848,601  
Work in process     64,646       11,111  
Finished goods     502,687       328,911  
    $ 1,672,155     $ 1,188,623  

 

Note 6. Property and Equipment

 

Property and equipment, net include the following at:

 

    September 30,     March 31,  
    2026     2026  
Computer equipment   $ 48,733     $ 49,469  
Furniture and equipment     78,052       73,865  
Machinery and equipment     1,192,528       1,197,854  
Leasehold improvements     99,498       92,106  
      1,418,811       1,413,294  
Less: accumulated depreciation     (1,113,622 )     (1,034,984 )
    $ 305,189     $ 378,310  

 

Depreciation expense for the three months ended September 30, 2026 and 2025, was $47,899 and $42,675, respectively. Depreciation expense for the six months ended September 30, 2026 and 2025 was $79,172 and $86,134, respectively.

 

Note 7. Intangibles

 

Intangibles, net include the following at:

 

    September 30,     March 31,  
    2026     2026  
Software and game design   $ 2,578,050     $ 2,578,050  
Trademarks     94,509       82,621  
Website     137,070       137,070  
      2,809,629       2,797,741  
Less: accumulated amortization     (1,481,744 )     (1,258,387 )
    $ 1,327,885     $ 1,539,354  

 

Amortization expense for the three months ended September 30, 2026 and 2025, was $111,678 and $114,331, respectively. Amortization expense for the six months ended September 30, 2026 and 2025 was $223,357 and $229,648, respectively.

 

22

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 8. Notes Payable

 

Convertible Notes

 

Effective August 25, 2025, the Company issued a secured convertible promissory note to Streeterville Capital, LLC in the amount of $2,220,000. The note was convertible into shares of Class A common stock calculated as the converting balance divided by 85% of the Nasdaq valuation price of $8.75 per share, which was the reference price established in connection with the Company’s direct listing. The note provided for payment of principal and accrued interest at maturity, nine months after the purchase price date. The note bore interest at a fixed rate of 6% and was secured by all assets of the Company. The note included an original issue discount of $200,000 plus additional closing costs of $20,000, which were being amortized over the contractual term of the note.

 

The Company granted warrants associated with this note to acquire shares of Class A common stock. In accordance with ASC 470-20, the Company allocated the proceeds between the note and the warrants using the relative fair value method. After giving effect to the bifurcation of the embedded derivative described below, the amount allocated to the warrants was revised to $1,229,045, which was recorded in equity as additional paid-in capital (“APIC”) – warrants, with a corresponding discount on the note payable that was being amortized over the contractual term of the note. Effective February 9, 2026, as a result of an amendment to the warrants, the Company recognized incremental fair value of $143,144 in Other Income (Expense). See Note 12 for additional information regarding the warrant exercises and related equity activity. 

 

On May 22, 2026, the note was exchanged pursuant to Prepaid Purchase Agreement #2 (“PPP #2”), and the note was extinguished. Accordingly, there was no outstanding balance under the note at September 30, 2026. As revised, the carrying value of the note at March 31, 2026 was $1,871,195 (principal of $2,220,000, less unamortized deferred loan costs of $4,000 and unamortized discount of $344,805). No discount amortization, amortization of deferred loan costs, or contractual interest expense was recognized during the three months ended September 30, 2026 because the note was extinguished on May 22, 2026. For the six months ended September 30, 2026, amortization of debt discounts and debt issuance costs included in interest expense were $329,427, and contractual interest expense was $18,870. See “Embedded Derivative Liabilities” and “Extinguishment of Convertible Promissory Notes” below for additional information.

 

Effective October 30, 2025, the Company issued a second secured convertible promissory note to Streeterville Capital, LLC in the amount of $560,000. The note was convertible into shares of Class A common stock calculated as the converting balance divided by 85% of the Nasdaq valuation price of $8.75 per share, which was the reference price established in connection with the Company’s direct listing. The note provided for payment of principal and accrued interest at maturity, nine months after the purchase price date. The note bore interest at a fixed rate of 6% and was secured by all assets of the Company. The note included an original issue discount of $50,000 plus additional closing costs of $10,000, which were being amortized over the contractual term of the note.

 

The Company granted warrants associated with the second note to acquire shares of Class A common stock. In accordance with ASC 470-20, the Company allocated the proceeds between the note and the warrants using the relative fair value method. After giving effect to the bifurcation of the embedded derivative described below, the amount allocated to the warrants was revised to $312,436, which was recorded in equity as additional paid-in capital (“APIC”) – warrants, with a corresponding discount on the note payable that was being amortized over the contractual term of the note. Effective February 9 and March 11, 2026, as a result of amendments to the warrants, the Company recognized aggregate incremental fair value of $112,949 in Other Income (Expense). Effective June 1, 2026, and June 29, 2026, the Company entered into additional amendments to the warrants reducing the exercise price to $4.00 per warrant share and $3.00 per warrant share, respectively, and recognized additional aggregate incremental fair value of $56,000 in Other Income (Expense). Effective July 21, 2026, the Company entered into additional amendments to the warrants reducing the exercise price to $2.50 and extending the expiration date from July 27, 2026 to August 27, 2026, subject to automatic extension for up to four additional consecutive one-month periods unless the Special Committee of the Board of Directors determines not to extend. The Company retained the right to terminate the reduced exercise price period early upon two trading days’ prior written notice to the investor, at which time the exercise price would revert to the original Nasdaq Valuation Price of $8.75 per share. As a result of the July 21, 2026 amendment, the Company recognized additional aggregate incremental fair value of $44,000 in Other Income (Expense). As of September 30, 2026, all 114,286 debt warrants granted with the October 30, 2025 secured convertible promissory note were outstanding.

 

23

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 8. Notes Payable (continued)

 

On May 22, 2026, the second note was exchanged pursuant to PPP #2, and the note was extinguished. Accordingly, there was no outstanding balance under the note at September 30, 2026. As revised, the carrying value of the note at March 31, 2026 was $363,855 (principal of $560,000 less unamortized deferred loan costs of $4,407 and unamortized discount of $191,738). No discount amortization, amortization of deferred loan costs, or contractual interest expense was recognized during the three months ended September 30, 2026 because the note was extinguished on May 22, 2026. For the six months ended September 30, 2026, amortization of debt discounts and debt issuance costs included in interest expense were $84,061, and contractual interest expense was $4,760. See “Embedded Derivative Liabilities” and “Extinguishment of Convertible Promissory Notes” below for additional information.

 

Effective December 19, 2025, the Company issued a third secured convertible promissory note to Streeterville Capital, LLC in the amount of $560,000. The note was convertible into shares of Class A common stock calculated as the converting balance divided by 85% of the Nasdaq valuation price of $8.75 per share, which was the reference price established in connection with the Company’s direct listing. The note provided for payment of principal and accrued interest at maturity, nine months after the purchase price date. The note bore interest at a fixed rate of 6% and was secured by all assets of the Company. The note included an original issue discount of $50,000 plus additional closing costs of $10,000, which were being amortized over the contractual term of the note.

 

The Company granted warrants associated with the third note to acquire shares of Class A common stock. In accordance with ASC 470-20, the Company allocated the proceeds between the note and the warrants using the relative fair value method. After giving effect to the bifurcation of the embedded derivative described below, the amount allocated to the warrants was revised to $300,251, which was recorded in equity as additional paid-in capital (“APIC”) – warrants, with a corresponding discount on the note payable that was being amortized over the contractual term of the note. Effective February 9 and March 11, 2026, as a result of amendments to the warrants, the Company recognized aggregate incremental fair value of $143,772 in Other Income (Expense). Effective June 1, 2026, and June 29, 2026, the Company entered into additional amendments to the warrants reducing the exercise price to $4.00 per warrant share and $3.00 per warrant share, respectively, and recognized additional aggregate incremental fair value of $56,000 in Other Income (Expense). Effective July 21, 2026, the Company entered into additional amendments to the warrants reducing the exercise price to $2.50 and extending the expiration date from July 27, 2026 to August 27, 2026, subject to automatic extension for up to four additional consecutive one-month periods unless the Special Committee of the Board of Directors determines not to extend. The Company retained the right to terminate the reduced exercise price period early upon two trading days’ prior written notice to the investor, at which time the exercise price would revert to the original Nasdaq Valuation Price of $8.75 per share. As a result of the July 21, 2026 amendment, the Company recognized additional aggregate incremental fair value of $44,000 in Other Income (Expense). As of September 30, 2026, all 114,286 debt warrants granted with the December 19, 2025 secured convertible promissory note were outstanding.

 

On May 22, 2026, the third note was exchanged pursuant to PPP #2, and the note was extinguished. Accordingly, there was no outstanding balance under the note at September 30, 2026. As revised, the carrying value of the note at March 31, 2026 was $278,844 (principal of $560,000 less unamortized deferred loan costs of $6,222 and unamortized discount of $274,934). No discount amortization, amortization of deferred loan costs, or contractual interest expense was recognized during the three months ended September 30, 2026 because the note was extinguished on May 22, 2026. For the six months ended September 30, 2026, amortization of debt discounts and debt issuance costs included in interest expense were $85,351, and contractual interest expense was $4,760. See “Embedded Derivative Liabilities” and “Extinguishment of Convertible Promissory Notes” below for additional information.

 

Embedded Derivative Liabilities

 

The Company determined that certain embedded features contained in the three secured convertible promissory notes required bifurcation and separate accounting as derivative liabilities under ASC 815. The derivative liabilities were initially measured at fair value, with corresponding amounts recorded as additional debt discounts, and were subsequently remeasured at fair value each period, with changes recognized through earnings.

 

The aggregate initial fair value of the embedded derivatives associated with the three notes was $459,188. As of March 31, 2026, the aggregate fair value of the derivative liabilities was $460,040, and the aggregate remaining unamortized derivative-related debt discount was $147,994. During the period from April 1, 2026 through the May 22, 2026 extinguishment, the Company recognized $86,736 of additional debt discount amortization associated with these embedded derivatives. See Note 2, “Fair Value Measurements,” for additional information regarding the Company’s fair value measurements and related Level 3 disclosures.

 

Immediately prior to the May 22, 2026 exchange, the aggregate derivative liabilities were $460,040. Upon extinguishment of the three notes, the derivative liabilities and the remaining derivative-related debt discount were derecognized together with the related debt host instruments. See Note 2, “Revision of Previously Issued Financial Statements,” for additional information regarding the correction of the Company’s historical accounting for these instruments.

 

24

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 8. Notes Payable (continued)

 

Extinguishment of Convertible Promissory Notes

 

On May 22, 2026, the Company entered into the PPP #2 with Streeterville Capital, LLC pursuant to the automatic exchange provisions of the existing secured convertible promissory notes. In connection with the transaction, the August 25, 2025, October 30, 2025, and December 19, 2025 secured convertible promissory notes, with an aggregate outstanding principal balance of $3,340,000 and accrued interest of $131,923, were exchanged in full for PPP #2, which had an original principal amount of $3,471,923. Upon completion of the exchange, the three secured convertible promissory notes had no remaining outstanding balance, and all liens securing the notes were released. Accordingly, as of September 30, 2026, none of the Company’s assets remained pledged as collateral for these notes, and PPP #2 is an unsecured obligation of the Company.

 

The Company accounted for the exchange as an extinguishment of debt under ASC 470-50. Immediately prior to the exchange, the aggregate carrying amount of the liabilities extinguished, including the debt host instruments and related embedded derivative liabilities, was $3,604,696. The Company elected the fair value option for PPP #2 upon its initial recognition and recorded PPP #2 at its May 22, 2026 fair value of $3,897,000. As a result, the Company recognized a loss on extinguishment of $292,304 during the three months ended June 30, 2026.

 

Prepaid Purchase Agreement

 

Effective August 25, 2025, the Company entered into an Equity Purchase Agreement with Streeterville Capital, LLC pursuant to which Streeterville Capital, LLC committed to provide up to $50,000,000 through one or more prepaid equity advances (each, an “Advance”). Following the Company’s direct listing on January 27, 2026, the Company entered into a Prepaid Purchase Agreement (the “PPP #1”) with Streeterville Capital, LLC and received an initial advance with an original principal amount of $8,640,000. Subsequent advances may be requested by the Company, subject to specified conditions, including minimum market capitalization, trading volume, Nasdaq compliance, and other customary conditions. As of September 30, 2026, the Company did not meet the specified conditions required to obtain additional advances under the Equity Purchase Agreement. Accordingly, no additional funding was available to the Company under the Equity Purchase Agreement as of that date, absent a waiver of the applicable conditions by Streeterville.

 

The Advances do not have a stated maturity date and bear interest at a rate of 6% per annum. The Advances are convertible into shares of the Company’s Class A common stock at conversion prices determined in accordance with the terms of the PPP #1. The PPP #1 includes an original issue discount of $640,000, which is amortized over 12 months. Under certain circumstances, including specified trigger events, the conversion price may be adjusted based on the market price of the Company’s common stock. The PPP #1 defines a floor price of $2.00 per share (the “Floor Price”); the Floor Price does not operate as a minimum purchase price, but if the purchase price remains below the Floor Price for six consecutive months, Streeterville Capital, LLC may elect to have the applicable purchase amount paid in cash. As of September 30, 2026, the Company’s common stock was trading below the $2.00 Floor Price.

 

The Company granted warrants associated with this PPP #1 to acquire shares of Class A common stock. In accordance with ASC 470-20, the Company allocated the proceeds between the note and the warrants using the relative fair value method. After giving effect to the bifurcation of the embedded derivative described below, the amount allocated to the warrants was revised to $4,017,499, which was recorded in equity as additional paid-in capital (“APIC”) – warrants, with a corresponding discount on the note payable that is amortized over the life of the note. Effective February 9, 2026 and March 11, 2026, as a result of amendments to the warrants, the Company recognized aggregate incremental fair value of $2,294,857 in Other Income (Expense). Effective June 1, 2026 and June 29, 2026, the Company entered into additional amendments to the warrants reducing the exercise price to $4.00 per warrant share and $3.00 per warrant share, respectively, and recognized additional aggregate incremental fair value of $472,150 in Other Income (Expense). Effective July 21, 2026, the Company entered into additional amendments to the warrants reducing the exercise price to $2.50 and extending the expiration date from July 27, 2026 to August 27, 2026, subject to automatic extension for up to four additional consecutive one-month periods unless the Special Committee of the Board of Directors determines not to extend. The Company retained the right to terminate the reduced exercise price period early upon two trading days’ prior written notice to the investor. As a result of the July 21, 2026 amendment, the Company recognized additional aggregate incremental fair value of $338,249 in Other Income (Expense). During the three and six months ended September 30, 2026, Streeterville Capital, LLC exercised 455,500 and 685,500 outstanding warrants, respectively, associated with the PPP #1 through a series of separate cash exercise transactions. In connection with such exercises, the Company received cash proceeds and issued shares of Class A common stock pursuant to the terms of the applicable warrant agreements. See Note 12 for additional information regarding the warrant exercises and related equity activity.

 

The Company determined that certain embedded features contained in PPP #1 required bifurcation and separate accounting as a derivative liability under ASC 815. The fair value of the embedded derivative was $2,453,051 upon initial recognition on January 27, 2026. After giving effect to the revised warrant allocation, the Company recorded a derivative-related debt discount of $2,453,051, equal to the initial fair value of the embedded derivative. No day-one loss was recognized. The derivative liability is subsequently remeasured at fair value at each reporting date, with changes in fair value recognized in earnings.

 

25

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 8. Notes Payable (continued)

 

As revised, the fair value of the PPP #1 derivative liability was $2,249,777 at March 31, 2026 and decreased to $1,233,095 at September 30, 2026. Accordingly, the Company recognized gains of $667,554 and $1,016,682 from changes in the fair value of the derivative liability during the three and six months ended September 30, 2026, respectively.

 

As revised, the carrying value of the debt host associated with PPP #1 at September 30, 2026 and March 31, 2026 was approximately $6.349 million and $2.794 million, respectively, representing principal of $8,640,000 less unamortized debt discounts of approximately $2.291 million and $5.846 million, respectively. The debt host is classified as a current liability and is included in current notes payable on the condensed consolidated balance sheets.

 

Discount amortization included in interest expense was approximately $1.778 million and $3.555 million for the three and six months ended September 30, 2026, respectively. Contractual interest expense on PPP #1 was $133,960 and $266,981 for the three and six months ended September 30, 2026, respectively. No discount amortization or contractual interest expense related to PPP #1 was recognized during the corresponding periods in 2025.

 

Second Prepaid Purchase Agreement

 

On May 22, 2026, the Company entered into PPP #2 with Streeterville Capital, LLC. PPP #2 had an original principal amount of $3,471,923, bears interest at 6% per annum, and contains terms substantially consistent with those of the original PPP #1, including the investor’s ability to apply outstanding amounts toward the purchase of shares of the Company’s Class A common stock in accordance with the terms of the agreement. See “Prepaid Purchase Agreement” above for additional information. The Company may prepay all or a portion of the outstanding balance, subject to specified prepayment premiums based on the timing of repayment. The agreement also contains customary events of default and a beneficial ownership limitation that generally prohibits the investor from beneficially owning more than 9.99% of the Company’s outstanding Class A common stock.

 

Upon initial recognition of PPP #2 on May 22, 2026, the Company elected the fair value option under ASC 825 and therefore measures the entire instrument at fair value on a recurring basis. PPP #2 was initially recognized at a fair value of $3,897,000. As of June 30, 2026, the fair value of PPP #2 remained $3,897,000. As of September 30, 2026, the fair value of PPP #2 was $3,687,380, comprising $3,610,158 separately presented as notes payable under the fair value option on the condensed consolidated balance sheet and $77,222 of accrued contractual interest included in accrued expenses on the condensed consolidated balance sheet.

 

Contractual interest expense on PPP #2 was $23,222 for the three months ended June 30, 2026. Because the total fair value of the instrument remained unchanged from May 22, 2026 through June 30, 2026, the Company recognized a corresponding $23,222 change in fair value of debt during the three months ended June 30, 2026. During the three months ended September 30, 2026, the Company recognized a gain on change in fair value of debt of $263,620, reflecting the $209,620 decrease in the fair value of PPP #2 and the effect of $54,000 of additional contractual interest accrued during the quarter and separately recognized in interest expense. For the six months ended September 30, 2026, the Company recognized an aggregate gain on change in fair value of debt of $286,842. There was no change in fair value attributable to instrument-specific credit risk during the six months ended September 30, 2026.

 

Exchange Note

 

Effective March 31, 2026, the Company entered into an exchange agreement with Streeterville Capital, LLC (the “Exchange Agreement”) pursuant to which certain previously issued 2024 subordinated promissory notes (see below “2024 Notes”) originally issued to various investors between July 15, 2024 and December 10, 2024 were exchanged for a new promissory note (the “Exchange Note”) in the aggregate principal amount of $2,681,718. The Exchange Note matures on July 1, 2027, and bears interest at a fixed rate of 6% per annum, compounded daily based on a 360-day year. The Exchange Note includes an original issue discount of $242,883, which is amortized over the life of the note.

 

Pursuant to the Exchange Agreement, Streeterville Capital, LLC acquired the 2024 Notes from the original holders and surrendered the 2024 Notes to the Company in exchange for the Exchange Note. Streeterville did not acquire the 2024 Note held by Ugo de Charette. Instead, on March 30, 2026, the Company repaid Ugo de Charette’s note in full through a cash payment of $130,723.

 

Upon surrender, the 2024 Notes were cancelled and the Company’s remaining obligations under the 2024 Notes became evidenced solely by the Exchange Note. No additional cash consideration was received by the Company in connection with the transaction.

 

26

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 8. Notes Payable (continued)

 

During the six months ended September 30, 2026, Streeterville made partial redemptions under the Exchange Agreement with an aggregate Redemption Amount of $852,976, pursuant to which 465,840 shares of Class A common stock were issued. The Redemption Amount included principal and accrued interest, and the outstanding principal balance of the Exchange Note was reduced by $786,862. The consideration received by the Company consisted of the corresponding reduction in indebtedness under the Exchange Note. The shares were issued free of any restrictive securities legend pursuant to Rule 144. The Company recognized a gain on extinguishment of debt of $37,492 during the three months ended September 30, 2026, and a net loss on extinguishment of debt of $101,428 during the six months ended September 30, 2026, in connection with these partial redemptions.

 

The carrying value of the Exchange Note at September 30, 2026 and March 31, 2026 was $1,791,886 and $2,438,835, respectively (principal of $1,894,856 and $2,681,718 less unamortized discount of $102,970 and $242,883, respectively). Discount amortization included in interest expense was $39,816 and $86,564 for the three and six months ended September 30, 2026, respectively. Contractual interest expense on the note was $34,268 and $73,074 for the three and six months ended September 30, 2026, respectively. No discount amortization or contractual interest expense related to the Exchange Note was recognized during the corresponding periods in 2025.

 

Beginning July 1, 2026, Streeterville has the right, at its sole and absolute discretion, to redeem up to $111,738.27 per month upon delivery of a Redemption Notice. The Exchange Note matures on July 1, 2027. Accordingly, as of September 30, 2026, the entire carrying value of $1,791,886 was classified as current notes payable on the condensed consolidated balance sheet.

 

Warrant Amendments

 

On June 1, 2026, June 29, 2026, and July 21, 2026, the Company entered into amendments to the Equity Financing Warrant, the Second Debt Financing Warrant, and the Third Debt Financing Warrant (collectively, the “Warrant Amendments”) with Streeterville Capital, LLC. The Warrant Amendments were intended to provide additional flexibility in connection with the Company’s ongoing relationship with Streeterville Capital. Effective June 1, 2026, the exercise price under each warrant was reduced from $6.00 per share to $4.00 per share, and the Reduced Exercise Price Period was extended through the original expiration date of the warrants on July 27, 2026. Effective June 29, 2026, the exercise price under each warrant was further reduced from $4.00 per share to $3.00 per share, while the expiration date remained unchanged. Effective July 21, 2026, the exercise price under each warrant was further reduced from $3.00 per share to $2.50 per share, and the expiration date was extended from July 27, 2026 to August 27, 2026, subject to automatic extension for up to four additional consecutive one-month periods unless the Special Committee of the Board of Directors determines not to extend. The Company retained the right to terminate the reduced exercise price period early upon two trading days’ prior written notice to the investor.

 

The Company accounted for each Warrant Amendment as a modification of the existing warrants. As a result, the Company recognized aggregate incremental fair value adjustments of $426,249 and $1,010,399 in Other Income (Expense) during the three and six months ended September 30, 2026, respectively, with a corresponding increase to additional paid-in capital.

 

Extinguishment of Certain 2024 Notes

 

In June 2025, the Company and certain investors amended the terms of the 2024 Notes to allow cancellation in exchange for Series B Preferred Stock and warrants. Under ASC 470, this amendment represented a debt extinguishment. At that time, the Company extinguished $400,000 of principal and $62,975 of accrued interest. In connection with the extinguishment, the Company issued 74,430 shares of Series B Preferred Stock, valued at $462,955 based on the Series B subscription price, and warrants to purchase common stock valued at $122,884 using a Black-Scholes model. As the total fair value of the equity instruments issued exceeded the carrying amount of the debt, the Company recorded a loss on debt extinguishment of $122,864.

 

Cancellation of Certain 2024 Notes

 

On June 30, 2025, the amended notes were cancelled in exchange for the issuance of 74,430 shares of Series B Preferred Stock and 74,430 warrants. This exchange was treated as a conversion within the amended terms of the notes, and therefore no additional gain or loss was recognized.

 

27

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 8. Notes Payable (continued)

 

Western Technology Investment Note

 

The Company repaid all outstanding obligations under its note payable with Western Technology Investment on August 22, 2025. There was no outstanding balance at September 30, 2026 or March 31, 2026. Amortization of debt discounts and debt issuance costs included in interest expense was $934 and $3,032 for the three and six months ended September 30, 2025, respectively. Interest expense on the note was $2,385 and $8,295 for the three and six months ended September 30, 2025, respectively. No discount amortization, amortization of deferred loan costs, or contractual interest expense related to the note payable with Western Technology Investment was recognized during the corresponding periods in 2026.

 

EIDL Loan

 

On August 29, 2020, the Company received a loan from the U.S. Small Business Administration under its Economic Injury Disaster Loan assistance program (the “EIDL Loan”). The principal amount was $25,000, with proceeds used for working capital.

 

The EIDL Loan matures in August 2050, bears interest at 3.75% per year, with accrued interest payable monthly beginning in March 2023, and principal payments beginning in September 2024.

 

The carrying amount of the EIDL Loan was $23,758 and $24,087 as of September 30, 2026 and March 31, 2026, respectively.

 

Future Maturities of Notes Payable

 

As of September 30, 2026, the future maturities of notes payable are as follows for the twelve-month periods ending September 30:

 

Twelve months ending September 30,   Notes
Payable
    EIDL     Total  
2027   $ 14,073,865     $ 581     $ 14,074,446  
2028     -       603       603  
2029     -       626       626  
2030     -       650       650  
2031     -       675       675  
Thereafter     -       20,623       20,623  
Total     14,073,865       23,758       14,097,623  
Less: unamortized discount     (2,394,161 )     -       (2,394,161 )
Add: PPP #2 fair value adjustment     138,235       -       138,235  
    $ 11,817,939     $ 23,758     $ 11,841,697  

 

28

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 9. Leases

 

The Company accounts for leases in accordance with ASC 842, Leases. The Company has elected the package of practical expedients permitted under the transition guidance within ASC 842, which allows the Company to (i) not reassess whether any expired or existing contracts contain leases, (ii) not reassess the lease classification of any expired or existing leases, and (iii) not reassess initial direct costs for any existing leases. The Company has also elected the short-term lease exemption for certain leases with a term of 12 months or less.

 

Right-of-use (“ROU”) assets are presented in non-current assets on the consolidated balance sheets, while the corresponding lease liabilities are split between current and non-current liabilities. Because the Company does not have access to the rate implicit in its leases, it applies an incremental borrowing rate based on the information available at lease commencement to determine the present value of future lease payments.

 

The Company leases office, warehouse, and apartment space in the United States, China, and Hong Kong under various operating lease agreements. The U.S. headquarters lease, originally entered into in 2015, has been extended multiple times and currently expires November 30, 2029, with monthly base rent of $15,558 as of September 30, 2026, escalating annually to $18,204. The Company’s China subsidiary, Virtuix Manufacturing (Zhuhai) Co., Ltd., leases office, warehouse, and storage space under an operating lease that expires on December 31, 2026. Monthly base rent under this lease is currently $11,972. The Company also maintains a month-to-month apartment lease in Zhuhai, China, that is accounted for under the Company’s short-term lease recognition exemption. In July 2025, the Company entered into office and apartment space leases in Hong Kong with monthly base rent of $897 and $1,987, respectively, that expire in July 2027.

 

As of September 30, 2026, ROU assets totaled $622,370, with current lease liabilities of $219,202 and non-current lease liabilities of $403,168. As of March 31, 2026, ROU assets totaled $779,514, with current lease liabilities of $286,702 and non-current lease liabilities of $492,812.

 

As of September 30, 2026, the future estimated minimum lease payments under non-cancelable operating leases are as follows for the twelve-month periods ending September 30:

 

Twelve months ending September 30   Future Lease Payments  
2027   $ 256,982  
2028     201,960  
2029     210,038  
2030     36,407  
Total lease payments     705,387  
Imputed Interest     (83,017 )
Recorded lease liability   $ 622,370  

 

29

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 9. Leases (continued) 

 

Lease expense recognized in the consolidated statements of operations for the three months ended September 30, 2026 and 2025, was $109,143 and $106,290, respectively. Lease expense recognized in the consolidated statements of operations for the six months ended September 30, 2026 and 2025, was $218,138 and $206,542, respectively.

 

Cash paid for operating leases during the three months ended September 30, 2026 and 2025 was $91,244 and $88,628, respectively. Cash paid for operating leases during the six months ended September 30, 2026 and 2025 was $182,488 and $171,219, respectively.

 

As of September 30, 2026, the weighted-average remaining lease term for the operating leases is 2.90 years, and the weighted-average discount rate is 7.31%. As of March 31, 2026, the weighted-average remaining lease term was 3.88 years, and the weighted-average discount rate was 7.04%.

 

Note 10. Research and Development

 

Research and Development expense for the three months ended September 30, 2026 and 2025, was $202,248 and $189,469, respectively. Research and Development expense for the six months ended September 30, 2026 and 2025, was $511,623 and $398,185, respectively.

 

Note 11. Commitments and Contingencies

 

In February 2024, the Company was named a co-defendant and served a citation by a customer related to alleged injuries obtained when attempting to use the Omni Arena attraction at an entertainment venue. The Company’s attorneys, retained by the Company’s insurance provider, filed a general denial and alleged contributory negligence against the plaintiff. During the quarter ended June 30, 2026, the parties signed a final settlement agreement and release, resolving the matter. All legal costs and settlement fees are covered by the Company’s insurance provider.

 

From time to time, the Company may become involved in legal proceedings and claims arising in the ordinary course of business. The Company assesses such matters based on the information available and records a liability when it is probable that a loss has been incurred and the amount can be reasonably estimated. The Company also considers whether disclosure is required for matters for which a loss is reasonably possible. The ultimate outcome of legal proceedings and claims is subject to inherent uncertainty and could have a material adverse effect on the Company’s business, financial condition, or results of operations. As of September 30, 2026, the Company was not subject to any legal proceedings and was not aware of any material legal proceedings pending or threatened against it.

 

Note 12. Capital Stock

 

Authorized Capital Stock

 

On August 6, 2025, stockholders approved, and on August 7, 2025, the Company filed with the Secretary of State of the State of Delaware, the Sixth Amended and Restated Certificate of Incorporation (the “Certificate”). Pursuant to the Certificate, the Company reclassified and converted each share of its previously outstanding capital stock into shares of Class A common stock, effective immediately upon the acceptance of the Certificate for filing by the Secretary of State of Delaware.

 

As a result of the reclassification and conversion, all outstanding shares of the Company’s capital stock, including all series of preferred stock and any previously outstanding common stock, were automatically reclassified and converted on a one-for-one basis into shares of Class A common stock. Following the effectiveness of the Certificate, only Class A common stock, Class B common stock, and undesignated and unissued Preferred Stock are authorized.

 

As of September 30, 2026, the Company is authorized to issue 300,000,000 shares of Class A common stock, 50,000,000 shares of Class B common stock, and 50,000,000 shares of Preferred Stock.

 

Capital Stock Rights

 

Holders of Class A common stock, Class B common stock, and future holders of Preferred Stock are entitled to dividends, voting rights, liquidation preferences, conversion rights, and anti-dilution protections as described in the Company’s Sixth Amended and Restated Certificate of Incorporation.

 

30

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 12. Capital Stock (continued)

 

Common Stock

 

Voting Rights

 

Holders of Class A common stock and Class B common stock generally vote together as a single class on all matters submitted to a vote of stockholders, except as otherwise required by Delaware law or the Company’s Certificate of Incorporation. Each share of Class A common stock is entitled to one vote per share. Each share of Class B common stock is entitled to twenty votes per share. The holders of Class B common stock will have the ability to control the outcome of matters submitted to stockholders for approval, including the election of directors and the approval of any change in control transaction, for so long as they hold a majority of the voting power of the outstanding capital stock.

 

Under the Company’s Certificate of Incorporation, the number of authorized shares of either class of common stock may be increased or decreased (but not below the number of shares then outstanding) by the affirmative vote of the holders of a majority in voting power of the outstanding shares of capital stock entitled to vote, without a separate class vote, except as otherwise required by law or the Certificate of Incorporation.

 

Dividend Rights

 

Subject to preferences that may apply to any shares of preferred stock outstanding at the time, holders of Class A common stock and Class B common stock are entitled to receive dividends and other distributions as may be declared from time to time by the board of directors out of funds legally available therefor. Dividends and distributions must be paid equally, identically, and ratably on a per-share basis to holders of Class A common stock and Class B common stock, unless different treatment is approved by a majority of each class, voting separately as a class. In the event a dividend is paid in the form of shares of common stock, holders of Class A common stock will receive Class A common stock and holders of Class B common stock will receive Class B common stock.

 

Subdivisions and Combinations

 

If the Company subdivides or combines the outstanding shares of either class of common stock, the outstanding shares of the other class will be subdivided or combined in the same proportion and manner, unless different treatment is approved by a majority of each class, voting separately as a class.

 

Conversion Rights

 

Each share of Class B common stock is convertible at any time at the option of the holder into one (1) share of Class A common stock. Shares of Class B common stock will automatically convert into an equal number of shares of Class A common stock upon (i) any transfer of such shares, except for certain permitted transfers to affiliates or family members as described in the Certificate, or (ii) the date specified by written notice and certification request from the Company if the holder fails to provide satisfactory certification of continued ownership, subject to certain exceptions. In addition, all outstanding shares of Class B common stock will automatically convert into Class A common stock upon the affirmative vote of the holders of at least two-thirds of the outstanding shares of Class B common stock, voting as a single class. Once converted, shares of Class B Common Stock may not be reissued.

 

Other Rights

 

Holders of Class A common stock and Class B common stock have no preemptive or subscription rights, and there are no redemption or sinking fund provisions applicable to either class. Upon liquidation, dissolution, or winding up of the Company, holders of Class A common stock and Class B common stock are entitled to share ratably in all assets remaining after payment of liabilities and any preferential rights of any outstanding preferred stock.

 

31

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 12. Capital Stock (continued)

 

Common Stock Equity Transactions

 

During the six months ended September 30, 2026, the Company issued an aggregate of 84,000 shares of Class A common stock pursuant to consulting, marketing, and media services agreements. Of these shares, 24,000 were issued to FMW Media Works, LLC in connection with a 12-month marketing and media services engagement. The shares were valued based on the Company’s closing stock price of $8.59 per share on January 29, 2026, the grant date, and the related stock-based compensation expense is recognized as the shares are issued over the term of the agreement. On July 27, 2026, the Company entered into a separate consulting services agreement with FMW Media Works, LLC for a one-week media engagement, pursuant to which the Company issued an additional 25,000 restricted shares of Class A common stock. The additional shares had an aggregate fair value of $54,500, based on the Company’s closing stock price of $2.18 per share on July 27, 2026, and were deemed fully earned upon execution of the agreement.

 

On August 19, 2026, the Company entered into a six-month consulting services agreement with Euroswiss Capital Partners Inc. for business development, financial consulting, and investor communications services in Europe. Pursuant to the agreement, as compensation for the services to be provided, the Company issued 35,000 shares of Class A common stock to Moonwood Overseas S.A. on August 24, 2026. The shares had an aggregate fair value of $56,700, based on the Company’s closing stock price of $1.62 per share on August 24, 2026.

 

During the six months ended September 30, 2026, Streeterville Capital, LLC exchanged portions of the Exchange Note with an aggregate Redemption Amount of $852,976, consisting of principal and accrued interest, for 465,840 shares of the Company’s Class A common stock, pursuant to the Exchange Agreement. The shares had an aggregate fair value of $901,066, determined based on the fair value of the Company’s Class A common stock on the exchange dates, which was recorded as common stock issued for debt extinguishment in the condensed consolidated statements of stockholders’ equity. The fair value of the shares issued exceeded the aggregate Redemption Amount by $48,090, which, together with the write-off of the related unamortized debt discount, resulted in a net loss on extinguishment of debt of $101,428 during the six months ended September 30, 2026. The shares were issued free of any restrictive securities legend pursuant to Rule 144. See Note 8 for additional information regarding the Exchange Note and related exchanges.

 

During the six months ended September 30, 2026, the Company incurred $179,287 of equity issuance costs, which were recorded as a reduction to additional paid-in capital. These costs were incurred pursuant to our placement agent agreement with Maxim Partners LLC, under which we are obligated to pay a cash success fee equal to 7.0% of gross proceeds received, including warrant exercise proceeds. For additional information, see Part II, Item 2, “Unregistered Sales of Equity Securities and Use of Proceeds.”

 

During the three months ended September 30, 2026, the Company issued 125,000 shares of Class A common stock upon the exercise of stock options held by an executive officer at an exercise price of $1.66 per share. The aggregate exercise price of $207,500 was satisfied by offsetting a compensation bonus of the same amount issued to the executive officer. The bonus was recognized as compensation expense, and no cash was exchanged in connection with the settlement of the bonus and exercise price.

 

Preferred Stock Equity Transactions

 

During the six months ended September 30, 2025, the Company issued Series B Preferred Stock in connection with equity financings and debt extinguishments. Additional information regarding these transactions is included in the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2026.

 

Warrants

 

Warrants are issued in connection with debt (see Note 8) and equity financings from time to time at the Company’s discretion.

 

The Company used expected annualized volatility of 80% in valuing the warrant amendments. Given the Company’s limited trading history following its January 2026 direct listing, the reasonableness of this assumption was evaluated using historical stock price volatility of selected publicly traded companies in comparable industries. The Company considered shorter historical lookback periods to be relevant given the relatively short expected terms of the warrants. The selected 80% volatility assumption was within the range of observed peer-company volatility and was considered a reasonable estimate for purposes of the warrant valuations.

 

June 1, 2026 Warrant Amendment

 

Effective June 1, 2026, the Company amended the Equity Financing Warrant, the Second Debt Financing Warrant and the Third Debt Financing Warrant to reduce the exercise price from $6.00 per share to $4.00 per share and extend the Reduced Exercise Price Period through the then-current expiration date of the warrants. The Company measured the incremental fair value of the modification by comparing the fair value of the warrants immediately before and immediately after the modification using a Black-Scholes option-pricing model.

 

32

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 12. Capital Stock (continued)

 

The significant assumptions used in the Black-Scholes valuation immediately before and after the June 1, 2026 modification included a stock price of $3.82, an expected term of approximately 0.15 years, expected volatility of 80%, a risk-free interest rate of 3.7%, and an expected dividend yield of 0%. The exercise price used in the valuation was $6.00 immediately before the modification and $4.00 immediately after the modification. The resulting incremental fair value was approximately $0.356 per warrant, or $424,403 in the aggregate. The Company recognized the incremental fair value in Other Income (Expense), with a corresponding increase to additional paid-in capital.

 

June 29, 2026 Warrant Amendment

 

Effective June 29, 2026, the Company further amended the Equity Financing Warrant, the Second Debt Financing Warrant and the Third Debt Financing Warrant to reduce the exercise price from $4.00 per share to $3.00 per share. The Company measured the incremental fair value of the modification by comparing the fair value of the warrants immediately before and immediately after the modification using a Black-Scholes option-pricing model.

 

The significant assumptions used in the Black-Scholes valuation immediately before and after the June 29, 2026 modification included a stock price of $2.73, an expected term of approximately 0.08 years, expected volatility of 80%, a risk-free interest rate of 3.7%, and an expected dividend yield of 0%. The exercise price used in the valuation was $4.00 immediately before the modification and $3.00 immediately after the modification. The resulting incremental fair value was approximately $0.134 per warrant, or $159,747 in the aggregate. The Company recognized the incremental fair value in Other Income (Expense), with a corresponding increase to additional paid-in capital.

 

July 21, 2026 Warrant Amendment

 

Effective July 21, 2026, the Company further amended the Equity Financing Warrant, the Second Debt Financing Warrant and the Third Debt Financing Warrant to reduce the exercise price from $3.00 per share to $2.50 per share. The amendment also extended the expiration date of the warrants and the reduced exercise price period from July 27, 2026 to August 27, 2026, with automatic extensions for up to four additional consecutive one-month periods unless the Special Committee of the Board of Directors determines not to extend, and permits the Company to terminate the reduced exercise price period early upon two trading days’ prior written notice to the investor. The Company measured the incremental fair value of the modification by comparing the fair value of the warrants immediately before and immediately after the modification using a Black-Scholes option-pricing model.

 

The significant assumptions used in the Black-Scholes valuation immediately before and after the July 21, 2026 modification included a stock price of $2.29, expected volatility of 80%, risk-free interest rates ranging from 3.75% to 4.02%, and an expected dividend yield of 0%, with exercise prices of $3.00 and $2.50 immediately before and after the modification, respectively. The expected term immediately before the modification was approximately 0.02 years. Following the modification, the Company applied a probability-weighted valuation approach to account for the potential monthly extensions of the warrants, using cumulative survival probabilities of 95%, 90%, 85%, and 80% beyond the August, September, October, and November 2026 expiration dates, respectively. The resulting probability-weighted expected term was approximately 0.39 years. The resulting incremental fair value was approximately $0.385 per warrant, or $426,249 in the aggregate, which the Company recognized in Other Income (Expense), with a corresponding increase to additional paid-in capital.

 

33

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 12. Capital Stock (continued)

 

During the six months ended September 30, 2026, Streeterville Capital, LLC exercised portions of its Equity Financing Warrant to purchase an aggregate of 685,500 shares of Class A common stock at a weighted-average exercise price of $3.74 per share, resulting in aggregate cash proceeds to the Company of $2,561,250.

 

The following is a rollforward of warrants to purchase shares of Class A common stock for the six months ended September 30, 2026:

 

    Number of
Warrants
    Weighted
Average
Exercise
Price
 
Beginning balance     1,422,142     $ 8.750  
Issued     -       -  
Exercised     (685,500 )     3.736  
Expired     -       -  
Ending balance     736,642     $ 2.500  

 

Warrants are recorded in equity based on their initial fair values or the amounts allocated to them in the related financing transactions, as applicable. The changes in the weighted-average exercise prices reflect the warrant amendments described above.

 

Note 13. Stock Compensation Expense

 

The Company accounts for stock-based compensation under ASC 718. Stock-based compensation expense related to stock options for the three months ended September 30, 2026 and 2025, was $7,018 and $10,953, respectively. Stock-based compensation expense related to stock options for the six months ended September 30, 2026 and 2025, was $14,612 and $21,850, respectively. As of September 30, 2026, total unrecognized compensation cost for non-vested stock options was $9,794, expected to be recognized over a weighted-average period of 8 months.

 

Stock-based compensation expense related to restricted stock units for the three and six months ended September 30, 2026, was $819,310 and $1,431,573, respectively. There was no stock-based compensation expense related to restricted stock units for the three or six months ended September 30, 2025. As of September 30, 2026, total unrecognized compensation cost related to nonvested restricted stock units was $3,775,506, which is expected to be recognized over a weighted-average period of approximately 2.9 years. 

 

During the three months ended September 30, 2026, the Company made various equity-based compensation awards to employees and directors. Among these awards, the Company granted 200,000 restricted stock units to an executive officer that vested immediately upon grant, resulting in stock-based compensation expense of $260,000. On September 24, 2026, the Company also accelerated the vesting of an aggregate of 78,742 previously outstanding restricted stock units held by certain directors and recognized the remaining unrecognized compensation cost associated with those awards. In September 2026, the Company also granted an aggregate of 692,574 restricted stock units to its non-employee directors and 100,000 restricted stock units to its Chief Financial Officer. The related compensation expense is included in the amounts disclosed above.

 

34

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 14. Income Taxes

 

Deferred taxes are recognized for temporary differences between the basis of assets and liabilities for financial statement and income tax purposes. The differences relate primarily to depreciable assets using accelerated depreciation methods for income tax purposes, share-based compensation expense, and for net operating loss carryforwards.

 

The Company recognizes deferred tax assets to the extent that it believes these assets are more likely than not to be realized. In making this determination, the Company considers all available positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax-planning strategies, and recent operating results. The federal tax rate in effect affecting future tax benefits at September 30, 2026 and 2025 was 21%. The Company assessed the need for a valuation allowance against its net deferred tax assets and determined that a full valuation allowance is required due to cumulative losses through September 30, 2026. Accordingly, no provision for deferred income taxes has been recognized.

 

Note 15. Investment in Joint Venture

 

As mentioned in Note 1, the Company had an investment in a Joint Venture named Heroix VR (Shanghai) Co., Ltd. (the “Joint Venture” or “Heroix”). VML had 49% ownership and did not have control over the Joint Venture. During the quarter ended June 30, 2026, the Company received a Certification of Dissolution and Tax Clearance from the People’s Republic of China confirming that Heroix had been legally dissolved, liquidated, and deregistered, with its legal personality terminated effective September 29, 2025. Based on this information, the Company concluded that it no longer possessed an ownership interest in Heroix and, accordingly, derecognized its remaining equity method investment. The investment was accounted for using the equity method until its derecognition during the quarter ended June 30, 2026.

 

For the three and six months ended September 30, 2026, the Joint Venture had operating revenue of $0, cost of goods sold of $0, operating costs of $0, and net loss of $0. Under the equity method, net loss attributable to the Company was $0, resulting in a share of loss in joint venture of $0 in the consolidated statement of operations for the three and six months ended September 30, 2026. The Company recognized a non-cash loss on derecognition of the Joint Venture of $40,619 during the six months ended September 30, 2026.

 

For the six months ended September 30, 2025, the Joint Venture had operating revenue of $0, cost of goods sold of $0, operating costs of $143, and net loss of $143. Under the equity method, net loss attributable to the Company was $70, resulting in a share of loss in joint venture of $70 in the consolidated statement of operations for the six months ended September 30, 2025. No share of loss in joint venture was recognized during the three months ended September 30, 2025.

 

35

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 16. Revenue Disaggregation

 

Revenue from product sales is generally recognized at a point in time upon shipment or installation, while revenue from service programs, subscriptions, extended warranties and Omniverse credits is recognized over time. See Note 2, “Revenue Recognition,” for additional information regarding the timing of revenue recognition.

 

Revenue streams from performance obligations included in net sales for the three months ended September 30, 2026 and 2025, in the consolidated statements of operations are as follows:

 

    September 30,     September 30,  
    2026     2025  
             
SALES            
Omni One(1)   $ 1,110,510     $ 542,524  
Omni Arena(2)     21,376       335,555  
Omni Pro units and accessories(2)     22,403       21,380  
Omniverse credits(3)     22,474       39,353  
Omni Care program(3)     13,334       46,000  
TOTAL SALES   $ 1,190,097     $ 984,812  

 

1. Includes product and digital game sales recognized at a point in time, as well as subscription and extended warranty revenue recognized over time. Of the Omni One revenue presented above, $28,271 and $26,861 for the three months ended September 30, 2026 and 2025, respectively, were recognized over time. The remaining Omni One revenue was recognized at a point in time.

 

2. Revenue recognized at a point in time.

 

3. Revenue recognized over time.

 

Revenue streams from performance obligations included in net sales for the six months ended September 30, 2026 and 2025, in the consolidated statements of operations are as follows:

 

    September 30,     September 30,  
    2026     2025  
             
SALES            
Omni One(1)   $ 1,765,059     $ 1,364,436  
Omni Arena(2)     46,391       436,821  
Omni Pro units and accessories(2)     41,847       36,571  
Omniverse credits(3)     49,433       84,453  
Omni Care program(3)     54,667       94,667  
TOTAL SALES   $ 1,957,397     $ 2,016,948  

 

1. Includes product and digital game sales recognized at a point in time, as well as subscription and extended warranty revenue recognized over time. Of the Omni One revenue presented above, $53,760 and $50,393 for the six months ended September 30, 2026 and 2025, respectively, were recognized over time. The remaining Omni One revenue was recognized at a point in time.

 

2. Revenue recognized at a point in time.

 

3. Revenue recognized over time.

 

Substantially all of the Company’s revenues are derived from customers located in the United States. Revenue attributable to individual foreign countries was not material for the periods presented.

 

36

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 17. Segment Reporting

 

The Company operates in a single operating segment: the design, development, marketing, and sale of omni-directional treadmills, accessories, and related services to consumer and commercial customers. This single operating segment has been identified based on internal management structure and reporting to the Company’s Chief Operating Decision Maker (“CODM”), the Company’s Chief Executive Officer.

 

The Company’s CODM evaluates segment performance based on the revenues, gross profit and operating loss of the segment and uses internal financial statements to make decisions regarding resource allocation. Revenues, gross profit and operating loss used by the CODM are presented on the accompanying consolidated statements of operations. The significant expense categories regularly provided to the CODM and included in the measure of segment operating loss are presented in the accompanying consolidated statements of operations. The measure of segment assets is represented as total assets presented on the accompanying consolidated balance sheets. While there are intercompany transactions between consolidated entities, these are eliminated in consolidation and do not impact the Company’s single segment presentation.

 

The Company has not identified any reportable segments other than the single operating segment discussed.

 

Note 18. Patents

 

As of September 30, 2026, the Company owns sixteen issued utility patents and ten issued design patents, and five additional applications are still pending. Four of the patents are also issued internationally in one or more countries, including Australia, Brazil, China, South Korea, Russia, Europe, and India.

 

Note 19. Subsequent Events

 

In October and November 2026, the Company issued an aggregate of 8,000 shares of Class A common stock to FMW Media Works LLC in connection with marketing and media services. These shares were issued as restricted securities in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder, as a transaction not involving a public offering to an accredited investor.

 

On November 11, 2026, the Company entered into a letter of intent (the “LOI”) concerning the proposed acquisition of all of the outstanding equity interests of STS International, Inc. (“STS”), an Arlington, Virginia-based provider of defense technology and services to the United States government.

 

The LOI contemplates a base purchase price of approximately $12 million, consisting of $8 million in cash and $4 million in shares of the Company’s common stock, subject to negotiation, adjustment, and the terms of a definitive purchase agreement. The proposed transaction also contemplates potential additional consideration, including contingent earnout payments, additional shares issuable under stock-price protection provisions, and possible additional consideration for certain intellectual property assets.

 

The LOI is nonbinding with respect to the proposed acquisition, and no definitive purchase agreement has been negotiated or executed. Material terms remain unresolved, including the final purchase price, potential earnouts, additional consideration, representations and warranties, indemnification provisions, and closing conditions. Neither party is obligated to consummate the proposed acquisition unless and until mutually acceptable definitive agreements are executed.

 

Certain provisions of the LOI, including confidentiality, exclusivity, operational covenants, and transaction expenses, are intended to be legally binding. The LOI provides for a $100,000 exclusivity fee payable by the Company to STS within five business days of execution. The fee is nonrefundable under all circumstances, including if the proposed acquisition is not completed, but would be credited against the cash consideration if the transaction closes.

 

37

 

 

VIRTUIX HOLDINGS INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

SEPTEMBER 30, 2026 AND 2025 (UNAUDITED)

 

Note 19. Subsequent Events (continued)

 

The proposed acquisition remains at a preliminary stage, and certain conditions must be satisfied before the parties may execute a definitive purchase agreement. These conditions include:

 

● Financial audit. Financial information furnished by STS is unaudited, has been prepared on a cash basis rather than in accordance with U.S. generally accepted accounting principles (“GAAP”), and has not been independently verified by the Company or its independent auditors. It is a condition to closing that the Company receive audited financial statements of STS accompanied by an unqualified audit opinion.

 

● Due diligence. The Company has not completed its financial, accounting, legal, tax, operational, commercial, and regulatory due diligence review of STS. Execution of a definitive purchase agreement is subject to the Company’s satisfaction with the results of that review.

 

● Fairness opinion. The Company’s Board of Directors must receive a fairness opinion from an independent financial advisor prior to closing satisfactory to the Board.

 

● Financing. The proposed acquisition contemplates $8 million in cash consideration, in addition to related transaction expenses and potential working capital requirements. The Company has not obtained a definitive financing commitment for the cash consideration. There can be no assurance that the necessary financing will be available on acceptable terms or at all.

 

● Definitive Agreement. The parties have not agreed upon all material terms of the proposed acquisition, and there can be no assurance that a definitive purchase agreement will be negotiated, approved, or executed.

 

Regulatory and other approvals. The proposed acquisition remains subject to applicable governmental, contractual, corporate, and other approvals or consents, including any required approvals from the U.S. Department of Defense.

 

The proposed transaction also involves risks relating to STS’s government contracts, contract vehicles, security clearances, certifications, intellectual property, and the possible effects of a change in ownership. Any definitive purchase agreement would be expected to include additional negotiated conditions, including the absence of specified material adverse changes, the accuracy of representations and warranties, and compliance with contractual covenants.

 

There can be no assurance that these conditions, including the completion of the audit and due diligence, receipt of a fairness opinion, and securing of financing, will be satisfied, that the parties will execute a definitive purchase agreement, or that the proposed acquisition will be completed on the terms currently contemplated or at all. The proposed transaction may be delayed, materially modified, or abandoned.

 

As of the date of issuance of these financial statements, the proposed acquisition has not been consummated, and the Company has not recognized any acquired assets or assumed liabilities in connection with the proposed acquisition.

 

38

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

 

Cautionary Note Regarding Forward-Looking Statements

 

All statements other than statements of historical fact included in this Report including, without limitation, statements under this Item regarding our financial position, business strategy and the plans and objectives of Management for future operations, are forward-looking statements. When used in this Report, words such as “anticipate,” “believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us or our Management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of our Management, as well as assumptions made by, and information currently available to, our Management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC. All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph.

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the unaudited condensed consolidated financial statements and the notes thereto included in this Report under “Item 1. Interim Financial Statements”.

 

Overview and History

 

We believe Virtuix is a leading developer of AI-driven, full-body simulation systems for immersive entertainment, defense training, and enterprise applications. We pioneer movement in AI-generated worlds, whether imaginary or real, through the development of omni-directional treadmills that let users walk and run in 360 degrees without boundaries. Our flagship product, Omni One, represents a breakthrough in natural locomotion, enabling full freedom of movement, including crouching, kneeling, and jumping, in every direction within a small footprint. We operate a vertically integrated business across product design, manufacturing, content and simulation development, and distribution, with a focus on three key markets: consumer, enterprise, and defense.

 

Our earlier products, Omni Pro and Omni Arena, established our footprint in commercial entertainment. We’ve sold more than 4,000 Omni Pro systems for enterprise, installed 80 Omni Arena systems at entertainment venues in the U.S., and built an Omni Arena player base of over 500,000 players who signed up with an email address to play. Omni One, our most recent product, was designed for the home consumer and supports full freedom of movement within popular virtual reality games. We also sell a version of Omni One for enterprise markets and, in parallel, we are developing immersive training systems for the defense market, including Virtual Terrain Walk (“VTW”), an AI-driven, multi-user simulation system for mission planning and leader rehearsals, and Infantry Fireteam Trainer (“IFT”), a four-person training system that enables infantry teams to physically maneuver together through mission scenarios.

 

We derive revenue through a combination of hardware sales and recurring software and service income. These include:

 

● Omni One hardware sales, with pricing ranging from $2,495 to $2,995.

 

● Omni Online subscription service ($14/month or $140/year), offering multiplayer access, esports leaderboards, and free games.

 

● Game sales via Omni One’s proprietary game store.

 

● Enterprise solutions, including Omni One Enterprise and Omni Arena systems.

 

● Accessory and replacement parts sales for Omni One and Omni Arena systems.

 

● Omni Care maintenance subscriptions for Omni Arena.

 

● Omniverse Credits for Omni Pro and Omni Arena gameplay (per-minute usage fees).

 

39

 

 

We target a gross margin of 40% on hardware sales of Omni One and second-hand Omni Arena systems, and 70% gross margin on Omni One Enterprise hardware sales. Actual gross margins may be lower than these targets due to promotional discounts offsetting sales and depreciation and amortization expenses included in cost of goods sold. Recurring revenue from Omni Online, game sales, Omni Care, and Omniverse Credits provides high-margin, predictable cash flows that recur after initial hardware sales.

 

Since inception, we have operated at a loss, with revenues of $1,957,397 and $2,016,948 for the six months ended September 30, 2026 and 2025, respectively, and $1,190,097 and $984,812 for the three months ended September 30, 2026 and 2025, respectively. Our net losses were $(13,538,077) and $(4,173,851) for the six months ended September 30, 2026 and 2025, respectively, and $(6,367,511) and $(1,866,696) for the three months ended September 30, 2026 and 2025, respectively. We anticipate continued operating losses as we pursue market penetration and revenue growth in fiscal year 2027.

 

Key milestones for achieving sustainable profitability include:

 

  ● Scaling Omni One consumer sales through increased marketing at an acceptable customer acquisition cost and increased adoption as part of the Made for Meta program.

 

● Supplementing potentially high-volume Omni One consumer sales with potentially high-value defense contracts. We believe a “dual-use” strategy of building consumer sales plus defense contracts can position us for achieving revenue growth and sustainable profitability.

 

Our technology is getting early traction in the defense market. Over the last year, we sold Omni One test units to the U.S. Marine Corps, the U.S. Air Force Academy, the U.S. Military Academy at West Point, the U.S. Army’s National Simulation Center, the U.S. Navy, and the Air National Guard. We were also selected for Phase 1 SBIR funding by the U.S. Air Force to advance the development of VTW, were named to be the lead integrator on the development of IFT by the U.S. Marine Corps Training and Education Command (TECOM), signed a development agreement with the U.S. Navy, and integrated Omni One in a Counter-UAS training system developed for evaluation by the U.S. Marine Corps. However, we expect that meaningful sales in the defense sector may not materialize until fiscal year 2028 at the earliest. Despite the long sales cycle for penetrating the defense market, we believe that our simulation systems will retain a strong competitive moat because of our expansive omni-directional treadmill patent portfolio and our position as a U.S. company. To sell to defense customers, we will need to comply with certain requirements and regulations to qualify for government contracts or awards, depending on the type of contract or award, including but not limited to compliance with the FAR and DFARS, Export Administration Regulations, cybersecurity regulations, and requirements and restrictions related to the secure sourcing of components, including the Buy American Act and Berry Amendment. For additional information, see “Risk Factors — Our business with governmental entities will be subject to the policies, priorities, regulations, mandates and funding levels of such governmental entities and may be negatively or positively impacted by any change thereto” of our Prospectus dated January 26, 2026.

 

Following our shift in R&D and marketing efforts to Omni One, and the shift in demand for entertainment attractions from staffed VR attractions such as Omni Arena to unstaffed, lower-tech offerings, we consider the Omni Arena business to be in sustaining mode. We no longer produce new systems or invest in new games or software upgrades for the system, but we continue to support our existing Omni Arena operators and earn recurring revenues from Omni Care maintenance contracts, Omniverse Credits sales, and the sale of repair and replacement parts. We also facilitate secondary market sales of Omni Arena systems and earn a target gross margin of approximately 40% on revenues earned from reselling second-hand systems and disassembling, moving, and installing such systems.

 

Our path to profitability relies on scaling Omni One sales at an acceptable customer acquisition cost and on gaining adoption in the defense sector. Although we believe that our plans are realistic, there is no guarantee that we will be able to scale Omni One sales or find product-market fit in the defense sector.

 

We believe Virtuix is at the leading edge of immersive entertainment, enterprise training, defense simulation, and the development of hyper-realistic digital twins of the real world through Gaussian splatting and other AI-driven 3D reconstruction technologies. In a world where AI is used to rapidly generate realistic virtual environments, whether imaginary game worlds or digital twins of the real world, we develop the technology and products for physically moving around in these virtual environments. We believe we are positioned to help define the next decade of XR advancements and be a leader in immersive gaming and simulation.

 

Factors Affecting our Business and Results of Operations

 

This section includes a summary of our historical results of operations, including detailed comparisons of our results for the three and six months ended September 30, 2026 and 2025. We have derived the three and six month data from our financial statements included elsewhere in this Report.

 

40

 

 

Results of Operations

 

Comparison of the Three Months Ended September 30, 2026 and 2025

 

The comparative 2025 financial information reflects the revisions described in Note 2 to the condensed consolidated financial statements.

 

Revenues

 

Sales for the three months ended September 30, 2026, were $1,190,097, a 21% increase from sales of $984,812 for the three months ended September 30, 2025. Sales related to Omni One increased to $1,110,510 in the three months ended September 30, 2026, from $542,524 in the comparable 2025 period, representing an increase of $567,986, or 105%. This increase is primarily attributable to the launch of Omni One for Quest in June 2026 in collaboration with Meta Platforms, Inc. Following the launch of Omni One for Quest, new orders for Omni One systems increased 230%, or by a factor of 3.3X, in the three months ended September 30, 2026 compared to the number of Omni One unit orders placed in the three months ended September 30, 2025. The number of orders for Omni One Enterprise systems increased 45% in the three months ended September 30, 2026 compared to the three months ended September 30, 2025. The increase in Omni One sales was partially offset by a decrease in Omni Arena sales of $314,179 in the three months ended September 30, 2026, as the Company has shifted its focus to selling and marketing the Omni One system. We no longer produce new Omni Arena systems, but we continue to support our existing operators.

 

The following table summarizes our revenue by product line:

 

    Three Months
Ended
September 30,
2026
    Three Months
Ended
September 30,
2025
 
SALES            
Omni One   $ 1,110,510     $ 542,524  
Omni Pro units and accessories     22,403       21,380  
Omniverse Credits     22,474       39,353  
Omni Care program     13,334       46,000  
Omni Arena     21,376       335,555  
TOTAL SALES   $ 1,190,097     $ 984,812  

 

Cost of Goods Sold

 

Cost of goods sold primarily consists of material costs and shipping costs of Omni One and Omni Arena.

 

Cost of goods sold in the three months ended September 30, 2026 was $894,898, an increase of $317,635 compared to cost of goods sold of $577,263 in the three months ended September 30, 2025. The increase was primarily attributable to higher Omni One hardware sales and the associated material and shipping costs, partially offset by a decrease in Omni Arena sales.

 

Gross profit in the three months ended September 30, 2026 was $295,199, a decrease of $112,350, compared to gross profit of $407,549 in the three months ended September 30, 2025. Gross margin as a percentage of revenue decreased to 25% from 41%, reflecting the change in revenue mix toward Omni One hardware, which has a lower margin than Omni Arena hardware and associated recurring service revenues. Omni One represented a substantially larger portion of revenue in the current period, while higher-margin Omni Arena and recurring service revenues, including Omni Care and Omniverse Credits, represented a larger portion of revenue in the prior-year period.

 

41

 

 

Operating Expenses

 

Operating expenses consist of general and administrative expenses, which are primarily salaries, professional fees, and expenses related to investor relations and the administrative functions of the Company, research and development expenses, which consist primarily of product development costs and salaries, and sales and marketing expenses, which represent advertising and other marketing costs, as well as the associated personnel costs.

 

    Three Months
Ended
September 30,
2026
    Three Months
Ended
September 30,
2025
 
Selling Expenses   $ 924,457     $ 345,791  
General & Administrative     4,005,950       1,407,057  
Research & Development     202,248       189,469  
Total Operating Expenses   $ 5,132,655     $ 1,942,317  

 

Total operating expenses increased to $5,132,655 in the three months ended September 30, 2026, from $1,942,317 in the three months ended September 30, 2025.

 

  ● Selling Expenses:    For the three months ended September 30, 2026 compared to the same period in 2025, Selling Expenses increased to $924,457 from $345,791. The increase was primarily attributable to higher digital advertising expenditures to promote the launch of Omni One for Quest, and top-of-funnel marketing to build the sales pipeline in preparation for the 2026 holiday season. The Company expects its investment in top-of-funnel marketing during the three months ended September 30, 2026, to convert to sales in the third quarter of fiscal year 2027.

 

  ● General and Administrative Expenses:   For the three months ended September 30, 2026 compared to the same period in 2025, General and Administrative Expenses increased to $4,005,950 from $1,407,057. The increase was primarily attributable to expenses associated with operating as a publicly traded company since our public listing in January 2026. Professional services, such as legal, accounting, investor relations, and other professional services, increased by $1,224,420 for the 2026 period compared to the same period in 2025. Employee stock compensation expense, a non-cash expense, increased by $815,374 for the 2026 period as a result of RSUs granted under the 2025 Omnibus Incentive Plan. Additionally, salary and payroll expenses increased by $505,946 for the 2026 period, and insurance expenses increased by $155,977 for the 2026 period. These increases were offset by a decrease of approximately $100,000 in miscellaneous other G&A expenses. Now that we have operated as a publicly traded company for nearly three quarters, we believe we have opportunities to reduce General and Administrative Expenses in future periods. We intend to identify potential cost-saving measures and evaluate opportunities to improve operational efficiency.

 

● Research and Development:   For the three months ended September 30, 2026 compared to the same period in 2025, Research and Development expenses increased to $202,248 from $189,469. This increase was due to an increase in staffing and salaries to advance Omni One for Quest and other projects in development.

 

Other Expense

 

For the three months ended September 30, 2026, Other Expense totaled $1,505,243, primarily driven by interest expense of $2,047,820, including $1,825,005 of non-cash amortization of debt discounts and debt issuance costs related to the Company’s financing arrangements, and $426,249 of non-cash financing expenses recognized in connection with amendments to certain outstanding warrants. These were partially offset by $667,554 of non-cash gain on change in fair value of PPP #1 derivative liability, $263,620 of non-cash gain on change in fair value of PPP #2, and $37,492 gain on debt extinguishment. For the three months ended September 30, 2025, Other Expense totaled $331,175 and consisted primarily of interest expense.

 

Net Loss

 

As a result of the foregoing, net loss for the three months ended September 30, 2026 was $(6,367,511) compared to $(1,866,696) for the three months ended September 30, 2025, representing an increase in net loss of $4,500,815. The increase was driven primarily by higher non-cash expenses such as amortization of debt discounts and debt issuance costs, warrant modification expenses, and stock compensation expenses, as well as higher professional services expenses related to operating as a publicly traded company.

 

42

 

 

Comparison of the Six Months Ended September 30, 2026 and 2025

 

The comparative 2025 financial information reflects the revisions described in Note 2 to the condensed consolidated financial statements.

 

Revenues

 

Sales for the six months ended September 30, 2026, were $1,957,397, a 3% decrease from sales of $2,016,948 for the six months ended September 30, 2025. The decrease reflected a $390,430 reduction in Omni Arena sales and a combined $75,020 reduction in Omniverse Credits and Omni Care revenue, partially offset by a $400,623 increase in Omni One sales. The decline in Omni Arena sales occurred as the Company shifted its focus to selling and marketing the Omni One system. We no longer produce new Omni Arena systems, but we continue to support our existing operators. Omni One revenues increased 29% in the six months ended September 30, 2026 compared to the six months ended September 30, 2025.

 

The following table summarizes our revenue by product line:

 

    Six Months
Ended
September 30,
2026
    Six Months
Ended
September 30,
2025
 
SALES            
Omni One   $ 1,765,059     $ 1,364,436  
Omni Pro units and accessories     41,847       36,571  
Omniverse Credits     49,433       84,453  
Omni Care program     54,667       94,667  
Omni Arena     46,391       436,821  
TOTAL SALES   $ 1,957,397     $ 2,016,948  

 

Cost of Goods Sold

 

Cost of goods sold primarily consists of material costs and shipping costs of Omni One and Omni Arena.

 

Cost of goods sold in the six months ended September 30, 2026 was $1,435,040, compared to $1,433,322 in the six months ended September 30, 2025, remaining relatively flat between periods. Changes in cost of goods sold were generally consistent with changes in revenue by product line.

 

Gross profit in the six months ended September 30, 2026 was $522,357, a decrease of $61,269, or 10%, compared to gross profit of $583,626 in the six months ended September 30, 2025. Gross margin as a percentage of revenues decreased to 27% in the six months ended September 30, 2026 from 29% in the six months ended September 30, 2025. The decrease in gross margin reflected a shift in revenue mix toward Omni One hardware, which has a lower margin than Omni Arena hardware and accounted for approximately 90% of total revenues compared to 68% in the prior-year period, and a corresponding reduction in revenues from higher-margin recurring service offerings, including Omni Care and Omniverse Credits.

 

Operating Expenses

 

Operating expenses consist of general and administrative expenses, which are primarily salaries, professional fees, and expenses related to investor relations and the administrative functions of the Company, research and development expenses, which consist primarily of product development costs and salaries, and sales and marketing expenses, which represent advertising and other marketing costs, as well as the associated personnel costs.

 

    Six Months
Ended
September 30,
2026
    Six Months
Ended
September 30,
2025
 
Selling Expenses   $ 1,663,435     $ 1,395,449  
General & Administrative     7,086,728       2,366,449  
Research & Development     511,623       398,185  
Total Operating Expenses   $ 9,261,786     $ 4,160,083  

 

43

 

 

Total operating expenses increased to $9,261,786 in the six months ended September 30, 2026, from $4,160,083 in the six months ended September 30, 2025.

 

● Selling Expenses:    For the six months ended September 30, 2026 compared to the same period in 2025, Selling Expenses increased to $1,663,435 from $1,395,449. The increase was primarily attributable to higher digital advertising expenditures to promote Omni One for Quest. The 2025 period was largely driven by the significant digital ad spend for our Regulation Crowdfunding (“Reg CF”) investment campaign with StartEngine that ended around the end of June 2025.

 

  ● General and Administrative Expenses:   For the six months ended September 30, 2026 compared to the same period in 2025, General and Administrative Expenses increased to $7,086,728 from $2,366,449. The increase was primarily attributable to expenses associated with operating as a publicly traded company since our public listing in January 2026. Professional services, such as legal, accounting, investor relations, and other professional services, increased by $2,580,595 for the 2026 period compared to the same period in 2025. Employee stock compensation expense, a non-cash expense, increased by $1,424,334 for the 2026 period as a result of RSUs granted under the 2025 Omnibus Incentive Plan. Additionally, salary and payroll expenses increased by $621,560 for the 2026 period, and insurance expenses increased by $306,810 for the 2026 period. These increases were offset by a decrease of approximately $215,000 in miscellaneous other G&A expenses. Now that we have operated as a publicly traded company for nearly three quarters, we believe we have opportunities to reduce General and Administrative Expenses in future periods. We intend to identify potential cost-saving measures and evaluate opportunities to improve operational efficiency.

 

● Research and Development:   For the six months ended September 30, 2026 compared to the same period in 2025, Research and Development expenses increased to $511,623 from $398,185. This increase was due to an increase in staffing and salaries to advance Omni One for Quest and other projects in development.

 

Other Expense

 

For the six months ended September 30, 2026, Other Expense totaled $4,724,445, primarily driven by interest expense of $4,587,412, including $4,140,678 of non-cash amortization of debt discounts and debt issuance costs related to the Company’s financing arrangements, $1,010,399 of non-cash financing expenses recognized in connection with amendments to certain outstanding warrants, and $393,732 of non-cash loss on debt extinguishment, consisting primarily of the loss recognized in connection with the May 22 exchange of the secured convertible promissory notes for PPP #2 and losses recognized in connection with Exchange Note limited redemptions during the six-month period. These were partially offset by $1,016,682 of non-cash gain on change in fair value of PPP #1 derivative liability and $286,842 of non-cash gain on change in fair value of PPP #2. For the six months ended September 30, 2025, Other Expense totaled $573,153, primarily comprised of interest expense and a $122,864 loss on extinguishment of certain 2024 subordinated promissory notes in connection with their amendment to permit settlement through the issuance of Series B Preferred Stock and warrants.

 

Net Loss

 

As a result of the foregoing, net loss for the six months ended September 30, 2026 was $(13,538,077) compared to $(4,173,851) for the six months ended September 30, 2025, representing an increase in net loss of $9,364,226. The increase was driven primarily by higher non-cash expenses such as amortization of debt discounts and debt issuance costs, warrant modification expenses, loss on debt extinguishment, and stock compensation expenses, as well as higher professional services expenses related to operating as a publicly traded company.

 

44

 

 

Non-GAAP Financial Measures

 

Management reviews a variety of operational and financial metrics to assess the Company’s performance, allocate resources, and inform strategic decision-making. In addition to net sales, net loss, and other measures prepared in accordance with accounting principles generally accepted in the United States (“GAAP”), this report includes certain operating metrics and non-GAAP financial measures that management considers meaningful in evaluating the Company’s operating performance.

 

These measures are used by management and the Board of Directors to assess trends in the business, evaluate the effectiveness of operational initiatives, and support decisions regarding investment and cost management. Management believes that the presentation of these non-GAAP financial measures provides investors with additional insight into the Company’s operating results and facilitates period-to-period comparisons.

 

Adjusted EBITDA

 

    For the Three Months Ended
September 30,
    For the Six Months Ended
September 30,
 
    2026     2025     2026     2025  
    (Unaudited)     (Unaudited)  
Reconciliation of GAAP net loss to Adjusted EBITDA                  
NET LOSS   $ (6,367,511 )   $ (1,866,696 )   $ (13,538,077 )   $ (4,173,851 )
Plus:                                
Taxes     24,812       753       74,203       24,171  
Interest expense, net(1)     2,047,733       331,345       4,587,162       450,459  
Depreciation and amortization     159,576       157,006       302,529       315,782  
EBITDA   $ (4,135,390 )   $ (1,377,592 )   $ (8,574,183 )   $ (3,383,439 )
Plus:                                
Stock-based compensation(2)     1,040,608       205,588       1,763,545       216,485  
Financing expense(3)     426,249       -       1,010,399       -  
Loss (gain) on extinguishment of debt     (37,492 )     -       393,732       122,864  
Less:                                
Change in fair value of financial instruments     (931,174 )     -       (1,303,524 )     -  
ADJUSTED EBITDA   $ (3,637,199 )   $ (1,172,004 )   $ (6,710,031 )   $ (3,044,090 )

 

1. Interest expense for the three and six months ended September 30, 2026 includes $1,825,005 and $4,140,678, respectively, of non-cash amortization of debt discounts and debt issuance costs related to the Company’s financing arrangements with Streeterville Capital, LLC. These amounts relate to original issue discounts, amounts allocated to warrants and bifurcated embedded derivatives, and deferred legal and other debt issuance costs. See Note 8 – Notes Payable to the condensed consolidated financial statements.

 

2. Stock-based compensation expense for the three and six months ended September 30, 2026 consisted of non-cash expenses of $214,280 and $317,360, respectively, related to equity awards granted to vendors and service providers, and $826,328 and $1,446,185, respectively, related to equity awards granted to employees, officers, and directors. For the three and six months ended September 30, 2025, the stock-based compensation adjustment included $194,635 in both periods related to shares issued to Maxim Partners LLC for advisory services, together with $10,953 and $21,850, respectively, related to equity awards granted to employees, officers, and directors.

 

3. Financing expense represents non-cash charges recognized in connection with amendments to certain outstanding warrants during the three and six months ended September 30, 2026, totaling $426,249 and $1,010,399, respectively. The charges represent the incremental fair value resulting from the warrant modifications, with corresponding increases to additional paid-in capital. No corresponding financing expense was recognized during the comparable periods in 2025.

 

Adjusted EBITDA is a non-GAAP financial measure that we use to evaluate our operating performance. Adjusted EBITDA represents net income (loss), adjusted to exclude: (i) provision for (benefit from) income taxes, (ii) interest expense, net, (iii) depreciation and amortization, (iv) stock-based compensation expense, (v) financing expense, (vi) gains or losses on extinguishment of debt, and (vii) gains or losses from changes in the fair value of financial instruments.

 

45

 

 

We believe Adjusted EBITDA is useful to investors because it provides a supplemental measure of our operating performance by excluding non-cash expenses and other items that may not be indicative of our core operating results or that may vary significantly from period to period. For the periods presented, such non-cash items include amortization of debt discounts and debt issuance costs, depreciation and amortization, stock-based compensation expense, and changes in the fair value of financial instruments, which can significantly impact reported net loss but do not impact our cash flow. However, Adjusted EBITDA has limitations and should not be considered in isolation or as a substitute for financial information prepared in accordance with GAAP. These limitations include the following:

 

● Stock-based compensation has been, and is expected to continue to be, a significant recurring expense and an important component of our compensation strategy.

 

● Depreciation and amortization relate to assets that may require replacement in the future, and Adjusted EBITDA does not reflect the cash requirements for capital expenditures.

 

● Adjusted EBITDA does not reflect changes in working capital or the cash requirements necessary to service our debt.

 

● Other companies, including companies in our industry, may calculate similarly titled non-GAAP measures differently, limiting their usefulness as comparative measures.

 

Accordingly, Adjusted EBITDA should be considered only as a supplement to, and not as a substitute for, net income (loss) and other measures prepared in accordance with GAAP.

 

Non-Cash Accounting Effects of the Company’s Financing Arrangements

 

Certain of the Company’s financing arrangements with Streeterville Capital, LLC contain features that require fair-value measurement under GAAP. Certain embedded features of the Company’s first pre-paid purchase arrangement (“PPP #1”) are accounted for separately as a derivative liability under ASC 815, and the Company elected the fair-value option under ASC 825 for its second pre-paid purchase arrangement (“PPP #2”), resulting in the entire PPP #2 instrument being measured at fair value on a recurring basis.

 

As of September 30, 2026, the Company had $4,920,475 of Level 3 financial liabilities associated with its financing arrangements with Streeterville, consisting of $1,233,095 for the PPP #1 embedded derivative liability and $3,687,380 for PPP #2. The debt host associated with PPP #1 and the Exchange Note are accounted for separately. The Level 3 amounts reflect fair-value measurements required under GAAP based on the contractual features of the instruments and market-participant assumptions. Changes in these fair value measurements are recognized in earnings but do not, in themselves, result in cash receipts or payments.

 

These fair-value measurements are determined using Monte Carlo simulation and other valuation techniques that incorporate assumptions and market-based inputs, including the market price and expected volatility of the Company’s Class A common stock, discount rates, expected timing of share settlements, and estimated probabilities of prepayment, default, change of control, and other contractual settlement events. As a result, the recorded fair values of these liabilities may fluctuate materially from period to period. During the six months ended September 30, 2026, the valuations reflected a significant decline in the Company’s stock price, from $6.77 at March 31, 2026 to $1.23 at September 30, 2026, along with increases in expected volatility and discount rates and changes in modeled settlement assumptions. These factors affect the expected value and timing of potential share and cash settlements, including the present value of future obligations. The fair-value gains reported below are included in the Company’s GAAP results of operations, but the remeasurement itself does not result in a corresponding receipt of cash.

 

For example, the fair value of the PPP #1 embedded derivative liability decreased from $2,249,777 at March 31, 2026 to $1,900,649 at June 30, 2026 and $1,233,095 at September 30, 2026. The Company therefore recognized non-cash gains of $667,554 and $1,016,682 during the three and six months ended September 30, 2026, respectively. Conversely, an increase in the calculated fair value of the liability in a future period would generally result in a non-cash charge to earnings, without the remeasurement itself requiring a corresponding cash payment during that period.

 

46

 

 

The fair value of PPP #2 decreased from $3,897,000 at June 30, 2026 to $3,687,380 at September 30, 2026. Because the Company recognizes contractual interest expense separately, the $263,620 fair-value gain recognized during the three months ended September 30, 2026 reflects both the $209,620 decrease in the total fair value of the instrument and the effect of $54,000 of contractual interest accrued separately during the quarter. For the six months ended September 30, 2026, the Company recognized a fair-value gain of $286,842. These gains did not provide cash to the Company.

 

The Company’s financing arrangements also result in non-cash amortization of debt discounts and debt issuance costs. Interest expense included $1,825,005 and $4,140,678 of such amortization for the three and six months ended September 30, 2026, respectively. These amounts arise from original issue discounts, amounts allocated to warrants and bifurcated embedded derivatives, and deferred legal and other debt issuance costs. Amortization reduces reported GAAP earnings over the applicable recognition periods but does not represent a corresponding cash interest payment in the period in which the expense is recognized. Contractual interest expense is distinct from this amortization: it represents interest accruing under the terms of the borrowing arrangements, and its recognition does not necessarily coincide with a cash payment.

 

The Streeterville warrants are equity-classified and are separate from the PPP derivative and fair-value liabilities. Amendments to the warrants resulted in non-cash financing expense reflecting the incremental fair value of the modified warrants, with corresponding increases to additional paid-in capital. The $2.50 exercise price following the July 21, 2026 amendment applies to the warrants and is not the variable share-purchase price under the PPP arrangements. Cash received from warrant exercises is a separate financing cash flow; recognition of the warrant-modification expense does not itself require a cash payment.

 

The Company also recognized gains and losses on debt extinguishment in connection with the exchange of the predecessor convertible notes for PPP #2 and the settlement of Exchange Note redemptions through the issuance of common stock. These amounts reflect differences between the carrying amounts of the obligations extinguished and the amounts recognized for the consideration issued. The September quarter included a $37,492 gain on Exchange Note redemptions. The six-month period included a $292,304 loss on the May 22, 2026 exchange and a net loss of $101,428 on Exchange Note redemptions, resulting in the $393,732 loss on debt extinguishment reported in the condensed consolidated statement of operations. These exchanges and equity settlements did not provide additional cash proceeds to the Company.

 

The following table categorizes selected GAAP income-statement components associated with the Streeterville financing arrangements for the periods presented. Parentheses indicate expenses or losses that reduce pre-tax income; other amounts represent gains that increase pre-tax income. Contractual interest is included separately for context and is not a measure of cash interest paid.

 

Financing-related item   (Unaudited)
Three Months Ended
September 30, 2026
    (Unaudited)
Six Months Ended
September 30, 2026
    Nature of item
Change in fair value of PPP #1 embedded derivative liability   $ 667,554     $ 1,016,682     Non-cash fair-value remeasurement gain.
Change in fair value of PPP #2   $ 263,620     $ 286,842     Non-cash fair-value gain; contractual interest is recognized separately.
Amortization of debt discounts and debt issuance costs   $ (1,825,005 )   $ (4,140,678 )   Non-cash amortization included in interest expense.
Contractual interest expense   $ (222,229 )   $ (445,667 )   Interest accruing under the borrowing terms; distinct from amortization and fair-value changes.
Financing expense from warrant modifications   $ (426,249 )   $ (1,010,399 )   Non-cash incremental fair value of amendments to equity-classified warrants.
Gain (loss) on extinguishment of debt   $ 37,492     $ (393,732 )   Non-cash effects of debt exchanges and equity-settled redemptions.

 

The characterization of these items as non-cash in the period does not mean that the underlying financing arrangements lack economic consequences or that these amounts should be disregarded in evaluating the Company’s financial condition or results of operations. The arrangements involve contractual obligations and may require future cash payments or the issuance of additional shares, with potential dilution to existing stockholders. The timing and amount of the GAAP income-statement effects may differ materially from the timing and amount of the associated cash flows.

 

47

 

 

Management believes that separately identifying and explaining these financing-related accounting effects assists investors in understanding the Company’s reported results, financial condition, and cash flows. These amounts remain components of the Company’s results determined in accordance with GAAP. This discussion does not adjust, exclude, or otherwise modify any GAAP measure and is not intended to be, and should not be viewed as, a non-GAAP financial measure or a substitute for the Company’s GAAP results. See Notes 2, 8, and 12 to the condensed consolidated financial statements and “Liquidity and Capital Resources” for additional information.

 

Liquidity and Capital Resources

 

We continue to experience negative cash flows from operations as we expand our business. Our cash flows from operating activities are significantly affected by our cash investments to support the growth of our business in areas such as sales and marketing, product development, and general and administrative expenses. Our operating cash flows are also affected by our working capital needs to support the scaling of manufacturing and inventories.

 

As of September 30, 2026, the Company had cash on hand of $4,963,127. Since its inception, the Company has incurred net losses and funded its operations primarily through the issuance of equity securities. As of September 30, 2026, the Company had a total stockholders’ deficit of $(6,176,852). The Company has incurred recurring losses from operations, and as of September 30, 2026, had an accumulated deficit of $(92,884,512).

 

The Company’s continued existence is dependent upon its ability to continue to execute its operating plan and to obtain additional debt or equity financing. The Company has developed plans to raise funds and continues to pursue sources of funding that management believes, if successful, would be sufficient to support the Company’s operations and growth. However, there can be no assurance that the Company will be successful in obtaining the additional financing required.

 

During the three and six months ended September 30, 2026, the Company received aggregate gross proceeds of $1,181,250 and $2,561,250, respectively, through the exercise of warrants, pursuant to which Virtuix issued 455,500 and 685,500 shares of Class A common stock, respectively.

 

On January 27, 2026, in connection with the closing of the Company’s direct listing, Streeterville funded the initial pre-paid purchase under the Equity Purchase Agreement. The Company received $8,000,000 in cash proceeds, net of an 8% original issue discount, and the pre-paid purchase had an original principal balance of $8,640,000 (“PPP #1”). PPP #1 bears interest at a rate of 6% per annum and has no stated maturity date.

 

On May 22, 2026, the Company and Streeterville exchanged the outstanding First Note, Second Note and Third Note, including accrued interest thereon, for a second pre-paid purchase under the Equity Purchase Agreement (“PPP #2”). PPP #2 had an original principal balance of $3,471,923. The exchange did not provide the Company with additional cash proceeds. As a result of the exchange, the Streeterville Notes were extinguished, and no amounts remained outstanding under those notes as of September 30, 2026.

 

48

 

 

PPP #2 bears interest at a rate of 6% per annum and contains terms substantially consistent with those of PPP #1, including Streeterville’s ability to apply outstanding amounts toward the purchase of shares of the Company’s Class A common stock in accordance with the applicable agreement. The Company may prepay all or a portion of the outstanding balance of each pre-paid purchase, subject to specified prepayment premiums. The agreements also contain customary events of default, ownership limitations and other Company covenants.

 

During the six months ended September 30, 2026, Streeterville delivered limited redemption notices under the Exchange Note with an aggregate redemption amount of $852,976. The Company settled the limited redemptions through the issuance of an aggregate of 465,840 shares of Class A common stock. The settlements were non-cash financing transactions and did not provide the Company with additional liquidity. As of September 30, 2026, the Exchange Note had an outstanding principal balance of $1,894,856.

 

Under the Equity Purchase Agreement, Streeterville committed to purchase up to an aggregate of $50,000,000 of the Company’s Class A common stock through one or more pre-paid purchases over a 24-month period. The Company’s ability to obtain additional advances is subject to several conditions, including minimum market-capitalization and trading-volume requirements, continued compliance with Nasdaq listing standards and the effectiveness of an applicable resale registration statement. As of September 30, 2026, the Company did not meet the conditions required to obtain additional advances under the Equity Purchase Agreement and therefore had no additional funding available under the agreement. See Note 8, “Notes Payable,” for further information. On September 30, 2026, the Company received a notice from Nasdaq that it did not satisfy the minimum market value of listed securities requirement for continued listing on The Nasdaq Global Market, and the Company has until March 29, 2027 to regain compliance. The notice constituted a trigger event under PPP #1 and PPP #2. In addition, the share purchase price under the pre-paid purchases has been below the $2.00 floor price since late July 2026. If the purchase price remains below the floor price for six consecutive months, Streeterville may elect cash settlement of applicable purchase amounts. For additional information, see “Risk Factors — Our pre-paid purchase arrangements with Streeterville may result in substantial dilution and, if our stock price is below the $2.00 Floor Price for six consecutive months, could require cash payments that adversely affect our liquidity” and “Risk Factors — There can be no assurance that we will be able to regain compliance with the continued listing requirements of Nasdaq” in Part II, Item 1A of this Quarterly Report on Form 10-Q.

 

See Note 8, Notes Payable, to the unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for additional information regarding PPP #1, PPP #2, the Exchange Note and the Equity Purchase Agreement.

 

As of September 30, 2026, our current obligations include the Exchange Note issued to Streeterville Capital, LLC, with a principal amount of $1,894,856 maturing in July 2027, an EIDL loan with a carrying amount of approximately $24,000 maturing in August 2050, PPP #1 with Streeterville Capital, LLC, with an original principal balance of $8,640,000, accrued interest of $358,571, and no stated maturity date, a PPP #2 advance with Streeterville Capital, LLC, with an original principal balance of $3,471,923, accrued interest of $77,222, and no stated maturity date, current operating lease obligations totaling approximately $219,000, and outstanding gift card liabilities of approximately $439,000.

 

We anticipate incurring additional losses for the foreseeable future, and we may never become profitable.

 

As of the date of this filing, the Company expects to require additional financing to fund its planned operations over the next 12 months. The Company’s recurring operating losses, limited liquidity and anticipated financing requirements raise substantial doubt about its ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued. Although the Company continues to pursue additional financing and other measures to support its operations, these plans do not alleviate substantial doubt. The timing and amount of additional financing required will depend on a number of factors, including the Company’s operating performance, cash expenditures and the timing and amount of any additional financing activities.

 

Our operating plan is predicated on a variety of assumptions including, but not limited to, the level of product demand, cost estimates, our ability to continue to raise additional financing and the state of the general economic environment in which we operate. There can be no assurance that these assumptions will prove accurate in all material respects, or that we will be able to successfully execute our operating plan. In the absence of additional appropriate financing, we may have to modify our plan or slow down the pace of development and commercialization.

 

The following table summarizes our cash flows from operating, investing, and financing activities for the six months ended September 30, 2026 and September 30, 2025:

 

    (Unaudited)
Six Months
Ended
September 30,
2026
    (Unaudited)
Six Months
Ended
September 30,
2025
 
Net cash used in operating activities   $ (6,857,206 )   $ (3,636,689 )
Net cash used in investing activities   $ (23,263 )   $ (22,580 )
Net cash provided by financing activities   $ 2,372,308     $ 3,745,928  

 

Net cash used in operating activities increased by approximately $3.2 million during the six months ended September 30, 2026 compared to the prior-year period, primarily reflecting the increase in net loss, substantially offset by non-cash expenses, including amortization of debt discounts and debt issuance costs, stock-based compensation, and warrant modification expenses, net of non-cash fair value gains. Net cash provided by financing activities decreased by approximately $1.4 million, as financing proceeds in 2026 were primarily generated through warrant exercises, compared to proceeds from preferred stock and convertible note issuances in 2025, while cash used in investing activities remained relatively consistent. 

 

49

 

 

Tariffs

 

Our products are currently manufactured primarily in China and imported into the United States. U.S. import tariff rates have fluctuated significantly in recent years and have the potential to materially impact our financial results by reducing our profit margins or requiring us to raise consumer selling prices, which could in turn depress demand. The significance of any such impact depends on the applicable tariff rates, their duration, and our ability to mitigate the associated costs. For additional information, see “Risk Factors — Unfavorable global economic and political conditions, including tariffs and trade barriers, could adversely affect our business, financial condition or results of operations” of our Prospectus dated January 26, 2026.

 

On February 20, 2026, the U.S. Supreme Court ruled against tariffs imposed by the Trump administration under the International Emergency Economic Powers Act (IEEPA). Following this ruling, the administration imposed a new 10% global tariff under Section 122 of the Trade Act of 1974, effective February 24, 2026. Section 122 tariffs are limited by statute to 150 days without congressional extension and expired on July 24, 2026. In May 2026, the U.S. Court of International Trade found the Section 122 tariffs unlawful, although this ruling was stayed pending appeal and the tariffs remained in effect through their expiration. The Company paid IEEPA tariffs on its imports during the period in which such tariffs were in effect and has received refunds from claims submitted to U.S. Customs and Border Protection. The amounts involved are not material to the Company’s condensed consolidated financial statements.

 

Effective July 24, 2026, the administration imposed additional tariffs under Section 301 of the Trade Act of 1974. These tariffs currently apply to imports from approximately 60 countries at rates ranging from 10% to 12.5%.

 

While the near-term tariff environment remains difficult to predict, and the duration, scope, and legal validity of currently imposed tariffs remain uncertain, the Company believes it is well positioned to manage a range of potential outcomes.

 

As detailed in our Prospectus, we have mitigated the potential impact of high tariffs on China-made goods by developing Taiwan as an alternative manufacturing location. In February 2026, the United States and Taiwan signed the U.S.-Taiwan Agreement on Reciprocal Trade, which caps the U.S. reciprocal tariff rate on Taiwanese goods at no more than 15%. This agreement is subject to legislative approval in Taiwan. Following the expiration of the Section 122 tariffs on July 24, 2026, Section 301 tariffs of 10% to 12.5% currently apply to imports from Taiwan. Future actions or modifications through Section 301 and other tariff-related measures could result in additional or different tariff rates on Taiwanese goods. Accordingly, the ultimate tariff treatment of Taiwanese goods remains subject to significant legal and policy uncertainty.

 

In January 2023, we opened a wholly owned Taiwan subsidiary named Virtuix Manufacturing Taiwan Ltd. and began outsourcing some Omni One materials to Taiwanese factories. If import tariffs on goods from China were to increase or remain elevated for a sustained period, we can expand our Taiwan manufacturing program by assembling the entire Omni One product in Taiwan. There can be no assurance, however, that tariff mitigation strategies, including geographic diversification, will fully offset the impact of new or increased tariffs, or that the current tariff framework applicable to Taiwanese goods will remain in effect.

 

Emerging Growth Company

 

We are an “emerging growth company,” as defined in the JumpStart Our Business Startups Act of 2012 (“JOBS Act”). The status of “emerging growth company” enables us to invest more in research & development and customer acquisition rather than compliance overhead. As an emerging growth company, we are eligible to take advantage of certain exemptions from various reporting and disclosure requirements that are applicable to public companies that are not emerging growth companies, and we have elected to take advantage of those exemptions. For so long as we remain an emerging growth company, we will not be required to:

 

● have an auditor attestation report on our internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act of 2002 (the “Sarbanes-Oxley Act”);

 

● submit certain executive compensation matters to shareholder advisory votes pursuant to the “say on frequency” and “say on pay” provisions (requiring a non-binding shareholder vote to approve compensation of certain executive officers) and the “say on golden parachute” provisions (requiring a non-binding shareholder vote to approve golden parachute arrangements for certain executive officers in connection with mergers and certain other business combinations) of the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010; or

 

● disclose certain executive compensation related items, such as the correlation between executive compensation and performance and comparisons of the chief executive officer’s compensation to median employee compensation.

 

50

 

 

In addition, the JOBS Act provides that an emerging growth company may take advantage of an extended transition period for complying with new or revised accounting standards that have different effective dates for public and private companies. This means that an emerging growth company can delay adopting certain accounting standards until such standards are otherwise applicable to private companies. We have elected to take advantage of the extended transition period. Since we will not be required to comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for other public companies, our financial statements may not be comparable to the financial statements of companies that comply with public company effective dates. If we were to subsequently elect to comply with these public company effective dates, such election would be irrevocable pursuant to Section 107 of the JOBS Act.

 

We will remain an emerging growth company for up to five years, or until the earliest of: (i) the last date of the fiscal year during which we had total annual gross revenues of $1.235 billion or more; (ii) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt; or (iii) the date on which we are deemed to be a “large accelerated filer” as defined under Rule 12b-2 under the Exchange Act.

 

We do not believe that being an emerging growth company will have a significant impact on our business. Also, even once we are no longer an emerging growth company, we still may not be subject to auditor attestation requirements of Section 404(b) of the Sarbanes-Oxley Act unless we meet the definition of an accelerated filer or a large accelerated filer.

 

Critical Accounting Policies and Estimates

 

The preparation of our condensed consolidated financial statements in accordance with GAAP requires management to apply accounting policies and make estimates, assumptions and judgments that affect the amounts reported in our financial statements and accompanying notes. We consider accounting policies and estimates to be critical when their application requires significant judgment or involves a significant level of estimation uncertainty and when changes in those judgments, assumptions or estimates have had, or are reasonably likely to have, a material effect on our financial condition or results of operations.

 

Management bases its estimates and judgments on historical experience, current conditions, contractual terms, available market information and other factors that management believes to be reasonable under the circumstances. Because estimates and judgments involve inherent uncertainty, actual results may differ from those estimates. The critical accounting policies and estimates discussed below should be read in conjunction with the significant accounting policies described in Note 2 to our condensed consolidated financial statements.

 

Except as described below, there have been no material changes to our critical accounting policies and estimates since March 31, 2026.

 

Revenue Recognition

 

We recognize revenue in accordance with ASC 606, Revenue from Contracts with Customers. The application of ASC 606 requires management to make judgments regarding the identification of performance obligations, the timing of the transfer of control of products and services to customers and, for arrangements containing multiple performance obligations, the allocation of the transaction price based on relative standalone selling prices.

 

Revenue from our hardware products is generally recognized upon shipment or installation, depending on when control transfers to the customer. Revenue associated with service and support arrangements, including Omni Care, Omni Online and extended warranties, is recognized over the applicable service period. Revenue from Omniverse credits is recognized over the estimated period in which the credits are expected to be consumed based on customer usage patterns. For arrangements containing multiple performance obligations, we use observable standalone selling prices when available to allocate consideration among the respective performance obligations. Changes in estimates or judgments regarding the timing of satisfaction of performance obligations, customer usage patterns or allocation of consideration could affect the timing and amount of revenue recognized. See Note 2 to our condensed consolidated financial statements for additional information regarding our revenue recognition policies.

 

51

 

 

Fair Value of Complex Financing Instruments

 

During the six months ended September 30, 2026, the Company corrected its analysis of certain financing arrangements, including its pre-paid purchase arrangements with Streeterville Capital, LLC and related debt and equity-linked features. As a result, certain embedded features are accounted for separately and measured at fair value, and certain financing instruments are measured in their entirety at fair value pursuant to the fair value option. The additional analysis also resulted in revisions to the accounting for certain previously reported amounts. Accordingly, the determination of fair value for these financing instruments and related features represents a critical accounting estimate for the current period. See Note 8 to the condensed consolidated financial statements for additional information regarding the Company’s financing arrangements. 

 

The Company estimates the fair value of these instruments and features using valuation techniques appropriate to the specific contractual terms and economic characteristics of each instrument. These techniques may include option-pricing methodologies, discounted cash flow analyses and probability-weighted scenario analyses. The valuations incorporate observable market information when available as well as significant assumptions for which directly observable market information may not be available.

 

Depending on the instrument or feature being valued, significant inputs and assumptions may include the market price of the Company’s Class A common stock, expected stock-price volatility, risk-free interest rates, expected term or settlement period, market yields or discount rates, and the probability and expected timing of conversion, prepayment, redemption, trigger events and other contractual settlement outcomes. The valuations also consider applicable contractual provisions, including floor prices, prepayment premiums, ownership limitations and other settlement provisions that may affect the amount or timing of expected cash or equity settlement.

 

Management develops these assumptions based on the facts and circumstances existing at each measurement date, including available market data, the contractual terms of the instruments, the Company’s historical experience, current liquidity and financing circumstances, and other contemporaneous information relevant to the probability and expected timing of potential settlement outcomes. Certain of these assumptions require significant judgment, particularly where a contractual outcome is dependent on future market conditions, financing activity or actions that may be taken by the Company or the counterparty.

 

The estimated fair values of these instruments and features may be sensitive to changes in the underlying assumptions. Changes in the Company’s stock price or expected volatility, market interest rates or discount rates, or the estimated probability or timing of conversion, prepayment or other contractual outcomes could result in materially different fair value measurements. As a result, changes in these estimates may materially affect the carrying amounts of the related financing instruments and derivative liabilities and the related gains, losses or other amounts recognized in the Company’s condensed consolidated financial statements.

 

Management reassesses the assumptions used in these valuations at each required measurement date. Because the ultimate timing and manner of settlement may differ from the assumptions used in the valuation models, actual results may differ materially from the amounts estimated, and the fair value of these instruments and features may fluctuate significantly from period to period. Certain of these fair value measurements utilize significant unobservable inputs and, accordingly, are classified within Level 3 of the fair value hierarchy.

 

Quantitative and Qualitative Disclosures About Market Risk

 

We have not utilized any derivative financial instruments for hedging purposes such as futures contracts, options and swaps, forward foreign exchange contracts or interest rate swaps and futures. We believe that adequate controls are in place to monitor any hedging activities, if they were to occur in the future. We do not intend to hedge any existing or future borrowings and, consequently, we do not expect to be affected by changes in market interest rates. We do currently have sales and own assets and operate facilities in countries outside the United States and, consequently, we may be affected by foreign currency fluctuations or exchange rate changes.

 

52

 

 

Recent Accounting Pronouncements

 

On December 14, 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740) — Improvements to Income Tax Disclosures, which enhances transparency regarding income tax disclosures, primarily through additional information regarding the income tax rate reconciliation and income taxes paid by jurisdiction. The Company adopted ASU 2023-09 effective April 1, 2026. The amendments are applied prospectively, with retrospective application permitted. Because the amendments relate solely to disclosures, adoption did not have a material impact on the Company’s consolidated financial position, results of operations or cash flows. The Company is currently evaluating the impact of the ASU on its annual income tax disclosures, which will first be reflected in the Company’s financial statements for the fiscal year ending March 31, 2027.

 

In November 2024, the FASB issued ASU 2024-03, Income Statement — Reporting Comprehensive Income (Subtopic 220-40): Expense Disaggregation Disclosures. The ASU requires public business entities to disclose in a tabular format significant expense categories that are included in each relevant income statement line item. As clarified by ASU 2025-01, the standard is effective for fiscal years beginning after December 15, 2026, and interim periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact that this standard will have on its consolidated financial statements and related disclosures.

 

Management has reviewed other recently issued but not yet effective accounting standards and believes they will not have a material impact on the Company’s consolidated financial statements. The Company will adopt applicable standards as required.

 

Off-Balance Sheet Arrangements

 

We have not entered into any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources and would be considered material to investors.

 

Internal Control Over Financial Reporting

 

Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles in the United States, or GAAP. Under standards established by the Public Company Accounting Oversight Board, or PCAOB, a deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or personnel, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. The PCAOB defines a material weakness as a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis.

 

During the preparation of the Company’s condensed consolidated financial statements for the three months ended June 30, 2026, management identified a material weakness in the Company’s internal control over financial reporting related to the accounting for complex financing transactions. This material weakness existed as of March 31, 2026 and continued to exist as of September 30, 2026. The material weakness is separate from the material weaknesses previously disclosed by the Company, which management concluded had been remediated as of March 31, 2026.

 

Specifically, the Company did not maintain effective controls designed to identify, evaluate, and document the application of GAAP to debt and other financing arrangements containing potentially complex terms and embedded features. As a result, management did not perform a timely technical accounting assessment of certain debt instruments to determine whether embedded features required bifurcation and separate accounting as derivative liabilities. This control deficiency resulted in errors in the Company’s accounting for certain financing arrangements and required adjustments and revision to prior period financial information to record embedded derivative liabilities and related accounting impacts.

 

Although management concluded that the identified control deficiency constituted a material weakness because there was a reasonable possibility that it could result in a material misstatement that would not be prevented or detected on a timely basis, management separately evaluated the actual errors resulting from the deficiency and concluded that those errors, individually and in the aggregate, were not material to the Company’s previously issued financial statements.

 

53

 

 

Management began implementing remediation measures during the quarter ended September 30, 2026, including enhancing its procedures used to identify financing transactions requiring technical accounting analysis, implementing formal and documented reviews of significant contractual terms and embedded features, strengthening review and approval by personnel with appropriate technical accounting expertise, and utilizing third-party technical accounting and valuation specialists when appropriate. These measures are intended to support timely and appropriately documented accounting conclusions for complex and non-routine financing transactions and the related financial statement disclosures.

 

Management believes that the control enhancements described above address the identified deficiencies in control design. As of September 30, 2026, the enhanced controls had not operated for a sufficient period to support a conclusion that they were operating effectively. Accordingly, management has not concluded that the material weakness has been remediated as of that date. Management, under the oversight of the Audit Committee, will continue to evaluate the controls, perform testing of their operating effectiveness and make further refinements as necessary. See Part I, Item 4, “Controls and Procedures,” for additional information regarding the Company’s disclosure controls and procedures.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk.

 

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this Item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

Disclosure controls and procedures are controls and other procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act is accumulated and communicated to management, including our Chief Executive Officer and Chief Financial Officer, to allow timely decisions regarding required disclosure.

 

Under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2026. Based on this evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were not effective as of September 30, 2026 due to the material weakness in internal control over financial reporting described below.

 

Material Weakness and Remediation

 

During the preparation of our condensed consolidated financial statements for the three months ended June 30, 2026, management identified a material weakness in internal control over financial reporting related to the accounting for complex financing transactions. Specifically, the Company did not maintain controls designed at a sufficient level of precision to timely identify, evaluate and document the application of GAAP to debt and other financing arrangements containing complex contractual terms and embedded features. This material weakness existed as of March 31, 2026 and continued to exist as of September 30, 2026. As of the date of this Quarterly Report, management has made substantial progress in implementing measures, including enhancements to the procedures for identifying financing transactions requiring technical accounting analysis, documenting and reviewing significant contractual terms and embedded features, and obtaining review and approval by personnel with appropriate technical accounting expertise, with assistance from third-party specialists when appropriate. Management believes these enhancements will address the identified deficiencies in control design. However, the enhanced controls have not yet operated for a sufficient period of time, and management has not yet obtained sufficient evidence of their operating effectiveness, to conclude that the material weakness has been remediated. See “Internal Control Over Financial Reporting” in Part I, Item 2 of this Quarterly Report for a description of the material weakness and management’s remediation efforts.

 

Changes in Internal Control over Financial Reporting

 

The material weakness described above reflected a deficiency in controls that existed as of March 31, 2026 and continued through September 30, 2026. During the quarter ended September 30, 2026, management has been implementing the remediation measures described under “Internal Control Over Financial Reporting” in Part I, Item 2 of this Quarterly Report. These measures had not operated for a sufficient period of time to demonstrate their effectiveness as of September 30, 2026, and the material weakness remained unremediated by that definition. Other than the remediation measures described above, there were no changes in the Company’s internal control over financial reporting during the quarter ended September 30, 2026 that materially affected, or were reasonably likely to materially affect, its internal control over financial reporting.

 

54

 

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

In February 2024, the Company was named a co-defendant and served a citation by a customer related to alleged injuries obtained when attempting to use the Omni Arena attraction at an entertainment venue. The Company’s attorneys, retained by the Company’s insurance provider, filed a general denial and alleged contributory negligence against the plaintiff. During the three months ended June 30, 2026, the parties signed a final settlement agreement and release, resolving the matter. All legal costs and settlement fees are covered by the Company’s insurance provider.

 

From time to time, we may be party to litigation arising in the ordinary course of business. As of September 30, 2026, we are not subject to any material legal proceedings nor, to the best of our knowledge, are any material legal proceedings pending or threatened against us.

 

Item 1A. Risk Factors.

 

As a smaller reporting company under Rule 12b-2 of the Exchange Act, we are not required to include risk factors in this Report. For additional risks relating to our operations carefully consider the factors discussed in “Risk Factors” of our Prospectus dated January 26, 2026, which could materially affect our business, financial condition or future results. Other than as set forth below, we have identified no material changes from the risk factors previously disclosed in the Prospectus, as updated by Part II, Item 1A of our Quarterly Report on Form 10-Q for the quarter ended June 30, 2026.

 

We have identified a material weakness in our internal control over financial reporting related to the accounting for complex financing transactions, and our failure to remediate this material weakness or otherwise maintain effective internal controls could adversely affect our financial reporting and investor confidence.

 

During the preparation of our condensed consolidated financial statements for the three months ended June 30, 2026, management identified a material weakness in our internal control over financial reporting related to the accounting for complex financing transactions. Specifically, the Company did not maintain effective controls designed to identify, evaluate, and document the application of GAAP to debt and other financing arrangements containing potentially complex terms and embedded features. As a result, management did not perform a timely technical accounting assessment of certain debt instruments to determine whether embedded features required bifurcation and separate accounting as derivative liabilities. This control deficiency resulted in errors in the Company’s accounting for certain financing arrangements and required adjustments and revision to prior period financial information to record embedded derivative liabilities and related accounting impacts.

 

This material weakness existed as of March 31, 2026 and continued to exist as of September 30, 2026. The material weakness resulted in errors in the accounting for certain financing arrangements during fiscal year 2026, which required revisions to previously reported financial information, as well as errors during the three months ended June 30, 2026 that were corrected prior to filing.

 

We have begun implementing remediation measures designed to strengthen our controls over complex and non-routine financing transactions, including enhanced procedures for identifying transactions requiring technical accounting analysis, documented review of significant contractual terms and embedded features, and the use of qualified technical accounting and valuation resources, including third-party specialists when appropriate. However, we cannot provide assurance that these measures will successfully remediate the material weakness or that additional material weaknesses or significant deficiencies will not be identified in the future. Management, under the oversight of the Audit Committee, is monitoring the implementation and effectiveness of these remediation measures.

 

Until this material weakness is remediated, there is a reasonable possibility that a material misstatement of our annual or interim financial statements may not be prevented or detected on a timely basis. If we are unable to remediate this material weakness or otherwise maintain effective internal control over financial reporting and disclosure controls and procedures, we could experience additional errors in our financial reporting, be required to revise or restate our financial statements, experience delays in meeting our reporting obligations, incur additional costs associated with remediation and compliance efforts, and experience reduced investor confidence in our financial reporting, any of which could adversely affect the market price of our Class A common stock.

 

Our pre-paid purchase arrangements with Streeterville may result in substantial dilution and, if our stock price is below the $2.00 Floor Price for six consecutive months, could require cash payments that adversely affect our liquidity.

 

As previously disclosed, we entered into an Equity Purchase Agreement with Streeterville Capital, LLC (“Streeterville”) under which Streeterville committed to purchase up to $50,000,000 of our Class A common stock through one or more pre-paid advances. On May 22, 2026, we entered into a second pre-paid purchase with Streeterville in exchange for our outstanding secured convertible promissory notes held by Streeterville. Under the pre-paid purchases, if specified trigger events occur, the share purchase price may be based on a market-price formula tied to 90% of the lowest volume-weighted average price of our Class A common stock during the applicable ten-trading-day measurement period. Because our Class A common stock has recently traded below $2.00 per share, issuances under this formula could require us to issue a substantially greater number of shares to satisfy a given portion of the outstanding pre-paid purchase balance, which could result in substantial dilution to existing stockholders and place downward pressure on the market price of our Class A common stock.

 

The pre-paid purchases also define a $2.00 floor price (the “Floor Price”). The Floor Price does not operate as a fixed minimum price at which shares may be issued in all circumstances. However, if the applicable share purchase price remains below the Floor Price for at least six consecutive months, Streeterville may elect to have the applicable purchase amount paid in cash rather than shares of Class A common stock. Trigger events under the pre-paid purchases have occurred, including our receipt of the Nasdaq deficiency notice on September 30, 2026. In addition, the applicable share purchase price under the pre-paid purchases has been below the Floor Price since late July 2026, such that the six-month condition could be satisfied as early as late January 2027. Any such cash payment requirement, or any default arising from our inability to deliver shares or comply with the pre-paid purchase documents, could materially and adversely affect our liquidity, financial condition and ability to continue executing our business strategy.

 

55

 

 

There can be no assurance that we will be able to regain compliance with the continued listing requirements of Nasdaq.

 

On September 30, 2026, we received a letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”). The Notice stated that, based on our market value of listed securities (“MVLS”) for the 30 consecutive business days from August 18, 2026 to September 29, 2026, we no longer meet the $50,000,000 minimum MVLS requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Requirement”). The Notice also stated that we do not meet the alternative total assets and total revenue standard under Nasdaq Listing Rule 5450(b)(3)(A). Under Nasdaq Listing Rule 5810(c)(3)(C), we have until March 29, 2027 (the “Compliance Date”) to regain compliance, which requires our MVLS to close at $50,000,000 or more for at least ten consecutive business days. If we do not regain compliance by the Compliance Date, we expect to receive written notice that our Class A common stock is subject to delisting. We may then appeal to a Nasdaq Hearings Panel or, alternatively, apply to transfer to The Nasdaq Capital Market, although any transfer depends upon satisfying Nasdaq’s applicable requirements and receiving approval. Accordingly, there can be no assurance that we will regain compliance by the Compliance Date, that any appeal or transfer application would succeed, or that we will otherwise maintain compliance with Nasdaq’s continued listing requirements.

 

In addition, under our Equity Purchase Agreement with Streeterville, we have agreed to maintain the listing of our Class A common stock on our principal market, and full compliance with Nasdaq’s continued listing requirements and a market capitalization of at least $95,000,000 are conditions to our ability to request additional pre-paid purchases. As a result, we do not currently expect to be able to obtain additional pre-paid purchases while we remain out of compliance. A delisting of our Class A common stock could also constitute an event of default under PPP #1 and PPP #2, which could permit Streeterville to accelerate the outstanding balances and require repayment in cash, together with a 7.5% increase in the outstanding balance and default interest of up to 15% per annum.

 

If Nasdaq delists our Class A common stock and we are not able to list it on another national securities exchange, our Class A common stock could be quoted on an over-the-counter market. If this were to occur, we and our stockholders could face material adverse consequences, including:

 

● a limited availability of market quotations for our Class A common stock;
     
  ● reduced liquidity for our Class A common stock;
     
  ● a limited amount of news and analyst coverage; and
     
  ● a decreased ability to obtain additional financing in the future.

 

Our proposed acquisition of STS International, Inc. may not be completed on the anticipated terms or timeline, or at all, and, if completed, could involve additional risks and uncertainties.

 

As previously disclosed in our Current Report on Form 8-K dated November 12, 2026, on November 11, 2026, we entered into a non-binding letter of intent (the “LOI”) to acquire STS International, Inc. (“STS”), a defense technology and services company, for base consideration of $12.0 million, consisting of $8.0 million in cash and $4.0 million in our Class A common stock. The LOI is not binding as to the acquisition or its economic terms, and those terms may change.

 

Completion is subject to, among other customary closing conditions, satisfactory due diligence by both parties, an audit of STS’s financial statements, together with the receipt of an unqualified opinion thereon, our obtaining financing for the cash consideration, required approvals and consents, a fairness opinion satisfactory to the Board of Directors, the absence of a material adverse change and the negotiation and execution of definitive agreements.

 

We have no committed financing for the cash consideration, and there is substantial doubt about our ability to continue as a going concern. We may be unable to raise the required cash on acceptable terms, or at all, before closing.

 

Negotiating definitive agreements, completing the audit and due diligence and obtaining financing may take longer than anticipated, and the results of the audit or due diligence could cause the terms to change or the transaction to be abandoned. In particular, the financial information STS has provided to us is unaudited prepared on a cash basis and may change materially following an audit or conversion to U.S. generally accepted accounting principles (“GAAP”), and STS’s reported revenues and profitability may not be sustainable. There can be no assurance that the acquisition will be completed on the anticipated terms, within the anticipated timeframe or at all. If it is not completed, we will have incurred transaction costs without realizing any benefit, and the market price of our Class A common stock could decline.

 

If completed, the acquisition would result in dilution to our existing stockholders through the issuance of shares as base consideration and, potentially, additional shares under the price-protection and earnout terms contemplated by the LOI. Any financing we obtain for the cash consideration may also require us to incur additional indebtedness and financing obligations or issue additional equity, which could further dilute our stockholders and adversely affect our liquidity, earnings and stockholders’ equity.

 

In addition, the acquisition would subject us to risks associated with STS’s business, including concentration of revenue in government contracts that may expire or be canceled or not renewed; uncertainties in defense spending and procurement; government contracting and regulatory compliance requirements; and cybersecurity and security-clearance requirements. We may experience difficulties integrating STS’s operations and may be unable to retain key STS personnel. If the acquired business does not perform as expected, we may be required to record impairment charges. Any of these risks could adversely affect our ability to maintain our listing on Nasdaq and the market price of our Class A common stock.

 

The foregoing is not an exhaustive description of the risks associated with the proposed acquisition, and other risks and uncertainties, including those not presently known to us or that we currently consider immaterial, could materially adversely affect our business, financial condition, results of operations and stockholders.

 

56

 

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

During the three months ended September 30, 2026, we issued an aggregate of 37,000 shares of Class A common stock to FMW Media Works LLC pursuant to marketing and media services agreements. Of these shares, 12,000 were issued under that certain agreement entered into in connection with a 12-month marketing and media services engagement, and 25,000 were issued under a separate consulting services agreement entered into on July 27, 2026 for a one-week media engagement. The consideration received by the Company consisted of marketing and media services. The shares were issued as restricted securities in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Regulation D promulgated thereunder, as a transaction not involving a public offering to an accredited investor.

 

On August 24, 2026, we issued 35,000 restricted shares of Class A common stock to Moonwood Overseas S.A. in connection with a consulting services agreement entered into with Euroswiss Capital Partners Inc. on August 19, 2026. The agreement provides for business development, financial consulting, and investor communications services in Europe over an initial six-month period. The shares were issued as restricted securities in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act of 1933, as amended (the “Securities Act”), and/or Regulation D promulgated thereunder, as a transaction not involving a public offering to an accredited investor.

 

Between July 1, 2026 and July 27, 2026, Streeterville Capital, LLC (“Streeterville”) exercised portions of the Equity Financing Warrant to purchase an aggregate of 455,500 shares of Class A common stock at a weighted-average exercise price of $2.59 per share, for aggregate proceeds to the Company of $1,181,250. The shares were issued upon exercise of warrants previously issued to Streeterville in connection with private financing transactions. Pursuant to our placement agent agreement with Maxim Partners LLC, we are obligated to pay a cash success fee equal to 7.0% of gross proceeds received, including warrant exercise proceeds, and to reimburse expenses. The issuance was made in reliance on the exemption from registration provided by Section 4(a)(2) of the Securities Act and/or Regulation D promulgated thereunder, as a transaction not involving a public offering.

 

During the three months ended September 30, 2026, Streeterville made partial redemptions in connection with the Exchange Agreement, pursuant to which new promissory notes in the principal amount of $568,477 were partitioned from the Exchange Note and exchanged for 372,507 shares of Class A common stock, reducing the outstanding balance of the Exchange Note by $527,808. The consideration received by the Company consisted of the corresponding reduction in indebtedness under the Exchange Note. The shares were issued free of any restrictive securities legend pursuant to Rule 144. The exchanges were made in reliance on the exemption from registration provided by Section 3(a)(9) of the Securities Act, as exchanges by the Company with an existing security holder.

 

We did not sell securities pursuant to a registration statement during the three months ended September 30, 2026 that would require disclosure of use of proceeds under Rule 463 under the Securities Act or Item 701(f) of Regulation S-K.

 

Item 3. Defaults Upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

Our Section 16 officers and directors, as defined in Rule 16a-1(f) of the Exchange Act, may from time to time enter into plans for the purchase or sale of our common stock that are intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) of the Exchange Act. During the quarter ended September 30, 2026, no Section 16 officers or directors, as defined in Rule 16a-1(f), adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement” (as defined in Item 408 of Regulation S-K of the Exchange Act).

 

Item 6. Exhibits.

 

Exhibit No.   Description
4.1   Amendment No. 5 to Equity Financing Warrant, dated July 21, 2026 (incorporated by reference to Exhibit 4.1 to the Current Report on Form 8-K filed July 21, 2026).
4.2   Amendment No. 5 to Second Debt Financing Warrant, dated July 21, 2026 (incorporated by reference to Exhibit 4.2 to the Current Report on Form 8-K filed July 21, 2026).
4.3   Amendment No. 5 to Third Debt Financing Warrant, dated July 21, 2026 (incorporated by reference to Exhibit 4.3 to the Current Report on Form 8-K filed July 21, 2026).
31.1   Certification of Principal Executive Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Certification of Principal Financial Officer Pursuant to Securities Exchange Act Rules 13a-14(a), as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   Inline XBRL Instance Document.
101.SCH   Inline XBRL Taxonomy Extension Schema Document.
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

57

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

Date: November 16, 2026 Virtuix Holdings Inc.
     
  By: /s/ Jan Goetgeluk
    Jan Goetgeluk
    Chief Executive Officer

 

  By: /s/ Thomas McGinnis
    Thomas McGinnis
    Chief Financial Officer

 

58

Keep reading